Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",A1BG,Alpha-1B-glycoprotein,16302,138,0.87 [0.34-2.23],0.77282618497281
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AAMDC,Mth938 domain-containing protein,15876,134,0.85 [0.62-1.19],0.3458644620578401
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AARSD1,Alanyl-tRNA editing protein Aarsd1,18490,159,1.03 [0.80-1.33],0.7937208000558215
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABCA2,ATP-binding cassette sub-family A member 2,15718,133,1.21 [0.76-1.92],0.4239704592711035
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABHD14B,Protein ABHD14B,18352,157,1.07 [0.82-1.39],0.6267595791790866
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABL1,Tyrosine-protein kinase ABL1,18490,159,1.21 [0.98-1.50],0.0752599068731534
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABO,Histo-blood group ABO system transferase,16290,140,0.96 [0.86-1.08],0.5065478865398129
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABRAXAS2,BRISC complex subunit Abraxas 2,15718,133,1.21 [0.94-1.57],0.1432054552576619
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",18156,158,1.44 [1.22-1.69],8.757125720327982e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",15972,137,1.10 [0.90-1.34],0.3455314050450127
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",16274,138,1.07 [0.89-1.28],0.4509500148900122
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACAN,Aggrecan core protein,18405,161,1.05 [0.62-1.76],0.8669337836505503
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE,Angiotensin-converting enzyme,16290,140,2.94 [1.77-4.90],3.223728625359416e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE2,Angiotensin-converting enzyme 2,18206,158,1.84 [1.49-2.28],1.3622534089130476e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACHE,Acetylcholinesterase,15945,138,1.81 [1.16-2.82],0.0092789187830722
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACOT13,Acyl-coenzyme A thioesterase 13,16196,139,1.19 [1.02-1.38],0.0250472795221027
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,18584,161,1.33 [1.05-1.69],0.0194914087494843
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP1,Low molecular weight phosphotyrosine protein phosphatase,15792,137,0.60 [0.39-0.91],0.0167284534967685
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP5,Tartrate-resistant acid phosphatase type 5,18679,162,1.69 [1.15-2.47],0.0074986539483142
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP6,Lysophosphatidic acid phosphatase type 6,18693,163,1.34 [1.06-1.70],0.0155303389978388
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACRBP,Acrosin-binding protein,16206,140,1.30 [0.88-1.91],0.1899695051761085
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACRV1,Acrosomal protein SP-10,15792,137,1.18 [1.04-1.33],0.0123345067166075
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACSL1,Long-chain-fatty-acid--CoA ligase 1,15718,133,1.29 [0.85-1.95],0.2278153716520238
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTA2,"Actin, aortic smooth muscle",18206,158,1.45 [1.12-1.88],0.0044809982404586
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTN2,Alpha-actinin-2,15718,133,1.22 [0.94-1.60],0.1351538243347551
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTN4,Alpha-actinin-4,18225,158,0.79 [0.47-1.34],0.3859868383821027
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,18368,157,3.07 [2.01-4.71],2.5468730255673784e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY1,Aminoacylase-1,18584,161,1.33 [1.07-1.64],0.0088285401472053
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,15718,133,1.44 [1.08-1.90],0.0115180884453109
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACYP1,Acylphosphatase-1,15885,138,1.00 [0.77-1.29],0.9762021741000828
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADA,Adenosine deaminase,18753,162,1.54 [1.06-2.22],0.0224315401891403
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADA2,Adenosine deaminase 2,18477,160,2.38 [1.78-3.18],4.179179098759858e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,15792,137,3.22 [2.24-4.61],2.2966343798355319e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,18206,158,1.78 [1.12-2.82],0.0149113924555391
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,18398,157,0.72 [0.48-1.07],0.1000364567677353
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,18753,162,0.91 [0.61-1.34],0.6220907340156869
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,18691,161,2.04 [1.33-3.11],0.0010492738672565
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,16196,139,2.58 [1.63-4.09],5.263592388730104e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,15792,137,2.11 [1.44-3.10],0.000124633404832
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,18801,163,0.30 [0.18-0.52],1.3791904943056971e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,18490,159,1.27 [0.92-1.76],0.1534683147018163
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,18206,158,1.38 [0.91-2.07],0.1286221842269424
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,15792,137,1.84 [1.17-2.88],0.0080573068914287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,18648,157,0.87 [0.63-1.21],0.4010223331579484
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,16282,139,4.06 [2.79-5.91],2.485654817422917e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL4,ADAMTS-like protein 4,15876,134,1.61 [0.80-3.25],0.1827484726626232
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL5,ADAMTS-like protein 5,16274,138,1.32 [0.88-1.97],0.1789160749285212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,18156,158,0.63 [0.35-1.13],0.1198892669500607
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADD1,Alpha-adducin,15945,138,0.93 [0.73-1.18],0.5242741510770176
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRB3,Adhesion G protein-coupled receptor B3,18368,157,1.31 [0.86-2.01],0.2141712502385394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRD1,Adhesion G-protein coupled receptor D1,15945,138,2.88 [2.04-4.08],2.3246344618850206e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE1,Adhesion G protein-coupled receptor E1,16196,139,1.60 [1.22-2.09],0.0005974648490294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE2,Adhesion G protein-coupled receptor E2,18660,162,1.74 [1.07-2.84],0.0264372214325111
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE5,Adhesion G protein-coupled receptor E5,18725,163,1.38 [0.89-2.13],0.1518548331210965
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRF5,Adhesion G protein-coupled receptor F5,16274,138,1.81 [1.01-3.23],0.0455770098854746
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRG1,Adhesion G-protein coupled receptor G1,18490,159,1.52 [1.34-1.74],3.0437801280042975e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRG2,Adhesion G-protein coupled receptor G2,18584,161,0.58 [0.37-0.92],0.0203870056791395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRV1,Adhesion G-protein coupled receptor V1,15723,135,1.13 [0.91-1.40],0.2790351663971634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADH1B,All-trans-retinol dehydrogenase,15945,138,1.08 [0.86-1.34],0.5155591883221684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,18206,158,1.08 [0.91-1.28],0.3781764197497056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADIPOQ,Adiponectin,16302,138,1.05 [0.85-1.30],0.6571472295655634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADM,Pro-adrenomedullin,18723,163,3.49 [2.06-5.90],3.251918762495444e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADRA2A,Alpha-2A adrenergic receptor,15718,133,1.17 [0.94-1.47],0.1647357569514679
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AFAP1,Actin filament-associated protein 1,15945,138,0.97 [0.78-1.19],0.7456604401052216
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AFM,Afamin,16302,138,0.66 [0.28-1.52],0.325347254413909
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AFP,Alpha-fetoprotein,18330,156,0.78 [0.62-0.98],0.0345391379442796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGBL2,Cytosolic carboxypeptidase 2,15723,135,0.84 [0.70-1.00],0.0501715852879817
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGER,Advanced glycosylation end product-specific receptor,18553,161,0.96 [0.69-1.32],0.7838894209992269
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGR2,Anterior gradient protein 2 homolog,18001,149,1.10 [0.95-1.27],0.2252720010638952
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGR3,Anterior gradient protein 3,18117,157,0.96 [0.74-1.23],0.7428128579764968
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRN,Agrin,18660,162,2.34 [1.72-3.19],6.54038431115597e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRP,Agouti-related protein,18753,162,1.17 [0.89-1.53],0.2518694331132551
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGT,Angiotensinogen,16290,140,0.98 [0.50-1.91],0.942891538500396
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGXT,Serine--pyruvate aminotransferase,18584,161,1.27 [1.07-1.52],0.0067202094626569
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHCY,Adenosylhomocysteinase,18584,161,1.19 [0.97-1.47],0.0971035561159546
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHNAK,Neuroblast differentiation-associated protein AHNAK,15876,134,0.91 [0.52-1.58],0.7285413270338477
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHNAK2,Protein AHNAK2,15876,134,1.54 [0.95-2.48],0.077853857899583
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,16206,140,1.13 [0.90-1.42],0.2878941532122769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHSG,Alpha-2-HS-glycoprotein,16290,140,0.83 [0.46-1.50],0.5353130303724775
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHSP,Alpha-hemoglobin-stabilizing protein,18550,160,1.06 [0.90-1.25],0.5004900474953311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIDA,"Axin interactor, dorsalization-associated protein",15834,134,0.97 [0.77-1.22],0.7877408595228764
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIF1,Allograft inflammatory factor 1,18156,158,1.47 [1.12-1.94],0.0057618755032044
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIF1L,Allograft inflammatory factor 1-like,15876,134,0.98 [0.71-1.36],0.9010104243798708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",18466,159,1.30 [1.14-1.48],8.708896878525599e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AK1,Adenylate kinase isoenzyme 1,18584,161,1.06 [0.85-1.33],0.5796291120626507
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AK2,"Adenylate kinase 2, mitochondrial",16250,141,1.14 [0.97-1.34],0.1257343206984896
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKAP12,A-kinase anchor protein 12,15945,138,1.08 [0.47-2.51],0.8556773253450606
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR1B1,Aldo-keto reductase family 1 member B1,18156,158,1.05 [0.86-1.28],0.642462433376499
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR1B10,Aldo-keto reductase family 1 member B10,15834,134,1.24 [0.97-1.59],0.0907032028798843
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR1C4,Aldo-keto reductase family 1 member C4,18206,158,1.07 [0.83-1.38],0.6090089229584936
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR7L,Aflatoxin B1 aldehyde reductase member 4,15792,137,1.21 [0.96-1.52],0.1113913054925922
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKT1S1,Proline-rich AKT1 substrate 1,18150,155,1.15 [0.92-1.44],0.2213029099921303
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKT2,RAC-beta serine/threonine-protein kinase,16246,139,1.00 [0.87-1.14],0.9640389729881056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKT3,RAC-gamma serine/threonine-protein kinase,18080,158,1.04 [0.80-1.36],0.7530840688765738
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALCAM,CD166 antigen,18801,163,1.04 [0.54-1.99],0.9136491021985133
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH1A1,Retinal dehydrogenase 1,18585,160,1.10 [0.85-1.42],0.4731960854343153
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH2,"Aldehyde dehydrogenase, mitochondrial",16206,140,1.08 [0.82-1.44],0.5772076039468579
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",18495,160,1.31 [1.11-1.54],0.0013880937814737
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",16246,139,1.75 [1.29-2.37],0.0002866669425503
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALMS1,Alstrom syndrome protein 1,15972,137,1.02 [0.71-1.46],0.912295608705038
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALPI,Intestinal-type alkaline phosphatase,15792,137,0.93 [0.80-1.07],0.3079367485847361
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALPP,"Alkaline phosphatase, placental type",18490,159,1.14 [1.01-1.28],0.0304336933817757
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMBN,Ameloblastin,18225,158,0.80 [0.44-1.45],0.4635282790807531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMBP,Protein AMBP,18690,162,2.68 [1.41-5.11],0.0026823810746778
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,16282,139,1.62 [0.83-3.19],0.1587544965091306
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMFR,E3 ubiquitin-protein ligase AMFR,18150,155,1.17 [0.94-1.47],0.1532725402612846
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMIGO1,Amphoterin-induced protein 1,15834,134,1.16 [0.85-1.59],0.3501138328265627
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMIGO2,Amphoterin-induced protein 2,18490,159,1.78 [0.98-3.23],0.0579974771480812
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMN,Protein amnionless,18225,158,0.89 [0.66-1.21],0.4679819288399768
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMOT,Angiomotin,15945,138,0.70 [0.46-1.06],0.0914297680818611
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMOTL2,Angiomotin-like protein 2,16135,140,0.99 [0.69-1.43],0.9727491440588366
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMPD3,AMP deaminase 3,16250,141,0.82 [0.65-1.03],0.0808301891488458
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,15252,127,1.07 [0.77-1.49],0.6801005843512209
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY2A,Pancreatic alpha-amylase,17820,157,0.80 [0.59-1.07],0.1281867028437274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY2B,Alpha-amylase 2B,17302,151,0.78 [0.58-1.05],0.1044585325326563
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANG,Angiogenin,18548,161,2.31 [1.61-3.29],4.426556494851446e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT1,Angiopoietin-1,18501,160,1.06 [0.89-1.26],0.5060720496151583
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT2,Angiopoietin-2,18723,163,2.99 [2.20-4.07],3.3861203927956805e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL1,Angiopoietin-related protein 1,18332,156,2.07 [1.25-3.42],0.0046721921485113
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL2,Angiopoietin-related protein 2,18601,162,1.39 [0.98-1.96],0.0652890332533843
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL3,Angiopoietin-related protein 3,18604,161,1.08 [0.75-1.55],0.6755273113916413
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL4,Angiopoietin-related protein 4,18629,162,2.12 [1.56-2.88],1.6597533287771602e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL7,Angiopoietin-related protein 7,18723,163,1.53 [1.06-2.20],0.0221575203201805
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANK2,Ankyrin-2,15718,133,1.00 [0.79-1.28],0.9697083428429898
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,15792,137,1.04 [0.84-1.29],0.7301722022507743
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANKRA2,Ankyrin repeat family A protein 2,15698,138,1.15 [0.86-1.53],0.3386746401897076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANKRD54,Ankyrin repeat domain-containing protein 54,18156,158,1.13 [0.89-1.43],0.3145492796094217
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,15876,134,0.81 [0.50-1.32],0.402140176555592
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANPEP,Aminopeptidase N,18643,161,1.48 [0.90-2.42],0.122889097847921
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA1,Annexin A1,15862,138,0.79 [0.51-1.21],0.2721835730996093
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA10,Annexin A10,18150,155,1.16 [0.99-1.36],0.0653842901594467
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA11,Annexin A11,18512,159,1.07 [0.86-1.35],0.5426836634387266
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA2,Annexin A2,15617,134,1.38 [1.13-1.67],0.0012787110824124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA3,Annexin A3,18691,161,1.09 [0.88-1.34],0.4311091037391125
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA4,Annexin A4,18505,159,1.11 [0.91-1.36],0.3012848622879561
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA5,Annexin A5,18095,152,1.49 [0.94-2.35],0.0885621152578666
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AOC1,Amiloride-sensitive amine oxidase [copper-containing],18225,158,1.14 [0.91-1.42],0.2677289347770694
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AOC3,Membrane primary amine oxidase,18671,161,1.88 [1.19-2.97],0.0071283232757736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP1G2,AP-1 complex subunit gamma-like 2,16206,140,1.09 [0.89-1.34],0.4152894898176911
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP2B1,AP-2 complex subunit beta,15834,134,1.13 [0.79-1.60],0.5059328818992797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP3B1,AP-3 complex subunit beta-1,16196,139,1.17 [0.94-1.46],0.1697559238269553
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP3S2,AP-3 complex subunit sigma-2,16250,141,1.12 [0.79-1.58],0.5175411280000353
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,18490,159,1.39 [1.04-1.88],0.028669700810559
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APCS,Serum amyloid P-component,16141,136,0.80 [0.50-1.27],0.3382456204802814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,18658,163,1.04 [0.81-1.33],0.7684048351984487
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APLP1,Amyloid-like protein 1,18584,161,0.52 [0.39-0.69],5.354796325781978e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOA1,Apolipoprotein A-I,16302,138,0.48 [0.25-0.93],0.0287455155444322
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOA2,Apolipoprotein A-II,16290,140,1.09 [0.79-1.51],0.5987154443133677
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOA4,Apolipoprotein A-IV,16302,138,0.75 [0.45-1.25],0.2701390901586944
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOB,Apolipoprotein B-100,16290,140,1.02 [0.48-2.17],0.9489524683637786
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOBR,Apolipoprotein B receptor,15876,134,1.39 [0.92-2.10],0.1169230951442582
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOC1,Apolipoprotein C-I,16272,137,0.34 [0.22-0.53],9.064205772053876e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOD,Apolipoprotein D,15580,130,1.02 [0.65-1.60],0.9345137097072728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOE,Apolipoprotein E,16302,138,0.73 [0.53-1.02],0.0646854738069661
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOF,Apolipoprotein F,16290,140,0.47 [0.30-0.71],0.0004151389599288
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOH,Beta-2-glycoprotein 1,18585,160,0.92 [0.63-1.36],0.6872005736721747
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOL1,Apolipoprotein L1,16290,140,0.74 [0.54-1.01],0.0554443991542241
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOM,Apolipoprotein M,18634,161,0.48 [0.30-0.77],0.0021911110552563
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APP,Amyloid-beta precursor protein,18568,160,1.22 [0.99-1.51],0.0630174148584573
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APPL2,DCC-interacting protein 13-beta,15945,138,1.04 [0.89-1.21],0.6540341077851044
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APRT,Adenine phosphoribosyltransferase,18361,157,1.13 [0.83-1.54],0.4439397138990175
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARAF,Serine/threonine-protein kinase A-Raf,15972,137,1.05 [0.81-1.35],0.726133504541318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AREG,Amphiregulin,18490,159,2.72 [2.13-3.48],8.907941857783628e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARF6,ADP-ribosylation factor 6,16196,139,0.96 [0.82-1.12],0.5945226885222542
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARFIP1,Arfaptin-1,16246,139,1.08 [0.85-1.38],0.5268599225591886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARG1,Arginase-1,18441,158,0.69 [0.52-0.91],0.0081964673850901
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARG2,"Arginase-2, mitochondrial",16206,140,1.00 [0.68-1.48],0.9807817707322743
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP1,Rho GTPase-activating protein 1,18156,158,1.16 [0.84-1.61],0.3629674694703156
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP25,Rho GTPase-activating protein 25,18156,158,1.11 [0.87-1.41],0.4142388090352653
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP30,Rho GTPase-activating protein 30,15972,137,0.96 [0.61-1.53],0.8764842681600734
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP45,Rho GTPase-activating protein 45,15945,138,1.08 [0.88-1.33],0.4686738517996237
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP5,Rho GTPase-activating protein 5,15698,138,1.11 [0.91-1.35],0.3185934302200663
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF1,Rho guanine nucleotide exchange factor 1,16250,141,1.12 [0.92-1.35],0.2561597749172184
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF10,Rho guanine nucleotide exchange factor 10,16246,139,1.16 [0.98-1.39],0.085611264985166
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF12,Rho guanine nucleotide exchange factor 12,18533,160,1.03 [0.89-1.19],0.6765495713277803
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF5,Rho guanine nucleotide exchange factor 5,15723,135,1.26 [1.01-1.57],0.0371398921311735
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARID3A,AT-rich interactive domain-containing protein 3A,15723,135,0.98 [0.63-1.53],0.9203793307400726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARID4B,AT-rich interactive domain-containing protein 4B,18150,155,1.12 [0.82-1.53],0.4906127984458911
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARL13B,ADP-ribosylation factor-like protein 13B,15718,133,1.29 [1.03-1.61],0.0282582209639459
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,15718,133,1.06 [0.69-1.64],0.7854969248437886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARMCX2,Armadillo repeat-containing X-linked protein 2,15723,135,0.94 [0.70-1.26],0.671541328988759
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARNT,Aryl hydrocarbon receptor nuclear translocator,18225,158,0.67 [0.42-1.08],0.1002662534082118
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,15718,133,1.17 [0.88-1.55],0.282005527865567
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARSA,Arylsulfatase A,18585,160,1.31 [0.97-1.78],0.0799340469003051
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARSB,Arylsulfatase B,18490,159,1.29 [1.01-1.66],0.0432752809568512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ART3,Ecto-ADP-ribosyltransferase 3,18671,161,1.44 [1.01-2.05],0.0430557336057583
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ART5,Ecto-ADP-ribosyltransferase 5,15723,135,0.97 [0.72-1.30],0.8308298847054741
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARTN,Artemin,18225,158,1.09 [0.82-1.43],0.5644900273338369
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASAH1,Acid ceramidase,16100,139,1.64 [1.23-2.18],0.0007053926982345
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASAH2,Neutral ceramidase,18398,157,0.63 [0.52-0.77],8.38659346889867e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,18398,157,2.54 [1.68-3.84],1.0040056241237044e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,16290,140,1.84 [1.04-3.28],0.0372558082290162
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASPN,Asporin,16274,138,1.55 [0.94-2.54],0.0832781687346717
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASPSCR1,Tether containing UBX domain for GLUT4,16246,139,1.08 [0.84-1.38],0.5652290163065625
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASRGL1,Isoaspartyl peptidase/L-asparaginase,15876,134,1.03 [0.87-1.22],0.7706638016808844
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASS1,Argininosuccinate synthase,15718,133,0.95 [0.77-1.18],0.6318302010530115
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATF2,Cyclic AMP-dependent transcription factor ATF-2,18150,155,0.98 [0.79-1.21],0.8421529097963304
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATF4,Cyclic AMP-dependent transcription factor ATF-4,15698,138,1.50 [0.97-2.33],0.0713258668879926
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATG16L1,Autophagy-related protein 16-1,16196,139,1.06 [0.87-1.29],0.5856109661349069
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATG4A,Cysteine protease ATG4A,18156,158,1.10 [0.86-1.39],0.4576197071575832
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATOX1,Copper transport protein ATOX1,18648,157,1.23 [1.00-1.53],0.053806043279762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,15718,133,1.39 [1.07-1.80],0.0144095035317065
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,15718,133,1.65 [1.03-2.65],0.0375058632134216
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,15718,133,1.06 [0.70-1.60],0.7912485921888193
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B4,Protein ATP1B4,15698,138,1.33 [0.92-1.91],0.1276990379011301
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP2B4,Plasma membrane calcium-transporting ATPase 4,15718,133,1.12 [0.84-1.48],0.4462428826141844
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP5F1D,"ATP synthase subunit delta, mitochondrial",15718,133,0.92 [0.66-1.29],0.6437292383415631
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP5IF1,"ATPase inhibitor, mitochondrial",18660,162,1.08 [0.95-1.23],0.2399266332467313
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP5PO,"ATP synthase subunit O, mitochondrial",18150,155,0.93 [0.64-1.36],0.7184312318411685
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6AP2,Renin receptor,18156,158,1.37 [1.00-1.89],0.0482628421587823
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1D,V-type proton ATPase subunit D,18490,159,0.86 [0.52-1.43],0.567652028594215
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1F,V-type proton ATPase subunit F,18121,155,1.24 [1.00-1.54],0.0466784650042699
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1G1,V-type proton ATPase subunit G 1,15876,134,1.17 [0.92-1.48],0.1951229190235128
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1G2,V-type proton ATPase subunit G 2,15718,133,0.99 [0.82-1.20],0.9332339468280902
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATRAID,All-trans retinoic acid-induced differentiation factor,16196,139,1.99 [1.36-2.89],0.0003421384781404
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATRN,"Attractin, Isoform 2",16302,138,0.28 [0.10-0.75],0.0115221660766881
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATXN10,Ataxin-10,18150,155,1.08 [0.87-1.33],0.500714031572046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATXN2,Ataxin-2,15723,135,1.05 [0.91-1.22],0.5158334854590951
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATXN2L,Ataxin-2-like protein,16246,139,1.21 [0.86-1.71],0.2679744039464996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATXN3,Ataxin-3,16250,141,0.94 [0.72-1.24],0.6703423265005075
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AXIN1,Axin-1,18533,160,1.08 [0.93-1.27],0.307748633032763
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AXL,Tyrosine-protein kinase receptor UFO,18671,161,1.03 [0.62-1.70],0.9191029798596662
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AZI2,5-azacytidine-induced protein 2,16246,139,1.15 [0.85-1.55],0.3736105585901793
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AZU1,Azurocidin,18002,156,1.13 [0.95-1.35],0.1597727640386033
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B2M,Beta-2-microglobulin,16302,138,1.87 [1.42-2.46],8.364508272833733e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,15718,133,1.53 [0.66-3.54],0.3215361173490243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",15876,134,2.20 [1.38-3.50],0.0009341382692769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B4GALT1,"Beta-1,4-galactosyltransferase 1",18660,162,3.13 [1.97-4.95],1.174369473040104e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B4GAT1,"Beta-1,4-glucuronyltransferase 1",18585,160,0.43 [0.24-0.77],0.0044245999769572
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BABAM1,BRISC and BRCA1-A complex member 1,15792,137,1.10 [0.58-2.09],0.7660043926145355
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BACH1,Transcription regulator protein BACH1,18533,160,1.17 [0.96-1.43],0.1181318091228432
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAG3,BAG family molecular chaperone regulator 3,18368,157,0.86 [0.60-1.24],0.4214640645897347
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAG4,BAG family molecular chaperone regulator 4,15792,137,0.95 [0.66-1.38],0.8030419400697472
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAG6,Large proline-rich protein BAG6,18206,158,1.36 [0.91-2.03],0.133559325804319
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,18156,158,1.29 [1.05-1.60],0.0172941664701741
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAMBI,BMP and activin membrane-bound inhibitor homolog,18156,158,1.92 [1.25-2.93],0.0027367471146794
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BANK1,B-cell scaffold protein with ankyrin repeats,18533,160,1.02 [0.89-1.18],0.748946592059359
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAP18,Chromatin complexes subunit BAP18,16250,141,1.14 [0.90-1.43],0.2774027259915153
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BATF,Basic leucine zipper transcriptional factor ATF-like,15834,134,1.03 [0.85-1.25],0.7477748112193235
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAX,Apoptosis regulator BAX,18124,154,1.20 [1.02-1.42],0.0321525360252091
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAM,Basal cell adhesion molecule,18585,160,2.47 [1.50-4.08],0.0003981227573994
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAN,Brevican core protein,18398,157,0.34 [0.23-0.50],7.377575458360744e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",16274,138,1.71 [1.05-2.80],0.0326403682205154
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",15723,135,0.97 [0.72-1.31],0.8556251447404559
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCHE,Cholinesterase,15990,134,0.42 [0.27-0.65],9.820029115464082e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2,Apoptosis regulator Bcl-2,16196,139,1.06 [0.79-1.42],0.6796396667555231
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2L1,Bcl-2-like protein 1,16250,141,1.09 [0.92-1.29],0.3444485823020682
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",18533,160,1.59 [1.11-2.29],0.0116142918673241
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2L15,Bcl-2-like protein 15,15792,137,1.01 [0.76-1.35],0.93851949450429
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL7A,B-cell CLL/lymphoma 7 protein family member A,15698,138,1.15 [0.91-1.44],0.2325774186626844
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL7B,B-cell CLL/lymphoma 7 protein family member B,16206,140,0.89 [0.60-1.33],0.5811752808415167
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCR,Breakpoint cluster region protein,18533,160,1.08 [0.92-1.27],0.3515848273562849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BDNF,Brain-derived neurotrophic factor,16282,139,0.95 [0.79-1.16],0.6346011224025668
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BECN1,Beclin-1,15876,134,1.09 [0.82-1.45],0.5648103967406795
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BEX3,Protein BEX3,15698,138,1.01 [0.69-1.47],0.9656277973242215
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BGLAP,Osteocalcin,16282,139,1.01 [0.84-1.21],0.9429195045770628
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BGN,Biglycan,18117,157,0.91 [0.80-1.04],0.1531254962216618
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BHLHE40,Class E basic helix-loop-helix protein 40,15723,135,1.11 [0.88-1.39],0.3705681860598329
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,15718,133,1.90 [0.95-3.81],0.0692711226359705
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BID,BH3-interacting domain death agonist,18533,160,1.07 [0.86-1.33],0.5500068833255864
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BIN2,Bridging integrator 2,18585,160,1.23 [1.05-1.45],0.0111006469802765
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BIRC2,Baculoviral IAP repeat-containing protein 2,18156,158,1.05 [0.83-1.33],0.6956832593695536
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLMH,Bleomycin hydrolase,18801,163,1.36 [0.90-2.08],0.1485168066970953
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLNK,B-cell linker protein,15792,137,1.03 [0.67-1.58],0.9103647819041734
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,15723,135,1.00 [0.78-1.26],0.9688928357003797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,16250,141,1.21 [0.80-1.83],0.3713668487857664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLVRB,Flavin reductase,18585,160,1.03 [0.83-1.27],0.8162198287912049
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMP10,Bone morphogenetic protein 10,15945,138,0.73 [0.41-1.30],0.2878531614296931
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMP4,Bone morphogenetic protein 4,18368,157,1.44 [1.10-1.90],0.008553886187922
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMP6,Bone morphogenetic protein 6,18180,158,1.69 [1.21-2.38],0.0023892582482196
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMPER,BMP-binding endothelial regulator protein,15945,138,3.41 [2.05-5.67],2.395798856934005e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,16274,138,1.26 [0.76-2.08],0.3791712011166634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,15792,137,1.63 [1.15-2.31],0.0058211051446318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BOC,Brother of CDO,18206,158,2.69 [1.48-4.90],0.001243531259225
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BOLA1,BolA-like protein 1,15723,135,1.22 [0.92-1.63],0.164389598252077
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BOLA2_BOLA2B,BolA-like protein 2,15876,134,0.98 [0.72-1.34],0.906663487194997
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFA2,BPI fold-containing family A member 2,15318,128,1.04 [0.89-1.21],0.6067994459896977
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFB1,BPI fold-containing family B member 1,18529,161,1.28 [1.02-1.60],0.0314253532596638
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFB2,BPI fold-containing family B member 2,16239,138,0.92 [0.72-1.18],0.513836409094916
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRAP,BRCA1-associated protein,16057,138,1.00 [0.86-1.17],0.9814117197484988
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRD1,Bromodomain-containing protein 1,15972,137,1.56 [0.95-2.55],0.0766691391692681
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRD2,Bromodomain-containing protein 2,15723,135,1.11 [0.67-1.84],0.67139364537946
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRD3,Bromodomain-containing protein 3,15718,133,0.78 [0.51-1.20],0.2651663872513448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRDT,Bromodomain testis-specific protein,15718,133,1.38 [0.87-2.21],0.1753512001034247
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRK1,Protein BRICK1,18150,155,1.51 [1.10-2.08],0.0105476363174669
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRME1,Break repair meiotic recombinase recruitment factor 1,15723,135,1.03 [0.67-1.59],0.8765659074927188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRSK2,Serine/threonine-protein kinase BRSK2,16246,139,1.32 [0.87-1.99],0.1868173217080202
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BSG,Basigin,18722,162,5.02 [2.81-8.96],4.64535979447299e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BSND,Barttin,15698,138,1.33 [0.89-2.01],0.1668635712792341
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,18723,162,0.95 [0.72-1.26],0.7275727766689232
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BST2,Bone marrow stromal antigen 2,18723,162,1.72 [1.40-2.10],1.899895144572557e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTC,Probetacellulin,18156,158,1.13 [0.93-1.37],0.2077450942379063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTD,Biotinidase,16302,138,0.34 [0.16-0.72],0.0050703022967799
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTLA,B- and T-lymphocyte attenuator,15698,138,1.10 [0.93-1.29],0.2587822060518391
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN1A1,Butyrophilin subfamily 1 member A1,16174,140,0.63 [0.37-1.07],0.0878984769803542
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN2A1,Butyrophilin subfamily 2 member A1,18660,162,2.91 [1.88-4.50],1.649336899555146e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN3A2,Butyrophilin subfamily 3 member A2,18533,160,1.96 [1.44-2.67],2.1516154977901923e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTNL10,Butyrophilin-like protein 10,15698,138,0.92 [0.62-1.36],0.6595575946383954
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C19orf12,Protein C19orf12,18150,155,1.15 [0.93-1.42],0.1890397430160547
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1GALT1C1,C1GALT1-specific chaperone 1,15718,133,1.38 [0.92-2.06],0.1201003583126508
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QA,Complement C1q subcomponent subunit A,18661,160,3.55 [2.03-6.22],9.455696278262374e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",16246,139,1.03 [0.82-1.29],0.8306011499558077
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QL2,Complement C1q-like protein 2,15792,137,0.70 [0.47-1.02],0.0663704936396299
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,18671,161,2.03 [1.52-2.70],1.291715335458014e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,15945,138,2.50 [1.61-3.88],4.306133949883503e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,16246,139,1.55 [1.03-2.33],0.0354423734938384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,15915,138,0.90 [0.64-1.28],0.5694594361079258
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1R,Complement C1r subcomponent,16302,138,0.99 [0.38-2.59],0.978817900349768
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1RL,Complement C1r subcomponent-like protein,16272,138,0.68 [0.31-1.50],0.3367839715917858
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1S,Complement C1s subcomponent,16302,138,1.55 [0.70-3.45],0.2844001279070286
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C2,Complement C2,18634,161,1.62 [0.83-3.14],0.155816447912129
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C2CD2L,Phospholipid transfer protein C2CD2L,18121,155,1.23 [0.88-1.71],0.226998511845229
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C2orf69,UPF0565 protein C2orf69,15834,134,1.26 [0.99-1.60],0.0596649584604431
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C3,Complement C3,15468,130,1.56 [1.16-2.11],0.0035083085014433
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C4BPB,C4b-binding protein beta chain,18648,157,0.82 [0.58-1.16],0.2593694250859159
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C5,Complement C5,16302,138,1.40 [0.44-4.48],0.5733360550775344
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C7,Complement component C7,15880,135,4.83 [3.17-7.36],2.0392831078931762e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C7orf50,Uncharacterized protein C7orf50,16250,141,1.27 [0.63-2.53],0.5038459836447663
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C8B,Complement component C8 beta chain,16302,138,0.93 [0.53-1.61],0.7832289408713714
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C9,Complement component C9,16290,140,1.40 [1.02-1.91],0.0356993215406605
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C9orf40,Uncharacterized protein C9orf40,16196,139,0.90 [0.73-1.10],0.3124116718937451
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA1,Carbonic anhydrase 1,18185,156,1.02 [0.81-1.30],0.8402350923214955
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA11,Carbonic anhydrase-related protein 11,18156,158,1.15 [0.77-1.73],0.4933635313194842
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA12,Carbonic anhydrase 12,18490,159,2.03 [1.36-3.03],0.0005602640794941
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA13,Carbonic anhydrase 13,18399,157,1.05 [0.91-1.21],0.5029367159358757
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA14,Carbonic anhydrase 14,18723,163,0.61 [0.41-0.90],0.0128502361282956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA2,Carbonic anhydrase 2,18515,160,1.05 [0.86-1.28],0.6119730502979022
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA3,Carbonic anhydrase 3,18772,163,1.04 [0.83-1.31],0.7418262274053808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA4,Carbonic anhydrase 4,18801,163,2.05 [1.15-3.65],0.0144910948460901
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA5A,"Carbonic anhydrase 5A, mitochondrial",18206,158,1.23 [1.07-1.41],0.0038088780134428
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA6,Carbonic anhydrase 6,18540,160,0.80 [0.64-0.99],0.0387796698152756
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA7,Carbonic anhydrase 7,15972,137,1.20 [0.77-1.87],0.419062657426727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA8,Carbonic anhydrase-related protein,15792,137,0.94 [0.48-1.87],0.8712459151035787
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA9,Carbonic anhydrase 9,18723,163,1.38 [1.07-1.78],0.013777133095405
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CABP2,Calcium-binding protein 2,15834,134,0.97 [0.73-1.28],0.8138603766587122
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,15723,135,1.22 [0.75-1.99],0.427937310060267
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,15718,133,0.79 [0.54-1.15],0.2159401033946654
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,15723,135,1.08 [0.82-1.42],0.5939380227608224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,16246,139,1.14 [0.93-1.39],0.2074260183263071
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACYBP,Calcyclin-binding protein,15920,138,1.02 [0.86-1.21],0.8279131375691153
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CADPS,Calcium-dependent secretion activator 1,15834,134,1.20 [0.86-1.69],0.2820117689555504
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALB1,Calbindin,18490,159,0.95 [0.69-1.30],0.7276309958018289
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALB2,Calretinin,18150,155,1.11 [0.71-1.73],0.6524988451633386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCA,Calcitonin,18369,157,1.48 [1.27-1.73],4.170162260634272e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCB,Calcitonin gene-related peptide 2,16250,141,1.52 [1.10-2.10],0.0111152539871735
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,18663,162,1.10 [0.95-1.27],0.1858418326595938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,15876,134,1.19 [0.95-1.49],0.1244325291503361
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALY,Neuron-specific vesicular protein calcyon,15718,133,1.61 [1.17-2.21],0.0034514698266341
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,18156,158,1.31 [0.95-1.80],0.096984643049681
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,15834,134,1.28 [0.97-1.68],0.0791401816495934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,16246,139,1.22 [1.05-1.43],0.0119197937219747
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CANT1,Soluble calcium-activated nucleotidase 1,18525,161,2.01 [1.03-3.92],0.041508401679816
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPG,Macrophage-capping protein,18408,158,1.29 [1.01-1.65],0.0423592295745804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPN3,Calpain-3,16206,140,1.35 [0.92-1.98],0.1204580265279603
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPS,Calcyphosin,16250,141,1.08 [0.93-1.24],0.3245131918896961
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CARHSP1,Calcium-regulated heat-stable protein 1,18150,155,0.99 [0.75-1.31],0.9331692866994552
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASC3,Protein CASC3,15834,134,1.40 [0.95-2.08],0.0927181024711641
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP1,Caspase-1,18150,155,1.17 [0.95-1.42],0.1335081810996388
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP10,Caspase-10,18150,155,1.11 [0.90-1.38],0.3196765618304277
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP2,Caspase-2,18533,160,1.10 [0.89-1.36],0.384186971379103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP3,Caspase-3,18801,163,1.10 [0.93-1.30],0.2594611390719838
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP4,Caspase-4,15972,137,1.10 [1.00-1.20],0.0390827593116736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP7,Caspase-7,16250,141,1.05 [0.86-1.28],0.644900079652204
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP8,Caspase-8,18660,162,0.92 [0.72-1.17],0.4995203191159207
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP9,Caspase-9,15792,137,1.04 [0.79-1.38],0.7670289070349637
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASQ2,Calsequestrin-2,15718,133,1.12 [0.81-1.56],0.4768234619124776
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAT,Catalase,16060,139,0.83 [0.61-1.13],0.2319961825617588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLIF,Cobalamin binding intrinsic factor,18550,161,1.08 [0.90-1.29],0.4230231773158388
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLN1,Cerebellin-1,15723,135,1.17 [1.01-1.36],0.0357418923196528
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLN4,Cerebellin-4,18723,163,0.49 [0.32-0.74],0.0007129768364991
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBS,Cystathionine beta-synthase,15876,134,1.59 [1.20-2.12],0.0014295827795669
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBX2,Chromobox protein homolog 2,15718,133,0.87 [0.54-1.42],0.5795149652570386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,18398,157,1.14 [0.93-1.39],0.1962731163588816
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCAR2,Cell cycle and apoptosis regulator protein 2,16250,141,1.16 [0.87-1.54],0.302416217816825
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC134,Coiled-coil domain-containing protein 134,16206,140,1.21 [0.87-1.68],0.2674157984151842
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC28A,Coiled-coil domain-containing protein 28A,15834,134,0.74 [0.42-1.31],0.3093298649749796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC50,Coiled-coil domain-containing protein 50,16246,139,1.14 [0.93-1.39],0.2189517302539999
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,18584,161,2.33 [1.69-3.19],1.732952535802917e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,15876,134,0.99 [0.76-1.29],0.9416647695978172
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL11,Eotaxin,18753,162,1.54 [1.05-2.25],0.0272562519331955
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL13,C-C motif chemokine 13,18725,162,0.90 [0.73-1.11],0.3250241751071596
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL14,C-C motif chemokine 14,18548,161,1.61 [1.19-2.17],0.0020098017583262
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL15,C-C motif chemokine 15,18801,163,1.87 [1.42-2.47],8.823375526600438e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL16,C-C motif chemokine 16,18801,163,1.81 [1.36-2.42],5.328192421652661e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL17,C-C motif chemokine 17,18551,162,1.24 [1.07-1.44],0.0035890579850511
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL18,C-C motif chemokine 18,18328,160,1.19 [0.99-1.42],0.0601239672733612
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL19,C-C motif chemokine 19,18723,162,1.07 [0.97-1.18],0.1927990868562167
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL2,C-C motif chemokine 2,18368,157,0.87 [0.66-1.15],0.3325582380164996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL20,C-C motif chemokine 20,18753,162,1.41 [1.25-1.59],1.3350750736738151e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL21,C-C motif chemokine 21,18660,162,2.12 [1.74-2.58],1.3649521980274196e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL22,C-C motif chemokine 22,18431,162,1.32 [1.04-1.69],0.0248574557875092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL23,C-C motif chemokine 23,18660,162,1.46 [1.05-2.03],0.0227319530124839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL24,C-C motif chemokine 24,18629,162,0.98 [0.82-1.16],0.8129139103242506
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL25,C-C motif chemokine 25,18753,162,1.06 [0.79-1.42],0.6978743883129223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL26,C-C motif chemokine 26,18533,160,1.15 [1.00-1.32],0.0514870772585924
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL27,C-C motif chemokine 27,18584,161,1.34 [1.05-1.70],0.0188093365835097
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL28,C-C motif chemokine 28,18474,160,1.39 [1.12-1.73],0.0029970138474085
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL3,C-C motif chemokine 3,18533,160,1.30 [1.07-1.58],0.0075465022325756
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL4,C-C motif chemokine 4,18604,162,1.16 [0.97-1.40],0.1111987788323709
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL5,C-C motif chemokine 5,18671,161,1.17 [1.01-1.34],0.0319050404460888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL7,C-C motif chemokine 7,18533,160,1.36 [1.10-1.67],0.0041700333291525
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL8,C-C motif chemokine 8,18690,162,0.97 [0.76-1.24],0.8259063247245673
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN1,CCN family member 1,18451,158,1.22 [1.00-1.49],0.0528245125024732
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN2,CCN family member 2,18558,161,1.27 [0.98-1.65],0.0692593908608691
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN3,CCN family member 3,18772,161,2.12 [1.51-2.97],1.2605919216043737e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN4,CCN family member 4,18723,163,1.82 [1.32-2.52],0.0002893510354384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN5,CCN family member 5,18585,160,1.53 [1.10-2.13],0.0121207255252479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCND2,G1/S-specific cyclin-D2,15972,137,1.06 [0.67-1.66],0.8117629329070274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCNE1,G1/S-specific cyclin-E1,15792,137,0.82 [0.61-1.10],0.1873492730566806
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCS,Copper chaperone for superoxide dismutase,18398,157,0.92 [0.67-1.25],0.5904612009282552
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCT5,T-complex protein 1 subunit epsilon,18156,158,1.27 [0.94-1.71],0.122822873436279
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD101,Immunoglobulin superfamily member 2,16196,139,1.44 [0.99-2.08],0.0548071344390954
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD109,CD109 antigen,18585,160,1.15 [0.75-1.77],0.5225363804863818
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD14,Monocyte differentiation antigen CD14,18240,158,1.93 [1.42-2.62],2.2668882743917253e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD160,CD160 antigen,18753,162,1.18 [0.90-1.56],0.224217889274693
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD163,Scavenger receptor cysteine-rich type 1 protein M130,18671,161,1.75 [1.29-2.36],0.0002832765563125
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD164,Sialomucin core protein 24,18585,160,1.20 [0.77-1.87],0.4192773416147279
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD164L2,CD164 sialomucin-like 2 protein,15834,134,0.96 [0.60-1.54],0.8603712789499898
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD177,CD177 antigen,18552,159,1.09 [0.97-1.23],0.1362844792090491
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD1C,T-cell surface glycoprotein CD1c,18648,157,0.58 [0.34-1.00],0.049111468991469
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD2,T-cell surface antigen CD2,15718,133,1.19 [0.83-1.71],0.3415426008241807
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD200,OX-2 membrane glycoprotein,18533,160,1.15 [0.68-1.94],0.5920248361393384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD200R1,Cell surface glycoprotein CD200 receptor 1,18483,160,1.10 [0.74-1.65],0.6281558733955229
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD207,C-type lectin domain family 4 member K,18173,156,1.57 [1.08-2.27],0.0171851017003227
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD209,CD209 antigen,18630,160,0.61 [0.42-0.88],0.0090235308442337
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD22,B-cell receptor CD22,18753,162,0.79 [0.57-1.08],0.1364138880128765
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD226,CD226 antigen,15792,137,0.84 [0.56-1.26],0.3953091951293218
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD244,Natural killer cell receptor 2B4,18753,162,1.09 [0.66-1.81],0.7332155121504761
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD248,Endosialin,16282,139,0.55 [0.36-0.84],0.0056038601226301
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD27,CD27 antigen,18648,157,2.38 [1.83-3.11],1.3965714884875679e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD274,Programmed cell death 1 ligand 1,18398,157,2.56 [1.89-3.46],1.0223042815965195e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD276,CD276 antigen,18581,162,2.37 [1.62-3.48],9.860133005482774e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD28,T-cell-specific surface glycoprotein CD28,18156,158,1.28 [0.92-1.76],0.1389731913126265
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD2AP,CD2-associated protein,18584,161,1.19 [0.95-1.48],0.1265682539830096
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300A,CMRF35-like molecule 8,15945,138,1.73 [1.04-2.90],0.0359422642034076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300C,CMRF35-like molecule 6,18723,162,2.14 [1.48-3.09],5.0010050702324186e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300E,CMRF35-like molecule 2,18661,163,2.33 [1.76-3.09],2.945123205612372e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300LF,CMRF35-like molecule 1,18723,163,1.66 [1.28-2.16],0.0001170168475789
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300LG,CMRF35-like molecule 9,18585,160,1.11 [0.77-1.59],0.5764128084116253
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD302,CD302 antigen,18490,159,2.77 [1.94-3.96],2.4267093899219357e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD33,Myeloid cell surface antigen CD33,18648,157,1.15 [0.95-1.38],0.1522589846216026
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD34,Hematopoietic progenitor cell antigen CD34,18669,162,0.49 [0.27-0.88],0.0163860150859788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD36,Platelet glycoprotein 4,15792,137,1.30 [0.91-1.85],0.153643128746332
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,18490,159,1.76 [1.24-2.51],0.0016651460762953
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD3D,T-cell surface glycoprotein CD3 delta chain,15723,135,1.37 [0.89-2.09],0.1514169154866717
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD3E,T-cell surface glycoprotein CD3 epsilon chain,15972,137,1.05 [0.65-1.70],0.8498529798039061
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD3G,T-cell surface glycoprotein CD3 gamma chain,15792,137,1.14 [0.97-1.35],0.113696378126615
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD4,T-cell surface glycoprotein CD4,18512,160,2.07 [1.49-2.89],1.4885748778375784e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD40,Tumor necrosis factor receptor superfamily member 5,18573,162,1.85 [1.43-2.40],3.499655888505572e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD40LG,CD40 ligand,18753,162,1.13 [0.94-1.36],0.1825407944864991
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD46,Membrane cofactor protein,18488,161,1.92 [1.24-2.97],0.0036142258771074
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD48,CD48 antigen,18629,162,2.32 [1.50-3.60],0.0001656489122911
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD5,T-cell surface glycoprotein CD5,18690,162,1.54 [1.09-2.18],0.0134204533014736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD55,Complement decay-accelerating factor,17944,154,1.97 [1.21-3.19],0.0061749310884426
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD58,Lymphocyte function-associated antigen 3,18555,162,1.17 [0.52-2.64],0.6986888433242137
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD59,CD59 glycoprotein,17947,159,2.45 [1.59-3.79],5.395757873768819e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD5L,CD5 antigen-like,16208,136,2.15 [1.53-3.01],8.523871008417595e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD6,T-cell differentiation antigen CD6,18722,162,0.98 [0.76-1.27],0.8715694395866331
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD63,CD63 antigen,18368,157,1.44 [1.08-1.93],0.0133827042891696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD69,Early activation antigen CD69,18505,161,1.19 [1.00-1.40],0.0453754751027668
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD7,T-cell antigen CD7,15755,136,1.66 [1.20-2.29],0.0021541722154221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD70,CD70 antigen,18533,160,1.31 [0.95-1.82],0.1006452240597107
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD72,B-cell differentiation antigen CD72,15945,138,1.40 [0.98-1.98],0.0614261451194157
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,18723,162,2.72 [1.92-3.84],1.344405738317692e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD79B,B-cell antigen receptor complex-associated protein beta chain,18753,162,1.82 [1.43-2.31],1.296219749950551e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD80,T-lymphocyte activation antigen CD80,16274,138,2.82 [1.90-4.19],2.4895974504983413e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD82,CD82 antigen,15972,137,1.34 [0.93-1.92],0.1115972995536117
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD83,CD83 antigen,18533,160,1.91 [1.33-2.74],0.0004039690122371
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD84,SLAM family member 5,18533,160,0.88 [0.56-1.37],0.5678394915351306
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD86,T-lymphocyte activation antigen CD86,16196,139,1.54 [0.89-2.65],0.1196739276308019
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD8A,T-cell surface glycoprotein CD8 alpha chain,18723,162,1.14 [0.87-1.49],0.3346952284444116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD93,Complement component C1q receptor,17916,155,1.65 [1.06-2.56],0.0260035888114198
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD99,CD99 antigen,18585,160,3.19 [1.74-5.83],0.00016643701382
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD99L2,CD99 antigen-like protein 2,18585,160,2.06 [1.18-3.60],0.011056840700153
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDA,Cytidine deaminase,16239,138,0.97 [0.68-1.40],0.8899189244268171
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDAN1,Codanin-1,16250,141,0.65 [0.29-1.48],0.30805180270699
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC123,Cell division cycle protein 123 homolog,15698,138,1.06 [0.84-1.34],0.6337070246382057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC25A,M-phase inducer phosphatase 1,15698,138,1.15 [0.78-1.70],0.4730884452527639
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC26,Anaphase-promoting complex subunit CDC26,16159,139,1.20 [0.94-1.53],0.1387674301280106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC27,Cell division cycle protein 27 homolog,18156,158,1.15 [0.91-1.47],0.2402459115488429
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC37,Hsp90 co-chaperone Cdc37,18648,157,1.05 [0.88-1.26],0.5549465427215579
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC42BPB,Serine/threonine-protein kinase MRCK beta,16196,139,1.12 [0.95-1.32],0.1661635182654118
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDCP1,CUB domain-containing protein 1,18398,157,1.67 [1.33-2.11],1.3006180617417258e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH1,Cadherin-1,17978,157,1.22 [0.87-1.71],0.2430343936670674
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH15,Cadherin-15,18694,162,1.09 [0.89-1.33],0.4132544397911322
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH17,Cadherin-17,18584,161,0.90 [0.73-1.11],0.3308828393886609
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH2,Cadherin-2,18584,161,1.84 [1.25-2.71],0.0018778126795854
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH22,Cadherin-22,15972,137,0.91 [0.51-1.64],0.7553903779967166
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH23,Cadherin-23,16250,141,1.18 [0.62-2.26],0.6163256433489948
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH3,Cadherin-3,18723,162,1.73 [1.23-2.42],0.0014780865568624
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH4,Cadherin-4,15723,135,1.17 [0.85-1.62],0.3392474499567707
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH5,Cadherin-5,18801,163,1.11 [0.69-1.77],0.6651465540614454
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH6,Cadherin-6,18584,161,1.22 [0.86-1.73],0.2757912467979956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR1,Cadherin-related family member 1,18150,155,1.15 [0.83-1.59],0.397226538434006
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR2,Cadherin-related family member 2,18490,159,1.48 [1.22-1.80],6.436210658751131e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR5,Cadherin-related family member 5,18584,161,0.42 [0.31-0.58],1.663683015144825e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDK1,Cyclin-dependent kinase 1,15698,138,1.35 [0.85-2.14],0.2027540339512891
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,16246,139,1.08 [0.81-1.42],0.6108226097208436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDKL5,Cyclin-dependent kinase-like 5,15723,135,1.05 [0.77-1.45],0.7446915608645879
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDKN1A,Cyclin-dependent kinase inhibitor 1,18490,159,1.03 [0.90-1.19],0.6282401257756862
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,18490,159,1.02 [0.87-1.19],0.794277662010111
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDNF,Cerebral dopamine neurotrophic factor,18490,159,1.32 [0.89-1.95],0.1716878409284186
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,18607,162,1.04 [0.63-1.72],0.8865832281588308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDSN,Corneodesmosin,18702,162,1.53 [1.12-2.09],0.0076066651602131
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,18616,155,3.09 [1.63-5.85],0.0005400529584448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,16196,139,0.44 [0.37-0.54],4.128845036283206e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,15972,137,0.92 [0.70-1.20],0.521267842006354
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,16196,139,2.14 [1.51-3.04],1.91872581528146e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,15972,137,1.36 [1.02-1.81],0.0372883341627054
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,18533,160,1.21 [1.03-1.41],0.021193333358549
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,18156,158,1.26 [0.94-1.69],0.1260642453981054
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,17948,157,1.42 [1.19-1.70],0.0001006873741292
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,16282,139,2.03 [1.54-2.68],5.740083342822433e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,18206,158,1.64 [1.28-2.11],0.0001050716728609
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEBPA,CCAAT/enhancer-binding protein alpha,15792,137,1.05 [0.64-1.71],0.8540713074940055
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEBPB,CCAAT/enhancer-binding protein beta,18206,158,0.99 [0.68-1.45],0.9576713334044112
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELA2A,Chymotrypsin-like elastase family member 2A,16282,139,0.72 [0.58-0.91],0.0053114022956854
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELA3A,Chymotrypsin-like elastase family member 3A,18771,163,0.71 [0.57-0.88],0.0016677876740089
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,15945,138,0.84 [0.49-1.46],0.5411395833849022
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEMIP2,Cell surface hyaluronidase,15792,137,1.40 [0.94-2.07],0.0976109816723422
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEND1,Cell cycle exit and neuronal differentiation protein 1,15723,135,1.23 [0.99-1.53],0.0667271859999578
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CENPF,Centromere protein F,15972,137,1.00 [0.73-1.35],0.9790758174210846
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CENPJ,Centromere protein J,15972,137,1.20 [0.98-1.47],0.0772333858452191
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP112,Centrosomal protein of 112 kDa,15718,133,1.08 [0.77-1.51],0.6469877985292263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP152,Centrosomal protein of 152 kDa,15698,138,1.23 [0.83-1.81],0.2963340726423694
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP164,Centrosomal protein of 164 kDa,18225,158,1.13 [0.92-1.40],0.2535876844678394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP170,Centrosomal protein of 170 kDa,15876,134,1.24 [1.00-1.53],0.051647138241264
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP20,Centrosomal protein 20,18156,158,1.24 [1.02-1.50],0.028318702861588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP290,Centrosomal protein of 290 kDa,15972,137,1.00 [0.72-1.38],0.991136564847206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP350,Centrosome-associated protein 350,15698,138,0.87 [0.55-1.38],0.5430391911620465
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP43,Centrosomal protein 43,18057,155,1.05 [0.85-1.31],0.636840440307493
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP85,Centrosomal protein of 85 kDa,18156,158,1.11 [0.88-1.40],0.3893029087358675
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CERT,Ceramide transfer protein,18150,155,1.18 [0.94-1.50],0.1585487452162142
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES1,Liver carboxylesterase 1,18639,161,1.13 [0.96-1.34],0.1339723780393088
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES2,Cocaine esterase,18490,159,1.11 [0.86-1.42],0.4261472351948734
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES3,Carboxylesterase 3,18490,159,1.08 [0.89-1.32],0.4390860742295499
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CETN2,Centrin-2,18150,155,1.25 [1.01-1.55],0.0412336649522229
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CETN3,Centrin-3,16196,139,1.08 [0.86-1.34],0.50464184568835
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFB,Complement factor B,16013,135,1.24 [0.74-2.08],0.4148191581303777
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFC1,Cryptic protein,18156,158,1.16 [0.86-1.55],0.3350543456096098
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFD,Complement factor D,16302,138,2.80 [1.46-5.38],0.0019830450146077
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFH,Complement factor H,15346,130,1.56 [0.73-3.33],0.2530212591055212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFHR2,Complement factor H-related protein 2,16173,134,0.98 [0.73-1.32],0.8864571079524753
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFHR4,Complement factor H-related protein 4,16273,138,1.11 [0.88-1.40],0.3789154198755937
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFHR5,Complement factor H-related protein 5,16076,135,1.19 [0.79-1.78],0.4044090092721619
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFI,Complement factor I,16302,138,0.65 [0.28-1.47],0.2962683411292774
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFP,Properdin,16302,138,0.21 [0.09-0.47],0.0001230214546527
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGA,Glycoprotein hormones alpha chain,18585,160,0.86 [0.74-0.98],0.0286944890147945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,16290,140,0.73 [0.49-1.10],0.1375445207477819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGN,Cingulin,15834,134,1.27 [0.88-1.83],0.1960508262972029
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,18584,161,1.85 [1.37-2.51],7.120347223933367e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,18156,158,1.11 [0.88-1.41],0.363395810033451
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHAD,Chondroadherin,15945,138,0.76 [0.56-1.03],0.0740170082720654
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",16250,141,2.17 [1.63-2.88],1.0788211822731923e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD6,MICOS complex subunit MIC25,16206,140,2.41 [1.64-3.55],8.12964080176286e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHEK2,Serine/threonine-protein kinase Chk2,18206,158,0.81 [0.51-1.28],0.3595708458125453
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHGA,Chromogranin-A,16282,139,1.38 [1.20-1.57],3.676210082100144e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHGB,Secretogranin-1,18667,162,1.05 [0.75-1.46],0.7911221991721631
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHI3L1,Chitinase-3-like protein 1,18206,159,1.60 [1.39-1.84],2.5399732875736817e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHIT1,Chitotriosidase-1,18651,163,1.11 [0.99-1.24],0.0776343346349113
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHL1,Neural cell adhesion molecule L1-like protein,18646,160,1.21 [0.76-1.91],0.4271298597017761
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHM,Rab proteins geranylgeranyltransferase component A 1,15834,134,0.96 [0.71-1.28],0.7700744416655823
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHMP1A,Charged multivesicular body protein 1a,18398,157,0.95 [0.79-1.14],0.5534606123179084
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHMP6,Charged multivesicular body protein 6,16274,138,0.86 [0.64-1.16],0.3257538074608886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHP1,Calcineurin B homologous protein 1,15723,135,0.99 [0.78-1.26],0.9200919039689164
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRDL1,Chordin-like protein 1,18629,162,2.38 [1.60-3.54],2.0701337545810144e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRDL2,Chordin-like protein 2,18584,161,1.54 [1.16-2.05],0.002693033654431
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRM1,Muscarinic acetylcholine receptor M1,15834,134,1.21 [0.79-1.85],0.3766473512222809
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CIAPIN1,Anamorsin,18648,157,1.11 [0.87-1.41],0.3983726063025311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CILP,Cartilage intermediate layer protein 1,16282,139,1.96 [1.43-2.67],2.689182843525441e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CINP,Cyclin-dependent kinase 2-interacting protein,15972,137,1.04 [0.71-1.53],0.8312386353481875
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CIRBP,Cold-inducible RNA-binding protein,16196,139,1.10 [0.92-1.31],0.3007840141560198
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CIT,Citron Rho-interacting kinase,15834,134,1.33 [0.95-1.87],0.0974631355430325
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,18667,162,2.82 [1.94-4.11],5.545758558681485e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKB,Creatine kinase B-type,16282,139,1.71 [1.31-2.24],8.436384000827558e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",18521,162,1.25 [1.01-1.56],0.0448561546698331
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLASP1,CLIP-associating protein 1,15698,138,1.02 [0.80-1.30],0.8841848672706742
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLC,Galectin-10,18554,161,1.23 [1.01-1.51],0.0381943213679767
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC10A,C-type lectin domain family 10 member A,18398,157,1.53 [1.02-2.29],0.0404531456781849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC11A,C-type lectin domain family 11 member A,18556,160,1.77 [1.32-2.38],0.0001498782709281
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC12A,C-type lectin domain family 12 member A,15792,137,2.66 [1.30-5.42],0.0072332764394017
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC14A,C-type lectin domain family 14 member A,18585,160,2.32 [1.56-3.45],3.118193545556194e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC1A,C-type lectin domain family 1 member A,18206,158,2.30 [1.58-3.34],1.424229699216379e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC1B,C-type lectin domain family 1 member B,18723,162,1.14 [0.98-1.32],0.0849473510456404
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC2L,C-type lectin domain family 2 member L,15834,134,1.02 [0.71-1.47],0.9116742264711786
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC3B,Tetranectin,15917,134,0.12 [0.06-0.23],6.32696142715129e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4A,C-type lectin domain family 4 member A,18533,160,0.62 [0.43-0.90],0.0126040016915783
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4C,C-type lectin domain family 4 member C,18533,160,1.02 [0.76-1.37],0.8970807972962604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,18533,160,1.64 [1.33-2.03],4.961989473955355e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4G,C-type lectin domain family 4 member G,18533,160,0.97 [0.63-1.48],0.8728507637256515
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4M,C-type lectin domain family 4 member M,16251,139,0.60 [0.43-0.85],0.0037441492747408
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,18529,161,2.46 [1.63-3.73],2.0910349711641405e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,18156,158,2.07 [1.58-2.71],1.5430482063139904e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC7A,C-type lectin domain family 7 member A,18753,162,1.43 [1.07-1.92],0.0148220924498005
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLGN,Calmegin,15834,134,1.62 [1.22-2.15],0.0007633413978124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLIC5,Chloride intracellular channel protein 5,15834,134,1.49 [0.98-2.27],0.064921570635254
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLINT1,Clathrin interactor 1,15698,138,0.93 [0.63-1.37],0.7273525493187964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLIP2,CAP-Gly domain-containing linker protein 2,18533,160,1.05 [0.92-1.20],0.4605600794789528
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLMP,CXADR-like membrane protein,18723,163,2.33 [1.30-4.16],0.0044628179349205
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLNS1A,Methylosome subunit pICln,15834,134,0.79 [0.47-1.33],0.3803786178508741
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",18369,157,1.19 [1.02-1.38],0.0253474225331829
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLPS,Colipase,18550,160,0.74 [0.62-0.89],0.0011863201163375
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSPN,Claspin,18121,155,0.60 [0.34-1.03],0.0646601939113483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN1,Calsyntenin-1,18150,155,1.10 [0.84-1.43],0.5044137176057211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN2,Calsyntenin-2,18753,162,1.88 [1.41-2.51],1.671149865496572e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN3,Calsyntenin-3,16250,141,2.20 [1.39-3.49],0.0007867057077891
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLTA,Clathrin light chain A,18206,158,1.11 [0.83-1.50],0.4777066896532418
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLU,Clusterin,16302,138,0.20 [0.07-0.55],0.0019263629654665
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLUL1,Clusterin-like protein 1,18552,161,0.93 [0.69-1.25],0.6330211065586746
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CMC1,COX assembly mitochondrial protein homolog,16274,138,1.11 [0.92-1.33],0.2846365467283974
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CMIP,C-Maf-inducing protein,16206,140,0.98 [0.80-1.20],0.838686795313331
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNDP1,Beta-Ala-His dipeptidase,18671,161,0.46 [0.37-0.59],1.8717468343870432e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNGB3,Cyclic nucleotide-gated cation channel beta-3,15723,135,0.99 [0.71-1.37],0.943756571398452
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",15842,134,1.01 [0.81-1.26],0.9435087138786448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNPY2,Protein canopy homolog 2,18206,158,1.07 [0.86-1.33],0.5514023398390326
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNPY4,Protein canopy homolog 4,18490,159,1.18 [0.97-1.43],0.1036838620177867
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNST,Consortin,18584,161,1.13 [0.99-1.29],0.0729318997189582
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTF,Ciliary neurotrophic factor,15723,135,1.12 [0.68-1.87],0.648835238490826
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN1,Contactin-1,18801,163,0.40 [0.25-0.63],7.346789270255525e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN2,Contactin-2,18723,163,0.97 [0.71-1.34],0.869229996553861
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN3,Contactin-3,18585,160,0.57 [0.37-0.89],0.0129121670444628
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN4,Contactin-4,18585,160,0.91 [0.50-1.63],0.7392824817630095
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN5,Contactin-5,18608,162,0.46 [0.32-0.66],3.19857415077757e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTNAP2,Contactin-associated protein-like 2,18533,160,1.31 [0.95-1.79],0.0971835987257231
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTNAP4,Contactin-associated protein-like 4,15834,134,1.03 [0.88-1.22],0.7025272102742516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COCH,Cochlin,16274,138,1.41 [1.02-1.95],0.038125692511378
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL15A1,Collagen alpha-1(XV) chain,16282,139,2.04 [1.24-3.35],0.0047200235041386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,18670,163,4.76 [2.82-8.05],5.469232154200894e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL1A1,Collagen alpha-1(I) chain,18801,163,1.33 [0.76-2.34],0.3151191747702991
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL24A1,Collagen alpha-1(XXIV) chain,16196,139,1.40 [1.03-1.89],0.0312124843203219
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL28A1,Collagen alpha-1(XXVIII) chain,15834,134,0.88 [0.69-1.11],0.2747834616442575
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL2A1,Collagen alpha-1(II) chain,15876,134,0.94 [0.75-1.16],0.5472968683959235
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL3A1,Collagen alpha-1(III) chain,16282,139,2.96 [1.49-5.88],0.0019086547913751
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,18584,161,2.72 [2.01-3.68],8.107878217967344e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL4A4,Collagen alpha-4(IV) chain,15949,137,1.33 [0.95-1.86],0.0968609432074451
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL5A1,Collagen alpha-1(V) chain,15945,138,2.08 [1.46-2.97],5.17659113875261e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,18801,163,2.52 [1.89-3.36],2.8526484293083885e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL9A1,Collagen alpha-1(IX) chain,18533,160,1.39 [1.05-1.84],0.0234034460848201
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL9A2,Collagen alpha-2(IX) chain,15972,137,0.79 [0.51-1.22],0.2838066307031062
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COLEC12,Collectin-12,18581,162,3.30 [2.15-5.05],4.029363901112768e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMMD1,COMM domain-containing protein 1,15876,134,1.11 [0.83-1.48],0.47319417233731
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMMD9,COMM domain-containing protein 9,16206,140,0.97 [0.63-1.51],0.9014145213495378
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMP,Cartilage oligomeric matrix protein,18383,159,1.19 [0.78-1.81],0.4306225102534879
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMT,Catechol O-methyltransferase,18022,155,1.23 [1.03-1.48],0.0231920763967453
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COPB2,Coatomer subunit beta',15718,133,1.24 [0.84-1.82],0.2808860783097995
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COPE,Coatomer subunit epsilon,18150,155,0.91 [0.64-1.27],0.566035234122757
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",15876,134,1.36 [0.96-1.94],0.0862194599935817
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CORO1A,Coronin-1A,18196,156,1.14 [0.97-1.33],0.1152338011150718
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CORO6,Coronin-6,15723,135,1.45 [0.97-2.18],0.0725399102761728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",18490,159,1.37 [1.13-1.67],0.0015287152635447
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COX6B1,Cytochrome c oxidase subunit 6B1,16274,138,1.06 [0.64-1.76],0.8249097802543698
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA1,Carboxypeptidase A1,18801,163,0.90 [0.73-1.11],0.3309746209461262
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA2,Carboxypeptidase A2,18668,162,0.76 [0.61-0.94],0.0130075265480097
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA4,Carboxypeptidase A4,15628,138,1.61 [1.08-2.38],0.0185903794897187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPB1,Carboxypeptidase B,18801,163,0.96 [0.77-1.19],0.6819227577835036
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPB2,Carboxypeptidase B2,16272,137,0.27 [0.13-0.55],0.0003348658317248
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPE,Carboxypeptidase E,18567,162,0.99 [0.69-1.44],0.9758189068984486
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPLX2,Complexin-2,15698,138,0.93 [0.55-1.57],0.7803800907738694
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPM,Carboxypeptidase M,18627,162,1.63 [1.09-2.43],0.0174388316933202
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",15792,137,1.34 [0.73-2.44],0.3437924380521926
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPPED1,Serine/threonine-protein phosphatase CPPED1,18723,162,1.15 [0.92-1.43],0.2136856799276453
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPQ,Carboxypeptidase Q,16244,139,0.70 [0.45-1.10],0.1245837891475991
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPTP,Ceramide-1-phosphate transfer protein,15718,133,1.13 [0.73-1.74],0.5911743330406994
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPVL,Probable serine carboxypeptidase CPVL,18694,162,1.48 [1.03-2.11],0.0333805481898629
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPXM1,Probable carboxypeptidase X1,18648,157,1.23 [1.01-1.50],0.0360195291299278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPXM2,Inactive carboxypeptidase-like protein X2,16274,138,2.57 [1.57-4.20],0.00017261227729
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CR1,Complement receptor type 1,16230,140,1.54 [0.99-2.41],0.0570718028733328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CR2,Complement receptor type 2,18671,161,0.88 [0.66-1.19],0.4147970929615238
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,18156,158,1.22 [1.04-1.44],0.0167611308671487
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRADD,Death domain-containing protein CRADD,18369,157,1.05 [0.86-1.28],0.6365046966368654
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREB3,Cyclic AMP-responsive element-binding protein 3,15698,138,1.02 [0.76-1.37],0.8782142359818653
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREBZF,CREB/ATF bZIP transcription factor,15698,138,1.93 [1.09-3.41],0.024640682768108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREG1,Protein CREG1,18345,154,1.74 [1.27-2.40],0.0006508833732723
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRELD1,Protein disulfide isomerase CRELD1,15945,138,2.34 [1.55-3.53],4.936457859954838e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRELD2,Protein disulfide isomerase CRELD2,18629,162,1.46 [1.11-1.91],0.0061323868509588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRH,Corticoliberin,18121,158,0.78 [0.66-0.94],0.0069664265482878
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRHBP,Corticotropin-releasing factor-binding protein,18581,162,1.81 [1.09-3.01],0.021971719229526
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRHR1,Corticotropin-releasing factor receptor 1,18206,158,1.10 [0.88-1.36],0.4129042625103569
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIM1,Cysteine-rich motor neuron 1 protein,18660,162,4.40 [2.39-8.12],2.1227806126200067e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIP2,Cysteine-rich protein 2,18398,157,1.14 [0.78-1.67],0.4868746637365526
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRISP2,Cysteine-rich secretory protein 2,18723,163,0.99 [0.80-1.22],0.921701895159723
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRISP3,Cysteine-rich secretory protein 3,16149,138,1.03 [0.56-1.87],0.932886590024256
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRKL,Crk-like protein,18603,162,1.05 [0.91-1.21],0.4916181244786701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRLF1,Cytokine receptor-like factor 1,18660,162,1.93 [1.11-3.33],0.0188401536142866
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRNN,Cornulin,18061,157,0.86 [0.70-1.05],0.1378959426939735
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRTAC1,Cartilage acidic protein 1,18801,163,0.35 [0.23-0.53],8.275478676294541e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRTAM,Cytotoxic and regulatory T-cell molecule,18398,157,1.09 [0.83-1.44],0.5185110575072445
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRTAP,Cartilage-associated protein,15834,134,1.02 [0.70-1.50],0.918317632760112
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRX,Cone-rod homeobox protein,18206,158,0.97 [0.84-1.13],0.7128240598234394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYBB1,Beta-crystallin B1,16274,138,1.23 [0.95-1.59],0.1139401737046728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYBB2,Beta-crystallin B2,16250,141,1.23 [1.07-1.43],0.0050355872050961
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYGD,Gamma-crystallin D,16250,141,1.05 [0.88-1.25],0.5776875311955731
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYM,Ketimine reductase mu-crystallin,15723,135,1.15 [0.93-1.42],0.1979615780046062
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYZL1,Quinone oxidoreductase-like protein 1,15876,134,1.07 [0.89-1.30],0.4680113349615927
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSDE1,Cold shock domain-containing protein E1,15718,133,1.06 [0.91-1.24],0.454158201416999
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,18660,162,4.17 [2.72-6.40],5.2760296100284996e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1R,Macrophage colony-stimulating factor 1 receptor,16290,140,1.72 [1.18-2.49],0.0043683049882637
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2,Granulocyte-macrophage colony-stimulating factor,15718,133,1.30 [0.84-1.99],0.2348015140892488
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,18398,157,1.29 [1.03-1.61],0.0255831261659902
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2RB,Cytokine receptor common subunit beta,15792,137,1.60 [1.06-2.39],0.0237447191935627
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF3,Granulocyte colony-stimulating factor,18225,158,1.45 [1.11-1.89],0.007010931666277
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF3R,Granulocyte colony-stimulating factor receptor,15792,137,1.68 [1.01-2.80],0.0450559027137259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSH1,Chorionic somatomammotropin hormone 1,16290,140,1.23 [0.71-2.13],0.4594471307673247
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSNK1D,Casein kinase I isoform delta,15792,137,0.93 [0.69-1.26],0.6554031737630612
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSNK2A1,Casein kinase II subunit alpha,16246,139,1.43 [1.00-2.05],0.0484939528218989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSPG4,Chondroitin sulfate proteoglycan 4,16282,139,0.85 [0.51-1.40],0.5183719104046932
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSPG5,Chondroitin sulfate proteoglycan 5,15723,135,1.05 [0.76-1.46],0.7508030972240889
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSRP3,Cysteine and glycine-rich protein 3,15718,133,1.07 [0.91-1.26],0.4264404814275133
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST1,Cystatin-SN,14183,125,1.19 [1.01-1.40],0.0324385833945091
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST3,Cystatin-C,18640,160,2.54 [1.73-3.72],1.7971211601189294e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST5,Cystatin-D,18207,156,1.18 [0.92-1.52],0.2003778628788904
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST6,Cystatin-M,18090,153,1.36 [1.03-1.78],0.0296087741821901
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST7,Cystatin-F,18604,162,1.19 [1.06-1.33],0.0042047748524497
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSTB,Cystatin-B,18316,162,1.89 [1.41-2.53],2.0574500391396565e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTAG1A_CTAG1B,Cancer/testis antigen 1,15944,137,0.77 [0.54-1.11],0.1682303290027192
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTBS,Di-N-acetylchitobiase,16052,139,1.18 [0.62-2.26],0.6097932725869706
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTF1,Cardiotrophin-1,18206,158,1.05 [0.89-1.25],0.5637642722437195
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTHRC1,Collagen triple helix repeat-containing protein 1,16282,139,3.35 [2.11-5.30],2.582209210705525e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTLA4,Cytotoxic T-lymphocyte protein 4,16282,139,1.43 [0.85-2.39],0.1746547160141093
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTNNA1,Catenin alpha-1,15723,135,1.16 [0.76-1.77],0.5050060389212849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRB1,Chymotrypsinogen B,18585,160,0.71 [0.57-0.90],0.0037901238960321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRC,Chymotrypsin-C,18581,162,0.65 [0.54-0.79],1.6758271211123314e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRL,Chymotrypsin-like protease CTRL-1,16250,141,0.73 [0.59-0.91],0.0039232322798707
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSB,Cathepsin B,18608,163,1.27 [0.99-1.62],0.0590175262725457
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSC,Dipeptidyl peptidase 1,18540,161,1.53 [1.12-2.07],0.0068632860393176
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSD,Cathepsin D,17418,149,1.75 [1.35-2.26],2.1887378668661703e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSE,Cathepsin E,15945,138,0.79 [0.57-1.10],0.1597490522884398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSF,Cathepsin F,18648,157,0.93 [0.65-1.33],0.6976598907223746
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSH,Pro-cathepsin H,18142,157,1.19 [0.98-1.45],0.0807789111871866
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSL,Cathepsin L1,18584,161,3.10 [1.84-5.24],2.198825850406522e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSO,Cathepsin O,18753,162,1.57 [1.02-2.39],0.0382802874200258
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSS,Cathepsin S,14503,120,1.99 [0.97-4.10],0.0621017602957915
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSV,Cathepsin L2,18662,161,0.93 [0.67-1.30],0.6869315675188733
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSZ,Cathepsin Z,18619,161,2.08 [1.37-3.15],0.000577014496414
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CUZD1,CUB and zona pellucida-like domain-containing protein 1,15834,134,1.31 [0.89-1.93],0.1678216977075221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CWC15,Spliceosome-associated protein CWC15 homolog,16097,137,1.04 [0.77-1.39],0.814747831549366
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CX3CL1,Fractalkine,18398,157,1.24 [0.81-1.90],0.3280756974141486
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,18533,160,1.82 [1.43-2.31],7.719589709090253e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL1,Growth-regulated alpha protein,18545,162,0.98 [0.84-1.15],0.8370837723550014
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL10,C-X-C motif chemokine 10,18660,162,1.34 [1.11-1.62],0.0025553215016222
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL11,C-X-C motif chemokine 11,18723,162,1.40 [1.22-1.61],2.0644691376004884e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL12,Stromal cell-derived factor 1,18225,158,1.76 [1.26-2.47],0.0010094794770886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL13,C-X-C motif chemokine 13,18723,162,1.48 [1.29-1.69],6.710232879482948e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL14,C-X-C motif chemokine 14,18225,158,1.01 [0.78-1.32],0.9151814526869544
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL16,C-X-C motif chemokine 16,18774,163,2.39 [1.35-4.24],0.0027728015126282
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL17,C-X-C motif chemokine 17,18753,162,1.99 [1.53-2.59],3.255617583543831e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL3,C-X-C motif chemokine 3,18573,162,0.98 [0.84-1.14],0.7837383341412084
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL5,C-X-C motif chemokine 5,18525,161,0.90 [0.80-1.02],0.0922113058913998
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL6,C-X-C motif chemokine 6,18753,162,0.84 [0.70-1.02],0.0732981108044583
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL8,Interleukin-8,18446,161,1.31 [1.11-1.54],0.001649189213649
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL9,C-X-C motif chemokine 9,18660,162,1.58 [1.32-1.88],3.7413126490263686e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYB5A,Cytochrome b5,15698,138,0.90 [0.69-1.17],0.4133574290178792
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYB5R2,NADH-cytochrome b5 reductase 2,16023,137,1.34 [1.01-1.78],0.044474308872209
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",15718,133,1.14 [0.96-1.36],0.1459316287977655
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYTH3,Cytohesin-3,15698,138,1.02 [0.80-1.29],0.8916506058259163
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYTL1,Cytokine-like protein 1,16282,139,2.37 [1.37-4.11],0.0020542332256855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAAM1,Disheveled-associated activator of morphogenesis 1,15945,138,1.03 [0.84-1.26],0.7755854813552513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAB2,Disabled homolog 2,18723,163,1.06 [0.93-1.20],0.410415523807642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAG1,Dystroglycan,18660,162,1.54 [1.13-2.09],0.0063027088019728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAND5,DAN domain family member 5,15792,137,1.29 [0.95-1.77],0.10693172446424
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAPK2,Death-associated protein kinase 2,15792,137,0.90 [0.65-1.26],0.5404491701292354
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,18533,160,0.98 [0.87-1.10],0.674538535687054
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DARS1,"Aspartate--tRNA ligase, cytoplasmic",18369,157,1.04 [0.85-1.27],0.7115488182326756
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBH,Dopamine beta-hydroxylase,16255,140,0.88 [0.77-1.00],0.055962695864834
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBI,Acyl-CoA-binding protein,18505,159,1.17 [0.97-1.41],0.106774567095018
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBN1,Drebrin,15792,137,1.17 [0.82-1.66],0.3831161551077414
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBNL,Drebrin-like protein,18660,162,1.12 [0.96-1.32],0.1520256779790817
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",18648,157,1.78 [1.19-2.67],0.0050851778188222
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCC,Netrin receptor DCC,15834,134,0.50 [0.20-1.26],0.141114943509244
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCDC2C,Doublecortin domain-containing protein 2C,15698,138,0.98 [0.73-1.30],0.8653284340465237
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCLRE1C,Protein artemis,15698,138,1.15 [0.67-1.98],0.6042184659792279
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCN,Decorin,18206,158,0.92 [0.51-1.67],0.7810170098003529
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTD,Deoxycytidylate deaminase,15945,138,0.99 [0.83-1.19],0.9413823107674776
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTN1,Dynactin subunit 1,18723,163,1.10 [0.88-1.38],0.3889058838646977
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTN2,Dynactin subunit 2,18490,159,0.93 [0.79-1.09],0.3678347322040047
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTN6,Dynactin subunit 6,18150,155,1.14 [0.94-1.39],0.1724642366174175
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTPP1,dCTP pyrophosphatase 1,18584,161,1.35 [0.87-2.09],0.1832347485911778
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCUN1D1,DCN1-like protein 1,15723,135,1.04 [0.82-1.32],0.7353613376139538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCUN1D2,DCN1-like protein 2,15698,138,0.89 [0.71-1.12],0.327460093153312
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCXR,L-xylulose reductase,18648,157,1.02 [0.79-1.33],0.8714967549341851
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDA1,DET1- and DDB1-associated protein 1,15718,133,1.34 [0.93-1.93],0.1172575706530988
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",18490,159,1.59 [1.19-2.13],0.0018380948685895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDC,Aromatic-L-amino-acid decarboxylase,18550,161,0.93 [0.70-1.25],0.6471846728733961
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDHD2,Phospholipase DDHD2,16246,139,1.14 [0.88-1.48],0.3049564559126
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDI2,Protein DDI1 homolog 2,15945,138,0.85 [0.69-1.06],0.1410011415101763
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDR1,Epithelial discoidin domain-containing receptor 1,18723,162,2.96 [1.81-4.86],1.7309445330671963e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDT,D-dopachrome decarboxylase,16282,139,0.89 [0.60-1.34],0.5808358806974669
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX1,ATP-dependent RNA helicase DDX1,16196,139,1.09 [0.79-1.52],0.6025653201417562
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX25,ATP-dependent RNA helicase DDX25,15834,134,0.86 [0.51-1.44],0.564970610456643
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX39A,ATP-dependent RNA helicase DDX39A,15792,137,0.89 [0.41-1.94],0.7721801667763706
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX4,Probable ATP-dependent RNA helicase DDX4,15792,137,0.99 [0.72-1.36],0.9465487998055602
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX53,Probable ATP-dependent RNA helicase DDX53,15834,134,1.58 [1.02-2.46],0.0426267591710183
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX58,Antiviral innate immune response receptor RIG-I,18156,158,1.11 [0.87-1.41],0.4135956023620719
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",18533,160,1.13 [0.97-1.31],0.1271987809471307
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFA1_DEFA1B,Neutrophil defensin 1,18217,157,1.30 [1.05-1.62],0.0166123694676758
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB103A_DEFB103B,Beta-defensin 103,15663,137,1.26 [0.91-1.75],0.1663431740875157
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB104A_DEFB104B,Beta-defensin 104,15723,135,1.08 [0.82-1.43],0.5861639334358653
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB116,Beta-defensin 116,15723,135,1.03 [0.82-1.30],0.7836650308482234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB118,Beta-defensin 118,15723,135,1.07 [0.81-1.42],0.6336492855416203
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB4A_DEFB4B,Beta-defensin 4A,18335,156,1.10 [1.00-1.20],0.0486797632368075
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DENND2B,DENN domain-containing protein 2B,15718,133,1.25 [0.91-1.72],0.1712254828839187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DENR,Density-regulated protein,15792,137,1.16 [0.87-1.56],0.3041232877276516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DFFA,DNA fragmentation factor subunit alpha,18753,162,1.10 [0.88-1.36],0.4062205002252432
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DGCR6,Protein DGCR6,15723,135,1.32 [0.92-1.89],0.128285921358329
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DGKA,Diacylglycerol kinase alpha,15792,137,1.09 [0.80-1.49],0.572810387449718
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DGKZ,Diacylglycerol kinase zeta,18225,158,0.88 [0.56-1.36],0.5565084821326292
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DHODH,Dihydroorotate dehydrogenase,15718,133,1.02 [0.70-1.48],0.9368038467348612
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DHPS,Deoxyhypusine synthase,16206,140,1.29 [0.89-1.89],0.1801444918277285
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,16250,141,1.26 [0.90-1.76],0.1818658213777096
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DIABLO,"Diablo homolog, mitochondrial",18529,161,1.07 [0.94-1.23],0.2849844144083588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DIPK1C,Divergent protein kinase domain 1C,15834,134,0.72 [0.45-1.14],0.1561625766315224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DIPK2B,Divergent protein kinase domain 2B,15945,138,1.25 [0.70-2.24],0.4583786638492541
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKK1,Dickkopf-related protein 1,18723,162,1.16 [0.91-1.48],0.2208157649897467
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKK3,Dickkopf-related protein 3,18801,163,0.93 [0.57-1.49],0.7488089193050873
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKK4,Dickkopf-related protein 4,18374,157,1.46 [1.13-1.90],0.004355756988328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKKL1,Dickkopf-like protein 1,18490,159,0.90 [0.77-1.06],0.2225776999936168
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLG4,Disks large homolog 4,16250,141,1.05 [0.83-1.34],0.669906480927143
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLGAP5,Disks large-associated protein 5,16246,139,0.83 [0.56-1.24],0.365420748009587
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLK1,Protein delta homolog 1,18801,163,0.83 [0.64-1.06],0.1405745290058059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLL1,Delta-like protein 1,18648,157,2.94 [1.97-4.38],1.295384199956065e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLL4,Delta-like protein 4,15876,134,0.95 [0.77-1.16],0.5995579287786925
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DMD,Dystrophin,15876,134,1.46 [1.12-1.90],0.0049493143881183
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DMP1,Dentin matrix acidic phosphoprotein 1,15876,134,0.85 [0.65-1.09],0.2019796370780253
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJA1,DnaJ homolog subfamily A member 1,15698,138,1.20 [0.87-1.66],0.2777509145510389
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJA2,DnaJ homolog subfamily A member 2,18698,162,1.13 [0.95-1.36],0.1682460598549017
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJA4,DnaJ homolog subfamily A member 4,16250,141,0.89 [0.71-1.12],0.3187707841697408
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB1,DnaJ homolog subfamily B member 1,18490,159,1.02 [0.86-1.21],0.8157901507578151
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB14,DnaJ homolog subfamily B member 14,16196,139,1.13 [0.87-1.45],0.3616262695752632
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB2,DnaJ homolog subfamily B member 2,15945,138,0.81 [0.59-1.12],0.2089668754914417
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB6,DnaJ homolog subfamily B member 6,15795,137,1.03 [0.84-1.26],0.7937744133539703
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB8,DnaJ homolog subfamily B member 8,18206,158,1.01 [0.80-1.29],0.9175188429595604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJC21,DnaJ homolog subfamily C member 21,16250,141,1.29 [0.84-1.98],0.2435771839375075
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJC6,Putative tyrosine-protein phosphatase auxilin,15876,134,1.12 [0.92-1.38],0.2593784948180976
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJC9,DnaJ homolog subfamily C member 9,16196,139,0.99 [0.80-1.23],0.9318881840521922
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNER,Delta and Notch-like epidermal growth factor-related receptor,18541,162,0.61 [0.35-1.07],0.0874152422407125
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNLZ,DNL-type zinc finger protein,15723,135,0.98 [0.80-1.21],0.8726438956608437
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNM1,Dynamin-1,16196,139,1.01 [0.88-1.17],0.8473225313839549
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNM3,Dynamin-3,16246,139,1.53 [1.18-2.00],0.0015964081370915
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNMBP,Dynamin-binding protein,18398,157,1.39 [1.10-1.75],0.0057757856893027
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNPEP,Aspartyl aminopeptidase,16250,141,0.95 [0.71-1.26],0.7177605885316025
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,18634,162,1.06 [0.81-1.40],0.6562146220294247
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOC2B,Double C2-like domain-containing protein beta,15834,134,1.29 [0.84-1.99],0.2471402568394953
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOCK9,Dedicator of cytokinesis protein 9,15723,135,1.02 [0.89-1.17],0.77073209666526
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOK1,Docking protein 1,16250,141,1.00 [0.89-1.14],0.940080273069164
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOK2,Docking protein 2,18584,161,1.13 [1.00-1.27],0.0483015620224108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPEP1,Dipeptidase 1,18369,157,0.99 [0.74-1.32],0.9413636739966252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPEP2,Dipeptidase 2,18490,159,1.62 [1.00-2.62],0.0511247174381124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP10,Inactive dipeptidyl peptidase 10,18533,160,1.18 [0.83-1.67],0.360631323200872
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP4,Dipeptidyl peptidase 4,18263,158,0.73 [0.44-1.19],0.2029577411417976
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP6,Dipeptidyl aminopeptidase-like protein 6,18490,159,0.68 [0.45-1.02],0.0638702721315761
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP7,Dipeptidyl peptidase 2,18449,159,1.63 [1.31-2.04],1.1901431467344282e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPT,Dermatopontin,18801,163,0.88 [0.51-1.52],0.6559196938994508
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPY30,Protein dpy-30 homolog,18658,163,1.52 [1.24-1.87],6.421916532393564e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DRAXIN,Draxin,18398,157,1.30 [0.94-1.79],0.1068312201107801
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DRG2,Developmentally-regulated GTP-binding protein 2,18490,159,1.07 [0.83-1.39],0.5839029828911269
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSC2,Desmocollin-2,18401,157,2.16 [1.52-3.05],1.4433040904978554e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSCAM,Down syndrome cell adhesion molecule,16246,139,1.14 [0.71-1.82],0.5854542560899461
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSG2,Desmoglein-2,18585,160,1.01 [0.60-1.69],0.9773139194267214
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSG3,Desmoglein-3,18658,162,1.66 [1.14-2.42],0.008194078682174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSG4,Desmoglein-4,18435,157,0.77 [0.58-1.04],0.0885632508297905
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTD1,D-aminoacyl-tRNA deacylase 1,15945,138,0.97 [0.80-1.18],0.762342223846493
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTNB,Dystrobrevin beta,16169,140,2.25 [1.63-3.09],6.680238431633517e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTX2,Probable E3 ubiquitin-protein ligase DTX2,15834,134,0.87 [0.64-1.18],0.3632775343967173
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTX3,Probable E3 ubiquitin-protein ligase DTX3,18490,159,2.19 [1.35-3.57],0.0015872365408297
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTYMK,Thymidylate kinase,16274,138,0.94 [0.73-1.20],0.6141940973808655
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUOX2,Dual oxidase 2,18206,158,1.07 [0.88-1.31],0.4888516526737444
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUSP13,Dual specificity protein phosphatase 13 isoform A,16206,140,1.09 [0.74-1.60],0.6719338319054884
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUSP29,Dual specificity phosphatase 29,15834,134,1.02 [0.78-1.34],0.8602480346778545
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUSP3,Dual specificity protein phosphatase 3,18150,155,0.87 [0.71-1.06],0.1589505126881565
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",16196,139,1.21 [1.03-1.42],0.0181440407197214
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DXO,Decapping and exoribonuclease protein,16250,141,1.27 [0.89-1.81],0.1806561703920364
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,16206,140,0.89 [0.59-1.33],0.5637668096459961
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DYNLT1,Dynein light chain Tctex-type 1,15834,134,0.81 [0.64-1.03],0.0793503035914795
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DYNLT3,Dynein light chain Tctex-type 3,16206,140,0.98 [0.66-1.45],0.922559546676605
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,18398,157,1.10 [0.94-1.29],0.2164875627574963
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EBI3_IL27,Interleukin-27,18693,163,3.11 [2.07-4.67],4.7928892515879643e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECE1,Endothelin-converting enzyme 1,18150,155,1.07 [0.72-1.58],0.7416229804226357
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",16274,138,1.34 [1.11-1.64],0.0029501795789412
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHS1,"Enoyl-CoA hydratase, mitochondrial",15876,134,1.46 [1.23-1.73],1.0972036376221982e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECI2,Enoyl-CoA delta isomerase 2,15718,133,1.44 [1.14-1.82],0.0022465265599929
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECM1,Extracellular matrix protein 1,15868,134,0.82 [0.52-1.28],0.3835158776778063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECSCR,Endothelial cell-specific chemotaxis regulator,15723,135,1.03 [0.74-1.43],0.8560291167068383
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,18723,163,2.57 [1.95-3.38],1.8728077972749758e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDAR,Tumor necrosis factor receptor superfamily member EDAR,18533,160,0.78 [0.66-0.92],0.0025704305087761
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDDM3B,Epididymal secretory protein E3-beta,16206,140,1.33 [1.10-1.60],0.0031508598467504
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,15718,133,0.95 [0.57-1.57],0.8396272040677395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDF1,Endothelial differentiation-related factor 1,16246,139,1.26 [1.03-1.55],0.0244023913357161
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,18206,158,1.38 [0.93-2.05],0.10973989802565
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDN1,Endothelin-1,15876,134,3.61 [2.24-5.82],1.3054136662796125e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDNRB,Endothelin receptor type B,15792,137,1.06 [0.75-1.50],0.7583241148883275
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EEF1D,Elongation factor 1-delta,16274,138,1.19 [1.00-1.43],0.0565900811004176
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFCAB14,EF-hand calcium-binding domain-containing protein 14,16196,139,1.70 [1.14-2.53],0.0087769398606318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFCAB2,Dynein regulatory complex protein 8,15972,137,1.19 [0.74-1.93],0.4749407032824007
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,18644,161,3.14 [2.13-4.62],6.976144234892929e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFHD1,EF-hand domain-containing protein D1,16246,139,1.41 [0.95-2.09],0.0844768397255838
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA1,Ephrin-A1,18558,160,2.05 [1.36-3.09],0.0006276093350202
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA4,Ephrin-A4,18368,157,2.16 [1.55-3.01],4.635081945052191e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNB2,Ephrin-B2,15834,134,1.31 [1.02-1.70],0.0372530570270557
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGF,Pro-epidermal growth factor,18549,161,1.08 [0.94-1.25],0.256583478787123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFL7,Epidermal growth factor-like protein 7,18156,158,2.03 [1.47-2.79],1.6755712603167004e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFLAM,Pikachurin,16196,139,1.35 [0.81-2.23],0.2459664379109032
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFR,Epidermal growth factor receptor,18801,163,,
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGLN1,Egl nine homolog 1,18533,160,1.38 [1.15-1.66],0.0005259045427895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EHBP1,EH domain-binding protein 1,16274,138,1.18 [0.94-1.48],0.1469447543502587
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EHD3,EH domain-containing protein 3,15876,134,0.95 [0.82-1.11],0.5334924417380739
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",16250,141,1.19 [0.89-1.58],0.2394249194001013
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",16123,139,1.17 [1.01-1.37],0.0423451294751728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,15718,133,1.32 [1.05-1.67],0.0195578525688797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,15876,134,1.20 [0.80-1.82],0.3786728498269314
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4B,Eukaryotic translation initiation factor 4B,18398,157,1.01 [0.78-1.31],0.9213215428146638
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4E,Eukaryotic translation initiation factor 4E,15792,137,1.04 [0.86-1.26],0.6916596219442699
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,18584,161,1.22 [0.99-1.49],0.061733914900793
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,18753,162,1.18 [1.02-1.37],0.0312314391171891
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,16246,139,1.24 [0.98-1.58],0.0730386275317771
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF5,Eukaryotic translation initiation factor 5,15718,133,0.97 [0.64-1.46],0.8750295942645424
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF5A,Eukaryotic translation initiation factor 5A-1,18225,158,1.37 [0.85-2.21],0.1898424809125909
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELAC1,Zinc phosphodiesterase ELAC protein 1,16246,139,1.03 [0.84-1.26],0.7492289550217668
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELAVL4,ELAV-like protein 4,15723,135,1.14 [0.93-1.38],0.2032631366580802
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELN,Elastin,16274,138,1.57 [1.05-2.36],0.0286450270639645
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELOA,Elongin-A,18490,159,1.09 [0.84-1.40],0.5166350708856808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELOB,Elongin-B,15718,133,1.38 [0.96-2.00],0.0851795190726102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENAH,Protein enabled homolog,18225,158,1.40 [1.05-1.86],0.022619926669663
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENDOU,Poly(U)-specific endoribonuclease,15008,124,1.30 [0.98-1.71],0.0670564360731118
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENG,Endoglin,18801,163,1.61 [0.72-3.63],0.2495760084418407
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENO1,Alpha-enolase,18547,160,1.21 [1.00-1.46],0.0487440925564215
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENO2,Gamma-enolase,18723,162,1.02 [0.82-1.27],0.8700438590225377
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENO3,Beta-enolase,15876,134,0.71 [0.52-0.98],0.0350869631350614
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENOPH1,Enolase-phosphatase E1,16206,140,0.88 [0.61-1.28],0.5015880114031609
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,15718,133,1.64 [0.95-2.85],0.076815347584948
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPEP,Glutamyl aminopeptidase,15718,133,1.24 [0.89-1.73],0.2084262463267168
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,18801,163,0.74 [0.48-1.13],0.1614305132960658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,18660,162,0.73 [0.55-0.97],0.0295212336022334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,15876,134,0.64 [0.42-0.98],0.0387294385266025
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,17962,153,1.45 [1.22-1.73],2.328315133873627e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENSA,Alpha-endosulfine,16206,140,1.13 [0.83-1.53],0.4414646654640458
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,18156,158,1.20 [0.87-1.65],0.2646070719010458
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,18206,158,1.61 [0.82-3.15],0.1654941385564297
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,18206,158,1.96 [1.09-3.54],0.0243034411720283
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTR1,Endosome-associated-trafficking regulator 1,15876,134,1.44 [1.12-1.86],0.004534401795456
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EP300,Histone acetyltransferase p300,15792,137,0.95 [0.55-1.64],0.8560165249246026
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPB41L5,Band 4.1-like protein 5,15834,134,1.19 [0.95-1.49],0.1384347995204197
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPCAM,Epithelial cell adhesion molecule,18568,162,1.10 [0.95-1.27],0.2040056362988658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPGN,Epigen,16206,140,1.08 [0.76-1.54],0.6663934015993469
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA1,Ephrin type-A receptor 1,18634,162,1.69 [1.12-2.57],0.0130807553382761
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA10,Ephrin type-A receptor 10,18150,155,1.01 [0.81-1.25],0.9431431002439876
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA2,Ephrin type-A receptor 2,17924,155,2.76 [2.00-3.81],8.177473247338147e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA4,Ephrin type-A receptor 4,15945,138,1.17 [0.67-2.05],0.5847543361442178
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHB4,Ephrin type-B receptor 4,18801,163,3.09 [1.99-4.79],4.528011888394822e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHB6,Ephrin type-B receptor 6,18369,157,1.31 [0.85-2.01],0.2176088017900287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHX2,Bifunctional epoxide hydrolase 2,18206,158,0.82 [0.62-1.07],0.1347057807362721
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPN1,Epsin-1,15972,137,0.98 [0.65-1.48],0.9147501373965452
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPO,Erythropoietin,18533,160,1.40 [1.21-1.63],1.0108917279637743e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPPK1,Epiplakin,15876,134,1.37 [1.10-1.71],0.0052958947608123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,18688,163,1.58 [1.03-2.42],0.0355069862739905
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB2,Receptor tyrosine-protein kinase erbB-2,18648,157,2.09 [1.16-3.76],0.0135251203119477
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB3,Receptor tyrosine-protein kinase erbB-3,18525,162,0.47 [0.23-0.95],0.0345997870845576
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB4,Receptor tyrosine-protein kinase erbB-4,18648,157,0.95 [0.53-1.69],0.8529527489570893
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBIN,Erbin,18490,159,1.09 [0.94-1.26],0.2413413638938324
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERC2,ERC protein 2,15834,134,0.99 [0.77-1.27],0.9558054946569028
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERCC1,DNA excision repair protein ERCC-1,15698,138,0.86 [0.49-1.49],0.5808259460231959
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EREG,Proepiregulin,18369,157,1.08 [0.90-1.29],0.3917766764621805
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERI1,3'-5' exoribonuclease 1,15972,137,1.10 [0.68-1.77],0.7060142996233705
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERMAP,Erythroid membrane-associated protein,15792,137,1.17 [0.82-1.65],0.3884844356479208
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,16206,140,1.24 [0.79-1.95],0.3507349495188322
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERP29,Endoplasmic reticulum resident protein 29,15945,138,1.05 [0.91-1.21],0.504544720671398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERP44,Endoplasmic reticulum resident protein 44,18451,158,1.22 [0.70-2.12],0.4913044057953148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,15718,133,0.73 [0.48-1.12],0.1559818366986357
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESAM,Endothelial cell-selective adhesion molecule,18801,163,1.97 [1.32-2.94],0.0009742932499344
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESM1,Endothelial cell-specific molecule 1,18581,162,1.16 [0.78-1.73],0.4605935210458248
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESPL1,Separin,15698,138,1.03 [0.78-1.35],0.8421666326785179
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESR1,Estrogen receptor,15792,137,0.88 [0.61-1.26],0.4744630458040429
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESYT2,Extended synaptotagmin-2,16250,141,1.31 [1.08-1.60],0.007475534777395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EVI2B,Protein EVI2B,15698,138,0.78 [0.48-1.26],0.3006248398817923
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EVI5,Ecotropic viral integration site 5 protein homolog,15792,137,1.01 [0.83-1.23],0.9216822353693644
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EVPL,Envoplakin,15972,137,1.23 [0.75-2.03],0.4057349832831308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EXOSC10,Exosome component 10,15718,133,1.28 [1.01-1.63],0.0437462723581512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EXTL1,Exostosin-like 1,15718,133,0.81 [0.53-1.22],0.312298175227246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EZR,Ezrin,18723,162,1.14 [0.67-1.96],0.6264996868855408
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F10,Coagulation factor X,16290,140,0.53 [0.30-0.93],0.0270548563860607
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F11,Coagulation factor XI,16072,136,0.30 [0.17-0.52],2.2387334150119745e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F11R,Junctional adhesion molecule A,18585,160,1.37 [1.06-1.76],0.0151228220510405
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F12,Coagulation factor XII,16302,138,0.65 [0.46-0.93],0.0184695035728361
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F13B,Coagulation factor XIII B chain,16208,136,0.46 [0.25-0.87],0.0174047721956947
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F2,Prothrombin,16302,138,0.34 [0.11-1.02],0.053540797649074
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F2R,Proteinase-activated receptor 1,18629,162,1.31 [1.01-1.69],0.0390518645821053
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F3,Tissue factor,18611,162,1.17 [0.69-1.99],0.5644066771425678
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F7,Coagulation factor VII,18642,161,0.56 [0.37-0.86],0.0078275236299431
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F9,Coagulation factor IX,18634,161,2.10 [0.97-4.57],0.0605866740767188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP1,"Fatty acid-binding protein, liver",18581,162,1.45 [1.27-1.65],3.9434281360993175e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP2,"Fatty acid-binding protein, intestinal",18584,161,1.22 [1.03-1.43],0.0194261983066557
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP3,"Fatty acid-binding protein, heart",16274,138,1.48 [1.13-1.92],0.0038415914286889
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",18801,163,1.16 [0.92-1.46],0.2098424872573113
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP5,Fatty acid-binding protein 5,18651,162,1.25 [1.02-1.53],0.0329615944261866
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP6,Gastrotropin,18172,158,1.10 [0.87-1.39],0.4405863888867083
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP9,Fatty acid-binding protein 9,18533,160,1.07 [0.83-1.37],0.6154175414761984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FADD,FAS-associated death domain protein,18584,161,1.09 [0.90-1.32],0.3672485156083409
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM13A,Protein FAM13A,16196,139,1.09 [0.85-1.40],0.4903509181156629
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM171A2,Protein FAM171A2,16246,139,1.11 [1.01-1.22],0.0361073662877869
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM171B,Protein FAM171B,16206,140,1.29 [0.73-2.28],0.3843838750082321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM172A,Cotranscriptional regulator FAM172A,15876,134,1.02 [0.77-1.36],0.8963144074169126
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM20A,Pseudokinase FAM20A,16274,138,2.07 [1.23-3.47],0.005894006934984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3B,Protein FAM3B,18490,159,1.92 [1.25-2.93],0.00273246971498
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3C,Protein FAM3C,18550,161,1.84 [1.21-2.80],0.0042993781806483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3D,Protein FAM3D,16196,139,1.08 [0.89-1.32],0.4122869447398695
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAP,Prolyl endopeptidase FAP,18801,163,0.76 [0.46-1.26],0.2907299933493388
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FARSA,Phenylalanine--tRNA ligase alpha subunit,15834,134,1.13 [0.90-1.43],0.2997504843065353
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAS,Tumor necrosis factor receptor superfamily member 6,18745,163,1.70 [1.29-2.24],0.0001788434217056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FASLG,Tumor necrosis factor ligand superfamily member 6,18753,162,0.56 [0.39-0.79],0.0011536212255188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBLN2,Fibulin-2,16282,139,2.57 [1.65-4.01],3.275548196405259e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBN2,Fibrillin-2,15834,134,0.85 [0.64-1.13],0.2595838853043269
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBP1,"Fructose-1,6-bisphosphatase 1",18584,161,1.29 [1.08-1.55],0.0049152676710234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,16274,138,1.26 [1.02-1.55],0.0350128140307436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCAR,Immunoglobulin alpha Fc receptor,18533,160,2.04 [1.54-2.70],5.846731596567371e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,16246,139,1.09 [0.54-2.20],0.7993802612680379
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCER2,Low affinity immunoglobulin epsilon Fc receptor,18585,160,0.97 [0.74-1.27],0.8161992948563335
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,18514,159,1.04 [0.82-1.33],0.7287713660780186
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,18156,158,0.87 [0.67-1.12],0.2834173716600201
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,18614,161,1.10 [0.82-1.48],0.5157137410503287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCN1,Ficolin-1,16255,140,1.28 [0.93-1.75],0.1260853926189459
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCN2,Ficolin-2,18508,160,0.68 [0.49-0.94],0.0212356308661166
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL1,Fc receptor-like protein 1,18584,161,0.62 [0.46-0.85],0.0024137071513886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL2,Fc receptor-like protein 2,18659,162,1.09 [0.84-1.42],0.5065845622183351
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL3,Fc receptor-like protein 3,18225,158,0.82 [0.63-1.06],0.1316099660988273
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL5,Fc receptor-like protein 5,18585,160,1.42 [1.15-1.77],0.0014283002878843
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL6,Fc receptor-like protein 6,18533,160,1.16 [0.95-1.43],0.1517115006599541
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRLB,Fc receptor-like B,18156,158,1.46 [1.25-1.70],1.1923550669219374e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FDX1,"Adrenodoxin, mitochondrial",15718,133,1.10 [0.84-1.44],0.4854680330442559
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FDX2,"Ferredoxin-2, mitochondrial",15718,133,1.41 [1.08-1.84],0.0114974253264524
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FEN1,Flap endonuclease 1,18156,158,1.05 [0.83-1.32],0.6889279216616785
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FES,Tyrosine-protein kinase Fes/Fps,18156,158,1.09 [0.81-1.46],0.5752317496087573
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FETUB,Fetuin-B,18634,161,0.82 [0.54-1.27],0.3783428226273398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGA,Fibrinogen alpha chain,15928,133,1.94 [1.16-3.26],0.0116675122102071
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",16246,139,1.03 [0.83-1.27],0.7795691372003054
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF12,Fibroblast growth factor 12,15792,137,1.24 [0.94-1.65],0.1315127296517545
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF16,Fibroblast growth factor 16,15792,137,1.02 [0.69-1.50],0.9382064605419712
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF19,Fibroblast growth factor 19,18660,162,1.10 [0.92-1.32],0.2957997285442038
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF2,Fibroblast growth factor 2,18533,160,1.15 [0.94-1.42],0.1702251386352676
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF20,Fibroblast growth factor 20,15792,137,1.07 [0.74-1.56],0.710161732902167
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF21,Fibroblast growth factor 21,18693,163,1.43 [1.29-1.59],2.9373665740926716e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF23,Fibroblast growth factor 23,18697,163,1.47 [1.23-1.77],3.0286591676740657e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF3,Fibroblast growth factor 3,15792,137,0.89 [0.49-1.64],0.7149759907977475
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF5,Fibroblast growth factor 5,18225,158,0.93 [0.60-1.45],0.7451712953213789
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF6,Fibroblast growth factor 6,15792,137,1.42 [1.02-1.98],0.0378488511556573
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF7,Fibroblast growth factor 7,15698,138,1.08 [0.89-1.32],0.4341294398650923
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF9,Fibroblast growth factor 9,15672,138,0.94 [0.61-1.44],0.764682444452306
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP1,Fibroblast growth factor-binding protein 1,18648,157,0.38 [0.25-0.57],2.6698852949011874e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP2,Fibroblast growth factor-binding protein 2,16282,139,0.63 [0.45-0.88],0.0063745643396689
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP3,Fibroblast growth factor-binding protein 3,16250,141,1.50 [0.98-2.29],0.0604671034283819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,18648,157,4.83 [2.76-8.43],3.194274740897036e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFR4,Fibroblast growth factor receptor 4,15945,138,0.60 [0.44-0.83],0.0021262781914656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGL1,Fibrinogen-like protein 1,16290,140,1.93 [1.56-2.39],1.5799710433747935e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGR,Tyrosine-protein kinase Fgr,18150,155,1.25 [1.01-1.54],0.0428685953804378
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FH,"Fumarate hydratase, mitochondrial",15723,135,1.08 [0.89-1.32],0.429296718887531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FHIP2A,FHF complex subunit HOOK interacting protein 2A,15718,133,0.73 [0.48-1.09],0.1252168666259994
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FHIT,Bis(5'-adenosyl)-triphosphatase,18150,155,1.07 [0.87-1.31],0.5284649715763771
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FIS1,Mitochondrial fission 1 protein,18578,162,1.12 [0.93-1.35],0.2255782537524752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,16246,139,1.13 [0.95-1.34],0.1565931178054084
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,18603,161,0.97 [0.85-1.11],0.6556755856337476
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,18398,157,1.45 [1.03-2.04],0.0321359283968304
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,18398,157,1.29 [1.10-1.52],0.0019711000208918
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,18121,155,1.30 [0.99-1.70],0.0620276028336464
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBPL,FK506-binding protein-like,16196,139,1.05 [0.79-1.41],0.7275463160194426
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLI1,Friend leukemia integration 1 transcription factor,18156,158,1.02 [0.89-1.16],0.821639950936015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,18398,157,2.61 [1.67-4.08],2.4742082952933616e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT1,Vascular endothelial growth factor receptor 1,18457,159,2.10 [1.22-3.65],0.0079042849500934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT3,Receptor-type tyrosine-protein kinase FLT3,18156,158,0.83 [0.51-1.33],0.4319598171219079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT3LG,Fms-related tyrosine kinase 3 ligand,18753,162,1.27 [0.86-1.90],0.2338138813702601
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT4,Vascular endothelial growth factor receptor 3,18648,157,1.27 [0.82-1.97],0.2756904822263142
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FMNL1,Formin-like protein 1,18150,155,1.02 [0.81-1.28],0.8791964142448039
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FMR1,Synaptic functional regulator FMR1,18156,158,0.91 [0.60-1.39],0.6726423228087894
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FN1,Fibronectin,16302,138,0.55 [0.29-1.04],0.0653610431395297
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FNDC1,Fibronectin type III domain-containing protein 1,16250,141,1.21 [0.85-1.72],0.2870381813803604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,16206,140,1.65 [1.08-2.51],0.0202943702559798
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLH1,Glutamate carboxypeptidase 2,15792,137,0.93 [0.74-1.15],0.4905652869921443
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR1,Folate receptor alpha,18580,156,1.72 [1.10-2.68],0.0168462198980606
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR2,Folate receptor beta,18723,162,2.13 [1.35-3.37],0.0012405743519131
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR3,Folate receptor gamma,18592,155,1.01 [0.93-1.09],0.8157568914327757
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOS,Proto-oncogene c-Fos,15672,138,1.87 [1.15-3.04],0.0110637335206413
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOSB,Protein fosB,18150,155,0.97 [0.67-1.40],0.8786441859245091
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOXJ3,Forkhead box protein J3,15792,137,1.08 [0.73-1.59],0.70564302751487
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOXO1,Forkhead box protein O1,18533,160,1.09 [0.92-1.29],0.3288885231350926
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOXO3,Forkhead box protein O3,18156,158,1.00 [0.85-1.17],0.952717465444212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FRMD4B,FERM domain-containing protein 4B,15718,133,1.29 [1.02-1.63],0.036315884091696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FRMD7,FERM domain-containing protein 7,15834,134,0.88 [0.53-1.47],0.6251058639572445
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FRZB,Secreted frizzled-related protein 3,18338,157,0.91 [0.52-1.59],0.7302357174119194
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSHB,Follitropin subunit beta,15876,134,0.68 [0.56-0.82],4.656836509140532e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FST,Follistatin,18629,162,1.47 [1.11-1.95],0.0065607854736714
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL1,Follistatin-related protein 1,15876,134,,
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL3,Follistatin-related protein 3,18548,161,3.52 [2.52-4.91],1.592605708248617e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FTCD,Formimidoyltransferase-cyclodeaminase,16213,141,1.05 [0.87-1.27],0.5908579776440772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUCA1,Tissue alpha-L-fucosidase,18707,161,1.07 [0.89-1.28],0.4616153713954742
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUOM,Fucose mutarotase,15945,138,1.62 [1.27-2.07],9.37746988036768e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FURIN,Furin,18648,157,1.03 [0.67-1.59],0.8840796333264274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUS,RNA-binding protein FUS,18131,158,1.31 [0.91-1.88],0.1423825439571826
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",15938,136,1.06 [0.80-1.40],0.6895231070557477
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,18723,162,2.54 [1.92-3.35],6.268745448653901e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT8,"Alpha-(1,6)-fucosyltransferase",18398,157,1.09 [0.85-1.39],0.4874709044049095
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FXN,"Frataxin, mitochondrial",18723,163,1.28 [1.05-1.55],0.0128357365953119
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FXYD5,FXYD domain-containing ion transport regulator 5,18225,158,1.13 [0.90-1.41],0.29877370092681
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FYB1,FYN-binding protein 1,18550,160,1.13 [0.96-1.32],0.1328486399045722
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FZD10,Frizzled-10,15834,134,1.04 [0.78-1.40],0.7707457099912125
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FZD8,Frizzled-8,15723,135,1.31 [0.96-1.78],0.0869478872437058
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GABARAP,Gamma-aminobutyric acid receptor-associated protein,16206,140,1.19 [0.90-1.59],0.2283162897630554
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,15972,137,0.89 [0.66-1.20],0.4361769240170533
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,15723,135,1.18 [0.92-1.49],0.18743103586914
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAD1,Glutamate decarboxylase 1,15698,138,1.58 [0.82-3.05],0.1698588197538302
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAD2,Glutamate decarboxylase 2,15792,137,1.20 [0.89-1.61],0.2349763107590766
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,15972,137,1.11 [0.80-1.54],0.5446325557407583
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,15876,134,1.55 [1.17-2.06],0.0024075384771974
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAGE2A,G antigen 2A,15698,138,0.99 [0.74-1.31],0.9202070557273678
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAL,Galanin peptides,18660,162,1.16 [0.94-1.43],0.1588475707300586
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,18490,159,2.33 [1.42-3.82],0.0008332479738093
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,18723,163,0.66 [0.39-1.12],0.1235324530880177
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,18225,158,0.85 [0.61-1.19],0.3358918072068859
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,16274,138,2.33 [1.42-3.83],0.000835857127279
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT7,N-acetylgalactosaminyltransferase 7,18490,159,0.55 [0.28-1.06],0.0731997622455355
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAMT,Guanidinoacetate N-methyltransferase,15718,133,1.01 [0.64-1.61],0.9649002241676128
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,15585,137,0.99 [0.57-1.70],0.964463364740752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GART,Trifunctional purine biosynthetic protein adenosine-3,16246,139,0.72 [0.35-1.49],0.3812616763770379
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAS2,Growth arrest-specific protein 2,15972,137,1.05 [0.76-1.44],0.7762578613525102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAS6,Growth arrest-specific protein 6,18697,163,2.32 [1.36-3.95],0.0019087359155597
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GASK1A,Golgi-associated kinase 1A,15718,133,0.52 [0.34-0.77],0.0013720640111722
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAST,Gastrin,16250,141,1.22 [1.11-1.35],5.404428164444905e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,15698,138,0.77 [0.40-1.46],0.4217892509024387
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",15876,134,1.34 [1.07-1.67],0.0102526885944967
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBA,Lysosomal acid glucosylceramidase,15834,134,1.05 [0.77-1.42],0.7713812655017691
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP1,Guanylate-binding protein 1,16221,141,1.26 [0.98-1.62],0.0765184535300942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP2,Guanylate-binding protein 2,18225,158,0.96 [0.74-1.24],0.7483015683664689
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP4,Guanylate-binding protein 4,18150,155,1.25 [0.94-1.68],0.1297064364703888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP6,Guanylate-binding protein 6,15718,133,1.29 [0.95-1.75],0.1033590816681369
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GC,Vitamin D-binding protein,16302,138,0.80 [0.42-1.53],0.5045938140438977
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCC1,GRIP and coiled-coil domain-containing protein 1,16250,141,1.11 [0.94-1.30],0.2129151240748896
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCG,Pro-glucagon,18156,158,1.01 [0.90-1.13],0.9158394982992116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,15564,136,1.40 [1.05-1.86],0.0219633455312571
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCLM,Glutamate--cysteine ligase regulatory subunit,15718,133,1.09 [0.75-1.58],0.6671486044563819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",18490,159,2.05 [1.39-3.02],0.0002786471852019
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF15,Growth/differentiation factor 15,18801,163,2.49 [2.01-3.08],4.751151815452815e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF2,Growth/differentiation factor 2,18584,161,0.69 [0.48-1.01],0.0556641745260966
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDNF,Glial cell line-derived neurotrophic factor,18150,155,1.53 [1.08-2.17],0.0158698480922677
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GET3,ATPase GET3,16274,138,1.36 [1.06-1.76],0.0175510219299542
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFAP,Glial fibrillary acidic protein,18125,157,1.13 [0.84-1.52],0.4223531659693161
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFER,FAD-linked sulfhydryl oxidase ALR,18156,158,1.35 [1.08-1.69],0.0080729982700477
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,18156,158,0.99 [0.87-1.12],0.8393985138783382
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA1,GDNF family receptor alpha-1,18693,163,2.74 [1.82-4.11],1.2452446324242249e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA2,GDNF family receptor alpha-2,18490,159,2.13 [1.09-4.15],0.0261119743818585
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA3,GDNF family receptor alpha-3,18341,156,0.87 [0.52-1.44],0.5824942553601627
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRAL,GDNF family receptor alpha-like,15758,137,0.54 [0.41-0.72],2.948420781257074e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGA1,ADP-ribosylation factor-binding protein GGA1,18150,155,1.17 [0.96-1.44],0.1272382464451643
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGACT,Gamma-glutamylaminecyclotransferase,16274,138,1.13 [0.89-1.43],0.3305571880211081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGCT,Gamma-glutamylcyclotransferase,16236,138,0.96 [0.67-1.38],0.8373414048041047
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGH,Gamma-glutamyl hydrolase,18295,159,1.29 [0.88-1.88],0.1901996114549915
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT1,Glutathione hydrolase 1 proenzyme,18558,160,1.84 [1.48-2.29],5.31572880001492e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT5,Glutathione hydrolase 5 proenzyme,18398,157,2.46 [1.45-4.18],0.00087125340213
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GH1,Somatotropin,18550,161,1.01 [0.93-1.10],0.7658038720427287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GH2,Growth hormone variant,18156,158,1.05 [0.97-1.14],0.2403404386318575
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHR,Growth hormone receptor,15945,138,0.27 [0.15-0.48],5.98066794153608e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHRHR,Growth hormone-releasing hormone receptor,18150,155,0.98 [0.74-1.30],0.8922908177257591
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHRL,Appetite-regulating hormone,18584,161,0.82 [0.70-0.96],0.0136101897277542
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GID8,Glucose-induced degradation protein 8 homolog,16246,139,1.03 [0.63-1.68],0.9133654652662196
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIGYF2,GRB10-interacting GYF protein 2,16246,139,1.20 [0.96-1.50],0.1029366067054815
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIMAP7,GTPase IMAP family member 7,15945,138,0.77 [0.44-1.37],0.3779927260120045
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIMAP8,GTPase IMAP family member 8,15698,138,1.03 [0.75-1.43],0.8410080424396055
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIP,Gastric inhibitory polypeptide,15876,134,1.22 [0.93-1.61],0.1538512986353613
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPC2,PDZ domain-containing protein GIPC2,16250,141,1.60 [1.00-2.55],0.050281517635519
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPC3,PDZ domain-containing protein GIPC3,16196,139,1.07 [0.90-1.28],0.4450609932075455
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPR,Gastric inhibitory polypeptide receptor,15792,137,0.91 [0.62-1.35],0.6505856161284806
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIT1,ARF GTPase-activating protein GIT1,15792,137,1.08 [0.91-1.29],0.3810818066299476
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GJA8,Gap junction alpha-8 protein,15698,138,1.03 [0.80-1.34],0.8025873408407779
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GKN1,Gastrokine-1,17820,149,1.06 [0.61-1.83],0.8393136946262785
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLA,Alpha-galactosidase A,15920,138,2.19 [1.46-3.30],0.0001632933127026
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLB1,Beta-galactosidase,18398,157,1.46 [1.04-2.04],0.0267928079632582
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLI2,Zinc finger protein GLI2,15792,137,1.39 [0.81-2.40],0.230393762154726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLO1,Lactoylglutathione lyase,18206,158,1.41 [1.11-1.79],0.0053644562761945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLOD4,Glyoxalase domain-containing protein 4,18547,162,1.13 [0.75-1.72],0.5566713554611047
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLP1R,Glucagon-like peptide 1 receptor,15723,135,1.08 [0.68-1.71],0.7396653181170725
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLRX,Glutaredoxin-1,18465,160,0.99 [0.76-1.27],0.9081583706743268
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",15945,138,1.21 [1.00-1.46],0.0493061965493075
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,18150,155,0.84 [0.59-1.21],0.348507423257591
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLYR1,Putative oxidoreductase GLYR1,16206,140,1.05 [0.79-1.38],0.7561011389931553
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GM2A,Ganglioside GM2 activator,15864,136,1.70 [1.30-2.22],9.721664437854118e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GMFG,Glia maturation factor gamma,16274,138,0.94 [0.74-1.20],0.6407471718199429
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GMPR,GMP reductase 1,18753,162,0.81 [0.61-1.08],0.1509879055459956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GMPR2,GMP reductase 2,15945,138,0.91 [0.70-1.17],0.4534237807357948
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNAS,Neuroendocrine secretory protein 55,16246,139,1.02 [0.84-1.23],0.8543850988735147
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,18156,158,1.12 [0.90-1.40],0.3067970904779333
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,15834,134,1.25 [0.94-1.67],0.1214179937104374
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNLY,Granulysin,18585,160,1.31 [1.01-1.71],0.0446867371727742
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNPDA1,Glucosamine-6-phosphate isomerase 1,15876,134,0.66 [0.37-1.17],0.1564811866741828
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNPDA2,Glucosamine-6-phosphate isomerase 2,15945,138,0.85 [0.53-1.37],0.5166395360841207
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOLGA3,Golgin subfamily A member 3,16246,139,1.12 [0.91-1.39],0.2789509046198762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOLM2,Protein GOLM2,18723,162,1.66 [0.94-2.94],0.0825479314464573
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,18533,160,1.05 [0.91-1.22],0.4853094797176202
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GORASP2,Golgi reassembly-stacking protein 2,16196,139,1.07 [0.75-1.53],0.7135496952236128
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOT1,"Aspartate aminotransferase, cytoplasmic",16282,139,1.56 [1.13-2.15],0.0072640089073933
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP1BA,Platelet glycoprotein Ib alpha chain,18509,159,1.04 [0.67-1.59],0.87299702760826
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP1BB,Platelet glycoprotein Ib beta chain,15718,133,1.19 [0.93-1.54],0.1682953529183279
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,17977,156,0.98 [0.83-1.17],0.8372903770882217
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP5,Platelet glycoprotein V,15945,138,0.81 [0.52-1.27],0.3628571659715878
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP6,Platelet glycoprotein VI,18550,160,1.06 [0.90-1.26],0.4785634245213307
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPA33,Cell surface A33 antigen,18490,159,1.01 [0.91-1.12],0.913616310943984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPC1,Glypican-1,18723,163,1.10 [0.69-1.75],0.6880706021823777
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPC5,Glypican-5,18398,157,0.58 [0.45-0.75],3.7829776132445374e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPD1,Glycerol-3-phosphate dehydrogenase,16206,140,1.29 [0.96-1.72],0.0872514293155866
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPHA2,Glycoprotein hormone alpha-2,16196,139,0.86 [0.57-1.31],0.4819922177104017
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPI,Glucose-6-phosphate isomerase,16290,140,1.16 [0.82-1.64],0.4106749889978288
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,16196,139,0.92 [0.73-1.15],0.4463348162459745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPKOW,G-patch domain and KOW motifs-containing protein,18150,155,1.47 [0.98-2.21],0.0652096937573143
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPNMB,Transmembrane glycoprotein NMB,18084,156,1.17 [0.71-1.94],0.5322976135776547
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR101,Probable G-protein coupled receptor 101,15723,135,0.99 [0.73-1.35],0.9723211803550008
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR158,Probable G-protein coupled receptor 158,16246,139,1.09 [0.69-1.73],0.7017937311806556
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR15L,Protein GPR15L,16196,139,1.66 [1.30-2.13],4.740555607489463e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR37,Prosaposin receptor GPR37,18206,158,1.70 [1.39-2.09],2.407499528360521e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPRC5C,G-protein coupled receptor family C group 5 member C,16206,140,1.43 [1.13-1.81],0.0034239134890356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRAP2,GRB2-related adapter protein 2,18584,161,1.03 [0.92-1.15],0.592900857029797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,16274,138,1.08 [0.83-1.42],0.5536779090772935
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRIK2,"Glutamate receptor ionotropic, kainate 2",16246,139,1.02 [0.70-1.48],0.9237813028716484
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",15723,135,0.81 [0.55-1.19],0.2812639666326504
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRK5,G protein-coupled receptor kinase 5,18206,158,1.05 [0.78-1.42],0.7379249112219841
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRN,Progranulin,18491,159,1.25 [0.72-2.18],0.4261132805750738
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRP,Gastrin-releasing peptide,15876,134,0.91 [0.68-1.23],0.5527926602003145
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRPEL1,"GrpE protein homolog 1, mitochondrial",18490,159,1.78 [1.47-2.15],1.9961325478367633e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRSF1,G-rich sequence factor 1,15620,138,1.10 [0.89-1.35],0.395117768628624
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSAP,Gamma-secretase-activating protein,18156,158,1.16 [1.00-1.35],0.05167158439569
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSN,Gelsolin,16236,140,0.48 [0.28-0.83],0.0083987703721187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSR,"Glutathione reductase, mitochondrial",16194,139,1.97 [0.97-4.00],0.0600146951038872
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTA1,Glutathione S-transferase A1,18554,161,0.93 [0.78-1.10],0.3949927611409841
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTA3,Glutathione S-transferase A3,18156,158,0.97 [0.80-1.17],0.7264673032931259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTM4,Glutathione S-transferase Mu 4,15718,133,1.24 [1.03-1.50],0.0254115493707454
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTP1,Glutathione S-transferase P,18032,153,1.09 [0.88-1.35],0.4135112799798197
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTT2B,Glutathione S-transferase theta-2B,16250,141,1.00 [0.93-1.07],0.9835023530384656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,15972,137,1.10 [0.89-1.36],0.3979368766479741
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GTPBP2,GTP-binding protein 2,15834,134,0.99 [0.80-1.23],0.9484491475090928
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUCA2A,Guanylin,18485,160,1.58 [1.10-2.26],0.0127994232775443
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUCY2C,Heat-stable enterotoxin receptor,15972,137,1.00 [0.81-1.23],0.9831725271045934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUK1,Guanylate kinase,15718,133,1.20 [0.81-1.77],0.3748192855162127
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUSB,Beta-glucuronidase,18679,162,1.60 [1.30-1.97],9.401598055349091e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GYS1,"Glycogen [starch] synthase, muscle",18206,158,1.17 [1.00-1.37],0.0537367203194407
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GZMA,Granzyme A,18753,162,1.37 [0.93-2.01],0.1138501385201459
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GZMB,Granzyme B,18533,160,1.04 [0.84-1.30],0.7051814318336285
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GZMH,Granzyme H,18206,158,1.23 [1.05-1.43],0.0088995465309772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",H2AP,Huntingtin-interacting protein M,15698,138,0.94 [0.67-1.34],0.7432869262683937
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",15718,133,1.00 [0.78-1.28],0.9746497952823306
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",18660,162,0.98 [0.81-1.19],0.8733774865834119
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAO1,Hydroxyacid oxidase 1,18723,163,1.12 [1.01-1.25],0.0375925546445122
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HARS1,"Histidine--tRNA ligase, cytoplasmic",18585,160,1.15 [0.95-1.39],0.1514234463378777
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,18690,162,2.03 [1.72-2.41],2.728521250228997e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,18585,160,2.04 [1.42-2.93],0.0001135634360156
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HBEGF,Proheparin-binding EGF-like growth factor,18660,162,0.90 [0.74-1.09],0.2871999180780056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HBQ1,Hemoglobin subunit theta-1,18723,163,1.01 [0.80-1.28],0.9174722588650664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HBZ,Hemoglobin subunit zeta,16274,138,0.89 [0.75-1.05],0.1531926328407207
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HCG22,Protein PBMUCL2,15718,133,1.01 [0.75-1.36],0.9465751092764528
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HCLS1,Hematopoietic lineage cell-specific protein,18753,162,1.20 [0.92-1.58],0.1771380504604393
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDAC8,Histone deacetylase 8,15792,137,0.82 [0.55-1.20],0.3033986142229887
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDAC9,Histone deacetylase 9,15723,135,0.98 [0.75-1.29],0.9050128868630004
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDDC2,5'-deoxynucleotidase HDDC2,16196,139,0.77 [0.52-1.13],0.178682753648708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDGF,Hepatoma-derived growth factor,18689,163,1.06 [0.91-1.24],0.4387746187855502
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDGFL2,Hepatoma-derived growth factor-related protein 2,16250,141,0.94 [0.71-1.24],0.6541292106422787
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEBP1,Heme-binding protein 1,18206,158,1.09 [0.83-1.44],0.5397688555804798
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEG1,Protein HEG homolog 1,15945,138,2.50 [1.38-4.54],0.0025949318652188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEPACAM2,HEPACAM family member 2,16250,141,0.89 [0.61-1.30],0.5495746551322895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEPH,Hephaestin,16274,138,1.46 [0.77-2.75],0.2437454065985335
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEXIM1,Protein HEXIM1,18533,160,1.21 [1.01-1.46],0.0354196089827363
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGF,Hepatocyte growth factor,18753,162,3.31 [2.45-4.48],8.493627710660283e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGFAC,Hepatocyte growth factor activator,16138,136,0.51 [0.36-0.72],0.0001219525276617
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,18156,158,1.13 [0.94-1.36],0.2034239188192736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HHEX,Hematopoietically-expressed homeobox protein HHEX,16250,141,1.18 [0.94-1.48],0.1456521805189868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIF1A,Hypoxia-inducible factor 1-alpha,15792,137,0.79 [0.57-1.09],0.1512742922909427
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIP1,Huntingtin-interacting protein 1,15718,133,1.42 [0.93-2.15],0.1008520548634012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIP1R,Huntingtin-interacting protein 1-related protein,16212,141,1.57 [1.18-2.08],0.0018377736269271
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HJV,Hemojuvelin,16246,139,1.20 [0.84-1.71],0.310441774209465
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HK2,Hexokinase-2,18206,158,1.20 [0.70-2.04],0.5135801388581078
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",16246,139,1.37 [0.83-2.28],0.2197565406395397
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",18487,158,1.73 [1.20-2.49],0.0034216330239193
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",18533,160,2.61 [1.77-3.84],1.0862276344805175e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMBS,Porphobilinogen deaminase,18723,163,0.90 [0.65-1.26],0.546609178324696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMCN2,Hemicentin-2,15922,137,1.27 [0.94-1.72],0.1214068774602907
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",15876,134,1.66 [1.22-2.26],0.0012153014945735
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",15718,133,1.54 [1.12-2.11],0.008433499477632
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMMR,Hyaluronan mediated motility receptor,15662,138,0.81 [0.55-1.21],0.3038176512290975
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMOX1,Heme oxygenase 1,18378,160,1.11 [0.83-1.48],0.4824456275276466
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMOX2,Heme oxygenase 2,18150,155,1.55 [1.19-2.01],0.0010435871477686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNF1A,Hepatocyte nuclear factor 1-alpha,15834,134,1.01 [0.79-1.29],0.9498120232575938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNMT,Histamine N-methyltransferase,18314,157,1.24 [0.92-1.67],0.1584978953801886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,18152,157,1.27 [1.05-1.52],0.0128141185591294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,16246,139,1.32 [0.98-1.80],0.0709947450944547
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPCAL1,Hippocalcin-like protein 1,18753,162,1.13 [0.92-1.38],0.2375210115643493
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPGDS,Hematopoietic prostaglandin D synthase,18156,158,0.50 [0.34-0.74],0.0004890841142584
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPSE,Heparanase,16055,139,1.18 [0.98-1.42],0.0738203627375264
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HRAS,GTPase Hras,15931,137,1.08 [0.92-1.26],0.3680929068002433
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,15876,134,1.13 [0.77-1.65],0.5314682382427518
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HRG,Histidine-rich glycoprotein,16208,136,0.61 [0.39-0.96],0.0327395641160178
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS1BP3,HCLS1-binding protein 3,15876,134,1.07 [0.88-1.30],0.5180279329696146
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,18490,159,1.05 [0.73-1.53],0.7796784267069595
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,18723,163,0.81 [0.54-1.20],0.2959056632912826
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,15792,137,1.51 [0.98-2.31],0.0615713160055794
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSBP1,Heat shock factor-binding protein 1,15876,134,1.08 [0.90-1.29],0.4132670722171515
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,18533,160,1.30 [0.92-1.83],0.1413556701719273
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,16250,141,1.17 [0.89-1.52],0.2625331567716156
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD17B3,Testosterone 17-beta-dehydrogenase 3,15718,133,1.07 [0.77-1.49],0.673938203832606
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,15876,134,1.71 [1.23-2.37],0.0013896829543805
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSP90B1,Endoplasmin,18059,154,0.97 [0.77-1.23],0.7998671488341642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPA1A,Heat shock 70 kDa protein 1A,18634,162,1.18 [0.96-1.44],0.1108757886784077
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPA2,Heat shock-related 70 kDa protein 2,16206,140,1.48 [0.97-2.25],0.0660908232147956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPB1,Heat shock protein beta-1,18301,158,1.17 [0.94-1.46],0.1673762979463595
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPB6,Heat shock protein beta-6,18723,163,1.75 [1.27-2.43],0.0007070953017445
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,18451,159,2.88 [1.98-4.18],2.7385002310529446e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HTR1A,5-hydroxytryptamine receptor 1A,15723,135,0.86 [0.66-1.12],0.2595593977989715
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HTR1B,5-hydroxytryptamine receptor 1B,15723,135,1.04 [0.71-1.53],0.8354718813605485
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HTRA2,"Serine protease HTRA2, mitochondrial",18648,157,1.33 [1.05-1.68],0.0160880242751093
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HYAL1,Hyaluronidase-1,18494,161,3.87 [2.31-6.46],2.44474178037878e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HYOU1,Hypoxia up-regulated protein 1,18801,163,1.13 [0.62-2.08],0.6830430390060585
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICA1,Islet cell autoantigen 1,18225,158,1.07 [0.89-1.29],0.4796132163274893
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM1,Intercellular adhesion molecule 1,18505,160,2.85 [1.91-4.23],2.41550220272354e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM2,Intercellular adhesion molecule 2,18801,163,2.10 [1.35-3.27],0.0010710807270494
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM3,Intercellular adhesion molecule 3,18801,163,2.19 [1.34-3.56],0.0016415108533014
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM4,Intercellular adhesion molecule 4,18533,160,0.91 [0.70-1.20],0.5078763191877225
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM5,Intercellular adhesion molecule 5,18584,161,1.88 [1.38-2.55],5.419858901332877e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICOSLG,ICOS ligand,18490,159,0.62 [0.30-1.31],0.2149952914243936
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ID4,DNA-binding protein inhibitor ID-4,15972,137,1.10 [0.75-1.63],0.6246113519808556
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDI2,Isopentenyl-diphosphate delta-isomerase 2,18150,155,1.20 [0.90-1.62],0.2155931493949224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDO1,"Indoleamine 2,3-dioxygenase 1",15876,134,1.21 [0.96-1.53],0.1106846024438057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDS,Iduronate 2-sulfatase,18753,162,0.19 [0.05-0.70],0.0123931478516567
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDUA,Alpha-L-iduronidase,18723,163,1.64 [1.20-2.24],0.0018853290159363
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,15787,134,2.69 [1.92-3.76],9.841486599596327e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,15972,137,1.17 [0.85-1.61],0.3361375888808543
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,15972,137,1.23 [0.81-1.88],0.3294185871931437
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNAR1,Interferon alpha/beta receptor 1,16196,139,1.21 [0.63-2.35],0.5654839764306688
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNG,Interferon gamma,18225,158,1.16 [1.02-1.32],0.0290395510856442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNGR1,Interferon gamma receptor 1,18660,162,2.50 [1.34-4.65],0.0039550480552137
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNGR2,Interferon gamma receptor 2,18398,157,1.46 [1.13-1.90],0.0043093049230985
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNL1,Interferon lambda-1,18150,155,1.21 [0.92-1.59],0.1712244723729218
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNL2,Interferon lambda-2,15723,135,1.17 [0.91-1.50],0.215608148553186
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNLR1,Interferon lambda receptor 1,18533,160,1.31 [0.93-1.85],0.1282222234948122
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNW1,Interferon omega-1,15718,133,1.29 [0.91-1.84],0.1489412106774471
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFT20,Intraflagellar transport protein 20 homolog,15834,134,1.04 [0.69-1.58],0.842659787108403
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGBP1,Immunoglobulin-binding protein 1,16246,139,0.93 [0.71-1.22],0.5890518076529803
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,15723,135,0.93 [0.64-1.35],0.6963616956934704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,16282,139,1.21 [0.65-2.26],0.5406578405239733
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF1R,Insulin-like growth factor 1 receptor,18490,159,2.98 [1.71-5.19],0.0001166035965829
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,15718,133,0.77 [0.49-1.21],0.2555237796679148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF2R,Cation-independent mannose-6-phosphate receptor,18585,160,2.46 [1.35-4.48],0.0033446534458876
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP1,Insulin-like growth factor-binding protein 1,18772,163,1.26 [1.12-1.42],9.693699575261958e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,18781,163,1.76 [1.39-2.22],2.818112662111276e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP3,Insulin-like growth factor-binding protein 3,18671,161,0.29 [0.21-0.40],4.259189031723861e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,18342,158,1.83 [1.45-2.32],4.60410369228008e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP6,Insulin-like growth factor-binding protein 6,18507,161,1.84 [1.31-2.59],0.0004520025043974
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,18801,163,2.78 [2.09-3.72],3.613579270244429e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,18584,161,2.68 [1.91-3.77],1.1504594966265011e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFL4,Insulin growth factor-like family member 4,15792,137,0.75 [0.55-1.02],0.0676319547481494
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGHMBP2,DNA-binding protein SMUBP-2,15718,133,1.11 [0.80-1.53],0.5267666701931694
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGLC2,Immunoglobulin lambda constant 2,16270,137,2.42 [1.75-3.36],1.1743482113924421e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGLON5,IgLON family member 5,15698,138,1.00 [0.83-1.19],0.9641810224511186
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF21,Immunoglobulin superfamily member 21,15876,134,1.24 [0.83-1.86],0.285520925883323
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF3,Immunoglobulin superfamily member 3,18490,159,1.99 [1.52-2.61],5.603659810975005e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,18584,161,1.89 [1.26-2.83],0.0020542049552525
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF9,Protein turtle homolog A,16274,138,1.28 [1.06-1.55],0.008957293194851
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IKBKG,NF-kappa-B essential modulator,18533,160,1.08 [0.91-1.27],0.3746985429775727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IKZF2,Zinc finger protein Helios,18156,158,1.08 [0.91-1.27],0.3782178517712241
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10,Interleukin-10,18225,158,0.94 [0.78-1.12],0.4787147748915844
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RA,Interleukin-10 receptor subunit alpha,18225,158,1.03 [0.79-1.33],0.8264255439980884
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,18660,162,3.07 [2.12-4.45],2.866057785485076e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL11,Interleukin-11,18225,158,0.86 [0.67-1.11],0.2540497920339872
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12A_IL12B,Interleukin-12,18490,159,1.15 [0.97-1.36],0.1071401949970491
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12B,Interleukin-12 subunit beta,18753,162,1.26 [0.99-1.60],0.0590777813667086
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12RB1,Interleukin-12 receptor subunit beta-1,18225,158,1.53 [1.08-2.18],0.0181079673026567
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12RB2,Interleukin-12 receptor subunit beta-2,15792,137,1.09 [0.71-1.65],0.701845793815473
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL13,Interleukin-13,18225,158,1.06 [0.78-1.43],0.7196692183456302
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL13RA1,Interleukin-13 receptor subunit alpha-1,18375,154,0.74 [0.39-1.41],0.3618833757412039
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL13RA2,Interleukin-13 receptor subunit alpha-2,15723,135,1.43 [0.80-2.55],0.2274125466478277
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15,Interleukin-15,18533,160,2.48 [1.66-3.69],8.074211935858238e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15RA,Interleukin-15 receptor subunit alpha,18225,158,1.69 [1.12-2.53],0.0118110035674243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL16,Pro-interleukin-16,18753,162,1.18 [0.85-1.64],0.3245501223236394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17A,Interleukin-17A,18196,158,1.53 [1.16-2.01],0.0026574020369849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17C,Interleukin-17C,18225,158,1.36 [1.15-1.62],0.0003961143822419
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17D,Interleukin-17D,18225,158,1.12 [0.75-1.68],0.5673190668541412
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17F,Interleukin-17F,18225,158,1.05 [0.87-1.26],0.6073006558085194
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17RA,Interleukin-17 receptor A,18585,160,1.24 [0.89-1.72],0.2077826770522242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17RB,Interleukin-17 receptor B,18307,159,0.66 [0.50-0.87],0.002877094656655
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18,Interleukin-18,18522,161,1.84 [1.38-2.44],3.074794204181252e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18BP,Interleukin-18-binding protein,18671,161,2.75 [1.89-4.00],1.127681986363233e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18R1,Interleukin-18 receptor 1,18753,162,1.93 [1.29-2.90],0.0013592014748417
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18RAP,Interleukin-18 receptor accessory protein,18282,157,0.94 [0.86-1.02],0.156470578021741
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL19,Interleukin-19,18114,158,1.85 [1.59-2.15],2.7474417107974414e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1A,Interleukin-1 alpha,18225,158,1.03 [0.81-1.32],0.8148176982685889
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1B,Interleukin-1 beta,18141,157,1.30 [1.03-1.63],0.024746714266676
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1R1,Interleukin-1 receptor type 1,18558,160,3.23 [1.83-5.67],4.747556604201737e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1R2,Interleukin-1 receptor type 2,18552,162,0.69 [0.34-1.38],0.2957571902744889
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RAP,Interleukin-1 receptor accessory protein,18585,160,0.39 [0.28-0.55],7.46772405599966e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL1,Interleukin-1 receptor-like 1,18745,163,2.26 [1.70-2.99],1.3829251327463956e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL2,Interleukin-1 receptor-like 2,18225,158,0.26 [0.19-0.37],5.3211782583201626e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RN,Interleukin-1 receptor antagonist protein,18538,162,1.33 [1.06-1.65],0.0128068205231879
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2,Interleukin-2,18225,158,0.75 [0.47-1.20],0.234129246774032
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL20,Interleukin-20,18225,158,1.08 [0.82-1.42],0.6047251192947001
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL20RA,Interleukin-20 receptor subunit alpha,18225,158,1.01 [0.72-1.42],0.9372918775756864
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL20RB,Interleukin-20 receptor subunit beta,15792,137,0.91 [0.60-1.37],0.6436905418064874
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL21R,Interleukin-21 receptor,15792,137,1.03 [0.76-1.38],0.8687842631667044
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL22,Interleukin-22,16206,140,1.73 [1.44-2.08],3.6233036953385837e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL22RA1,Interleukin-22 receptor subunit alpha-1,18225,158,0.91 [0.63-1.29],0.5863783810020213
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL24,Interleukin-24,18225,158,1.00 [0.75-1.34],0.9959988645578446
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL25,Interleukin-25,15644,138,1.02 [0.63-1.67],0.9209607449619804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,18417,160,2.50 [1.87-3.34],7.266908794885804e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RB,Interleukin-2 receptor subunit beta,18225,158,0.75 [0.49-1.15],0.1890024803612763
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RG,Cytokine receptor common subunit gamma,16206,140,1.15 [0.80-1.65],0.4627404860900704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL3,Interleukin-3,15698,138,1.24 [0.92-1.68],0.1537960449921853
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL31,Interleukin-31,15792,137,1.06 [0.78-1.45],0.690436854371922
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL31RA,Interleukin-31 receptor subunit alpha,15722,135,0.88 [0.55-1.39],0.5751320055584421
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL32,Interleukin-32,18533,160,1.58 [1.18-2.10],0.001873214384615
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL33,Interleukin-33,18225,158,1.04 [0.71-1.53],0.8356570797180969
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL34,Interleukin-34,18124,154,1.21 [0.80-1.82],0.3595358275180758
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL36A,Interleukin-36 alpha,15792,137,1.22 [0.93-1.60],0.1559665823868349
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL36G,Interleukin-36 gamma,15721,137,1.30 [1.07-1.58],0.0091748488900766
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL3RA,Interleukin-3 receptor subunit alpha,18225,158,1.82 [1.20-2.77],0.0052145782952172
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL4,Interleukin-4,18225,158,0.90 [0.78-1.03],0.1217921462340262
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,18533,160,2.21 [1.62-3.01],4.429903041245586e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL5,Interleukin-5,18225,158,0.97 [0.87-1.08],0.534322538470461
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL5RA,Interleukin-5 receptor subunit alpha,18533,160,1.09 [0.86-1.39],0.4625609957759096
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6,Interleukin-6,18490,159,1.67 [1.49-1.87],3.6310319321171137e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6R,Interleukin-6 receptor subunit alpha,18483,160,1.26 [0.83-1.92],0.2740752727715568
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6ST,Interleukin-6 receptor subunit beta,18584,161,4.16 [1.89-9.16],0.0003966806620316
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL7,Interleukin-7,18533,160,0.99 [0.79-1.24],0.9396204846506792
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL7R,Interleukin-7 receptor subunit alpha,18585,160,0.89 [0.68-1.15],0.3634175930523463
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL9,Interleukin-9,15972,137,0.99 [0.72-1.35],0.9431828793352864
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,18114,154,1.27 [1.01-1.61],0.0403294675790493
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMMT,MICOS complex subunit MIC60,16206,140,1.64 [1.23-2.18],0.0007675316402271
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMPA1,Inositol monophosphatase 1,18398,157,1.07 [0.84-1.37],0.5734231879508898
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMPACT,Protein IMPACT,16250,141,0.97 [0.71-1.31],0.8409336824998582
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMPG1,Interphotoreceptor matrix proteoglycan 1,15723,135,1.43 [0.84-2.43],0.1932059668321852
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ING1,Inhibitor of growth protein 1,18121,155,1.02 [0.74-1.41],0.898144145944108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INHBB,Inhibin beta B chain,15945,138,1.76 [1.35-2.29],2.412489640283841e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INHBC,Inhibin beta C chain,18585,160,1.08 [0.75-1.56],0.6739614938638648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPP1,Inositol polyphosphate 1-phosphatase,18490,159,1.18 [0.90-1.54],0.2307451904080834
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",15876,134,1.19 [0.88-1.60],0.262508850705536
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",16246,139,1.00 [0.68-1.48],0.9816963981949752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",18490,159,1.15 [0.99-1.34],0.0702424712627639
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL3,Insulin-like 3,16250,141,1.10 [0.98-1.24],0.1125395225624062
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL4,Early placenta insulin-like peptide,16206,140,1.33 [1.02-1.75],0.037825960997284
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL5,Insulin-like peptide INSL5,16196,139,1.26 [1.08-1.47],0.0025928715377758
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSR,Insulin receptor,15792,137,3.51 [1.37-8.96],0.0087911608569296
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IPCEF1,Interactor protein for cytohesin exchange factors 1,18368,157,1.12 [0.95-1.33],0.1674562532091001
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IQGAP2,Ras GTPase-activating-like protein IQGAP2,18490,159,1.29 [0.99-1.68],0.0565258115786598
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",18206,158,1.25 [1.07-1.46],0.0046339264488108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IRAK1,Interleukin-1 receptor-associated kinase 1,18225,158,1.22 [0.98-1.51],0.0705625111052791
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IRAK4,Interleukin-1 receptor-associated kinase 4,18533,160,1.02 [0.88-1.17],0.8073478473301259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,17918,151,0.96 [0.65-1.41],0.8300826173070097
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ISM1,Isthmin-1,18533,160,0.96 [0.67-1.39],0.8472825844438631
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ISM2,Isthmin-2,16282,139,1.27 [0.86-1.86],0.2258093982398247
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IST1,IST1 homolog,16079,139,1.05 [0.89-1.25],0.5486086921092981
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA11,Integrin alpha-11,18533,160,0.57 [0.39-0.85],0.005466630529161
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA2,Integrin alpha-2,15945,138,0.53 [0.33-0.84],0.0064561523217608
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA5,Integrin alpha-5,18585,160,2.21 [1.28-3.83],0.0046419090279886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA6,Integrin alpha-6,18533,160,0.98 [0.74-1.30],0.8903430031135366
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAL,Integrin alpha-L,15792,137,1.46 [0.97-2.21],0.0684024286367898
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAM,Integrin alpha-M,18585,160,0.58 [0.37-0.93],0.0222073252146742
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAV,Integrin alpha-V,18723,163,0.23 [0.11-0.50],0.0002095350971286
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAX,Integrin alpha-X,15972,137,1.21 [0.93-1.58],0.1572570304910713
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB1,Integrin beta-1,18575,160,1.10 [0.58-2.08],0.7792689696675403
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB1BP1,Integrin beta-1-binding protein 1,18156,158,1.16 [0.82-1.64],0.4095590661774465
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB1BP2,Integrin beta-1-binding protein 2,18206,158,1.16 [1.02-1.33],0.0287116525351755
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB2,Integrin beta-2,18463,162,0.56 [0.34-0.92],0.0220578371098981
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB5,Integrin beta-5,18648,157,1.26 [0.87-1.82],0.2262017473749118
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB6,Integrin beta-6,18225,158,1.42 [0.91-2.24],0.1246053138125114
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB7,Integrin beta-7,18723,163,1.22 [0.91-1.63],0.1897098093210792
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGBL1,Integrin beta-like protein 1,16282,139,2.24 [1.62-3.11],1.3283799299896898e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,16302,138,0.86 [0.34-2.21],0.7589617863197453
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,18671,161,1.58 [1.10-2.28],0.014146769963055
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,16302,138,0.92 [0.50-1.70],0.7924822237033649
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,16206,140,1.36 [0.97-1.92],0.0741219837822331
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITM2A,Integral membrane protein 2A,18533,160,0.97 [0.77-1.22],0.7912743931834278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITPA,Inosine triphosphate pyrophosphatase,15718,133,1.17 [0.91-1.51],0.2199962842237707
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",15876,134,1.14 [0.91-1.42],0.2702463227486569
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",15723,135,1.28 [0.89-1.83],0.1782551934653156
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",18150,155,1.36 [1.04-1.79],0.0257633069827458
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IZUMO1,Izumo sperm-egg fusion protein 1,15698,138,1.28 [0.95-1.73],0.1025247415371094
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JAM2,Junctional adhesion molecule B,18723,162,1.87 [1.19-2.95],0.0069319979238656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JAM3,Junctional adhesion molecule C,15945,138,1.49 [1.10-2.04],0.0109301544942202
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JCHAIN,Immunoglobulin J chain,18225,158,1.45 [1.17-1.81],0.000832811508329
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,15698,138,0.92 [0.67-1.25],0.5817379549598214
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JPT2,Jupiter microtubule associated homolog 2,16196,139,1.09 [0.89-1.32],0.4088174677911272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JUN,Transcription factor AP-1,18225,158,1.26 [0.99-1.62],0.0648681981399062
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,18490,159,1.09 [0.80-1.49],0.5815170011512798
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KAZN,Kazrin,16196,139,1.13 [0.96-1.33],0.1419267676073238
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCNC4,Potassium voltage-gated channel subfamily C member 4,15723,135,1.02 [0.75-1.40],0.8921266396541877
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCNH2,Potassium voltage-gated channel subfamily H member 2,15834,134,1.07 [0.85-1.34],0.5886946947088667
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCNIP4,Kv channel-interacting protein 4,18150,155,0.80 [0.56-1.13],0.2056495278621928
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCTD5,BTB/POZ domain-containing protein KCTD5,15957,139,1.33 [0.97-1.84],0.0784726463642636
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KDM3A,Lysine-specific demethylase 3A,15792,137,0.93 [0.72-1.18],0.541796863828611
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KDR,Vascular endothelial growth factor receptor 2,18648,157,0.65 [0.37-1.14],0.1354945129178404
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KEL,Kell blood group glycoprotein,18150,155,1.45 [0.99-2.13],0.057048664213191
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KHDC3L,KH domain-containing protein 3,15698,138,0.98 [0.76-1.25],0.8424227465273998
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KHK,Ketohexokinase,15876,134,1.25 [0.96-1.64],0.0993241101648118
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA0319,Dyslexia-associated protein KIAA0319,16250,141,1.11 [0.66-1.88],0.6959827890049098
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA1549,UPF0606 protein KIAA1549,15972,137,0.97 [0.75-1.25],0.7972481287828934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA1549L,UPF0606 protein KIAA1549L,15972,137,1.12 [0.66-1.91],0.670593494205677
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA2013,Uncharacterized protein KIAA2013,16206,140,0.92 [0.65-1.31],0.635905923320193
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIF1C,Kinesin-like protein KIF1C,15718,133,1.63 [1.15-2.32],0.0064051239108216
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIF20B,Kinesin-like protein KIF20B,15723,135,0.82 [0.64-1.05],0.1126527741010771
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIF22,Kinesin-like protein KIF22,15718,133,1.04 [0.90-1.20],0.580622890423059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIFBP,KIF-binding protein,18490,159,1.08 [0.90-1.30],0.3820000363157664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,16206,140,1.25 [1.04-1.49],0.0170261157340265
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,18156,158,1.25 [1.05-1.50],0.0135645514444901
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,16196,139,1.01 [0.91-1.11],0.8620178134920232
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,18156,158,1.00 [0.89-1.13],0.9476255657165022
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,15698,138,1.18 [1.01-1.38],0.0327720768229334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIRREL1,Kin of IRRE-like protein 1,15723,135,1.11 [0.85-1.45],0.4382768974522825
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIRREL2,Kin of IRRE-like protein 2,18150,155,0.88 [0.61-1.27],0.4838213468596672
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIT,Mast/stem cell growth factor receptor Kit,18634,161,0.42 [0.26-0.67],0.0002453440379917
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KITLG,Kit ligand,18584,161,0.52 [0.37-0.73],0.0001728248567712
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLB,Beta-klotho,18150,155,1.07 [0.88-1.31],0.4843834186605762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLF4,Krueppel-like factor 4,15723,135,1.23 [0.81-1.87],0.3341056117759875
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLHL41,Kelch-like protein 41,16246,139,1.03 [0.73-1.44],0.8696899699727828
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK1,Kallikrein-1,18408,155,1.09 [0.98-1.20],0.1171220608971024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK10,Kallikrein-10,18597,156,1.88 [1.42-2.50],1.370195576608423e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK11,Kallikrein-11,18478,156,2.29 [1.76-2.98],6.62636014565334e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK12,Kallikrein-12,18156,158,1.00 [0.90-1.11],0.9870940258643928
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK13,Kallikrein-13,18169,154,1.18 [0.87-1.61],0.2804479879844751
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK14,Kallikrein-14,18723,163,1.45 [1.10-1.91],0.0087908254725761
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK15,Kallikrein-15,16170,140,1.10 [0.81-1.49],0.5467402803563084
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK3,Prostate-specific antigen,16282,139,1.09 [0.99-1.20],0.0684308901430825
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK4,Kallikrein-4,18723,163,1.65 [1.37-1.98],1.3820680235226145e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK6,Kallikrein-6,18612,157,1.13 [0.71-1.80],0.6095868942358433
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK7,Kallikrein-7,15539,136,0.76 [0.48-1.20],0.2407936203739776
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK8,Kallikrein-8,17978,152,2.03 [1.42-2.88],8.595616714213031e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLKB1,Plasma kallikrein,15946,135,0.17 [0.09-0.31],4.940440022729664e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRB1,Killer cell lectin-like receptor subfamily B member 1,18753,162,1.36 [0.97-1.89],0.0722613007819589
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,15723,135,1.23 [0.98-1.55],0.0745271257057933
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRD1,Natural killer cells antigen CD94,18753,162,1.54 [1.14-2.07],0.0044292494688206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRF1,Killer cell lectin-like receptor subfamily F member 1,15792,137,1.40 [1.03-1.90],0.0328477651425639
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRK1,NKG2-D type II integral membrane protein,16250,141,1.10 [0.78-1.57],0.5806688220596243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT14,"Keratin, type I cytoskeletal 14",17567,150,0.79 [0.45-1.41],0.4333467437263267
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT17,"Keratin, type I cytoskeletal 17",15718,133,0.95 [0.61-1.50],0.8305933341526794
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT18,"Keratin, type I cytoskeletal 18",18490,159,1.29 [1.11-1.50],0.0009767728988249
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT19,"Keratin, type I cytoskeletal 19",18495,160,1.14 [0.94-1.38],0.1712210877966259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT5,"Keratin, type II cytoskeletal 5",18150,155,1.08 [0.82-1.43],0.5784048813607061
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT6C,"Keratin, type II cytoskeletal 6C",15718,133,1.81 [1.31-2.49],0.0003184393773569
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT8,"Keratin, type II cytoskeletal 8",15723,135,1.28 [1.10-1.50],0.0014305780195343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KYAT1,Kynurenine--oxoglutarate transaminase 1,18557,161,1.17 [0.91-1.49],0.2171450420292086
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KYNU,Kynureninase,18753,162,1.24 [0.92-1.69],0.1628596493835507
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",L1CAM,Neural cell adhesion molecule L1,18648,157,1.23 [0.75-2.00],0.4117043907617413
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,16274,138,1.20 [1.00-1.44],0.0528702586340347
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LACRT,Extracellular glycoprotein lacritin,16178,140,0.92 [0.64-1.32],0.6373675128624368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LACTB2,Endoribonuclease LACTB2,18584,161,1.17 [0.94-1.46],0.1532564504342584
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAG3,Lymphocyte activation gene 3 protein,18490,159,1.11 [0.79-1.54],0.5507708678471368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,18581,162,2.45 [1.86-3.24],2.7165404449945757e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,18398,157,1.11 [0.96-1.27],0.1584516638965417
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMA1,Laminin subunit alpha-1,15718,133,0.96 [0.68-1.34],0.8049022249961081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMA4,Laminin subunit alpha-4,18660,162,2.17 [1.47-3.22],0.0001125461912326
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMB1,Laminin subunit beta-1,15876,134,1.15 [0.66-2.01],0.6144356871328094
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP1,Lysosome-associated membrane glycoprotein 1,15801,137,1.62 [1.14-2.29],0.0067285045785174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP2,Lysosome-associated membrane glycoprotein 2,18002,158,0.80 [0.41-1.58],0.5233995708418084
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP3,Lysosome-associated membrane glycoprotein 3,18722,162,1.79 [1.40-2.31],4.715134565810966e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMTOR5,Ragulator complex protein LAMTOR5,16206,140,0.86 [0.55-1.33],0.4960907645318848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAP3,Cytosol aminopeptidase,18225,158,1.16 [0.87-1.55],0.3071406033280643
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LARP1,La-related protein 1,16206,140,1.06 [0.81-1.37],0.6757267741422779
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAT,Linker for activation of T-cells family member 1,18753,162,1.12 [0.92-1.36],0.247100614682468
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAT2,Linker for activation of T-cells family member 2,18490,159,1.07 [0.95-1.20],0.2602262581379392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LATS1,Serine/threonine-protein kinase LATS1,15792,137,1.03 [0.84-1.27],0.7690750440793538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAYN,Layilin,18369,157,2.01 [1.44-2.80],3.950312022421797e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LBP,Lipopolysaccharide-binding protein,18671,161,1.86 [1.48-2.35],1.266639402383334e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LBR,Delta(14)-sterol reductase LBR,18723,162,1.37 [1.14-1.63],0.0005626953235576
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCAT,Phosphatidylcholine-sterol acyltransferase,16290,140,0.24 [0.13-0.46],1.2526895766826235e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCN15,Lipocalin-15,16246,139,1.10 [0.86-1.41],0.4322693446274461
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,18034,153,1.89 [1.42-2.51],1.1688222541238511e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCP1,Plastin-2,16282,139,0.99 [0.70-1.40],0.9465960670540072
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LDLR,Low-density lipoprotein receptor,18619,161,0.57 [0.43-0.75],6.880441368009113e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LDLRAP1,Low density lipoprotein receptor adapter protein 1,16246,139,1.08 [0.91-1.28],0.3987650067614159
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LECT2,Leukocyte cell-derived chemotaxin-2,16274,138,1.26 [0.99-1.60],0.058856429560905
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEFTY2,Left-right determination factor 2,18693,163,0.86 [0.66-1.12],0.2553065716204784
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEG1,Protein LEG1 homolog,15439,133,1.48 [1.18-1.85],0.0005522660709808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LELP1,Late cornified envelope-like proline-rich protein 1,15723,135,0.93 [0.74-1.17],0.5400042694000182
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEO1,RNA polymerase-associated protein LEO1,16246,139,1.37 [0.96-1.96],0.0831597463758566
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEP,Leptin,18584,161,0.89 [0.76-1.04],0.1358894070687855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEPR,Leptin receptor,18584,161,1.32 [0.85-2.05],0.2091527357125163
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LETM1,Mitochondrial proton/calcium exchanger protein,16246,139,1.63 [1.25-2.13],0.00035348819264
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS1,Galectin-1,18584,161,1.63 [1.13-2.35],0.0087708017655898
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3,Galectin-3,18625,163,1.00 [0.63-1.58],0.988048795733264
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3BP,Galectin-3-binding protein,16302,138,2.86 [1.94-4.22],1.0120494911564633e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS4,Galectin-4,18581,162,2.00 [1.60-2.49],7.14398369013708e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS7_LGALS7B,Galectin-7,18496,160,2.00 [1.54-2.59],1.5342529797243613e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS8,Galectin-8,18723,162,1.13 [0.90-1.43],0.2989116873549072
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS9,Galectin-9,18573,162,2.66 [1.80-3.92],7.998346607170662e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGMN,Legumain,18660,162,2.73 [1.88-3.95],1.264343732754352e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LHB,Lutropin subunit beta,18156,158,0.87 [0.73-1.04],0.1215619579999146
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,18594,162,0.98 [0.77-1.23],0.8348562673396295
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIF,Leukemia inhibitory factor,18150,155,1.17 [0.89-1.54],0.2560052611520207
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIFR,Leukemia inhibitory factor receptor,18533,160,2.57 [1.49-4.44],0.0007091677965238
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,18585,160,1.45 [0.97-2.16],0.0690478982870488
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,16282,139,1.05 [0.92-1.19],0.4715926980482574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,15718,133,1.12 [0.82-1.52],0.4719357238471489
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,18550,161,3.00 [1.96-4.58],4.01888223908768e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,16274,138,1.32 [1.05-1.67],0.0165493529220051
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,18801,163,1.08 [0.66-1.78],0.7583820641147281
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,18725,163,1.19 [0.79-1.79],0.4151830263705621
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,18225,158,1.59 [1.19-2.13],0.0018926217815049
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,18801,163,0.86 [0.71-1.04],0.1229414937830561
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIPF,Gastric triacylglycerol lipase,15876,134,0.90 [0.69-1.16],0.4069836055678367
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMNB1,Lamin-B1,16167,139,1.22 [0.94-1.57],0.1324284557070211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMNB2,Lamin-B2,16250,141,2.03 [1.27-3.25],0.003100934045619
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMOD1,Leiomodin-1,16246,139,1.48 [1.02-2.13],0.036462315585492
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMOD2,Leiomodin-2,15723,135,1.21 [0.94-1.54],0.1341633623928217
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LONP1,"Lon protease homolog, mitochondrial",15876,134,1.43 [1.19-1.72],0.0001824890147772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPA,Apolipoprotein(a),15932,135,1.01 [0.92-1.11],0.8578142417638661
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPCAT2,Lysophosphatidylcholine acyltransferase 2,18490,159,1.26 [0.96-1.66],0.0999878721534625
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPL,Lipoprotein lipase,18584,161,0.84 [0.64-1.10],0.1988261825123681
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPO,Lactoperoxidase,17932,154,1.63 [1.30-2.04],2.3066605497708626e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPP,Lipoma-preferred partner,15718,133,1.02 [0.78-1.33],0.8999319886272442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,15718,133,1.22 [0.94-1.58],0.1284372199607586
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,15834,134,0.95 [0.65-1.40],0.8043767832544889
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRG1,Leucine-rich alpha-2-glycoprotein,16302,138,2.43 [1.39-4.24],0.0018536064315847
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,18660,162,1.49 [1.01-2.20],0.0428507448214531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,15736,137,1.61 [0.97-2.68],0.0643978362583087
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP1,Prolow-density lipoprotein receptor-related protein 1,18490,159,1.82 [1.11-3.01],0.0185784401131026
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP11,Low-density lipoprotein receptor-related protein 11,18584,161,1.56 [1.08-2.24],0.0175561971117774
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP2,Low-density lipoprotein receptor-related protein 2,15834,134,0.85 [0.52-1.37],0.500492574700304
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP2BP,LRP2-binding protein,15834,134,1.06 [0.86-1.29],0.5978777735524782
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,18723,162,1.34 [1.10-1.64],0.0037362421037745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC25,Leucine-rich repeat-containing protein 25,18490,159,1.57 [1.14-2.16],0.0054125275301233
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC37A2,Leucine-rich repeat-containing protein 37A2,16196,139,0.95 [0.64-1.39],0.7833598122845882
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC38,Leucine-rich repeat-containing protein 38,15834,134,1.10 [0.78-1.56],0.5865419513485118
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC59,Leucine-rich repeat-containing protein 59,16274,138,1.27 [0.92-1.75],0.1407583748398583
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,16206,140,1.41 [1.01-1.96],0.0411286207727616
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRN1,Leucine-rich repeat neuronal protein 1,18225,158,0.50 [0.36-0.71],0.0001082986661239
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,15834,134,1.32 [0.92-1.89],0.1271042270753986
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,16246,139,0.99 [0.54-1.83],0.9815132307490684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LSM1,U6 snRNA-associated Sm-like protein LSm1,18156,158,0.87 [0.66-1.16],0.3446207138788552
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LSM8,U6 snRNA-associated Sm-like protein LSm8,15972,137,0.93 [0.74-1.16],0.523368021398019
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LSP1,Lymphocyte-specific protein 1,18533,160,1.22 [0.85-1.76],0.2792851374108168
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTA,Lymphotoxin-alpha,18533,160,0.99 [0.70-1.40],0.9623817276109582
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTA4H,Leukotriene A-4 hydrolase,18723,163,0.99 [0.78-1.26],0.9489336679081658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTB,Lymphotoxin-beta,16206,140,0.51 [0.29-0.90],0.0192616941393356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,18801,163,2.22 [1.52-3.24],3.226555719960091e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP3,Latent-transforming growth factor beta-binding protein 3,18156,158,1.44 [1.16-1.77],0.0007340483066197
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,18499,162,3.38 [2.31-4.94],3.5400514902831973e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTO1,Protein LTO1 homolog,18225,158,1.06 [0.75-1.50],0.7468635264736339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LUZP2,Leucine zipper protein 2,16206,140,0.95 [0.65-1.39],0.8077475080232843
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LXN,Latexin,18321,156,0.92 [0.74-1.15],0.4643993987591643
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY6D,Lymphocyte antigen 6D,18484,161,1.71 [1.28-2.29],0.0003307982662936
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY75,Lymphocyte antigen 75,18533,160,0.85 [0.59-1.22],0.3805855404716582
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY9,T-lymphocyte surface antigen Ly-9,18335,158,2.24 [1.44-3.49],0.0003389979291364
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY96,Lymphocyte antigen 96,18398,157,3.32 [2.44-4.52],2.3778490516124574e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYAR,Cell growth-regulating nucleolar protein,18156,158,0.95 [0.71-1.27],0.7222662449864817
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYN,Tyrosine-protein kinase Lyn,18490,159,1.12 [0.94-1.33],0.2139935477338113
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPD1,Ly6/PLAUR domain-containing protein 1,18150,155,1.07 [0.86-1.33],0.5536090962180256
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPD3,Ly6/PLAUR domain-containing protein 3,18499,157,1.51 [1.01-2.27],0.0456478710528007
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPD8,Ly6/PLAUR domain-containing protein 8,18156,158,1.65 [1.32-2.06],1.229698119224587e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPLA2,Acyl-protein thioesterase 2,15723,135,0.97 [0.82-1.14],0.6866254664355189
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,15834,134,1.03 [0.89-1.21],0.6763887445881127
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,16302,138,2.41 [1.07-5.42],0.0328873606407715
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYZL2,Lysozyme-like protein 2,15698,138,1.08 [0.70-1.68],0.7175913105530909
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LZTFL1,Leucine zipper transcription factor-like protein 1,15945,138,0.90 [0.70-1.15],0.3979278774601964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",M6PR,Cation-dependent mannose-6-phosphate receptor,15876,134,1.65 [1.19-2.30],0.0028149889167265
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,18329,156,1.43 [1.14-1.78],0.0016732647034018
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAEA,E3 ubiquitin-protein transferase MAEA,18156,158,1.02 [0.70-1.51],0.9029962648623936
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAG,Myelin-associated glycoprotein,15834,134,1.27 [0.88-1.82],0.2017106659117546
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAGEA3,Melanoma-associated antigen 3,15972,137,0.99 [0.81-1.20],0.8874565218412934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAGED1,Melanoma-associated antigen D1,18156,158,1.02 [0.75-1.38],0.9204223276553828
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAMDC2,MAM domain-containing protein 2,16274,138,2.01 [1.35-3.00],0.0005855078544211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAMDC4,Apical endosomal glycoprotein,16206,140,0.98 [0.74-1.31],0.9107346763793523
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",15876,134,1.05 [0.54-2.04],0.8822149546113509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAN2B2,Epididymis-specific alpha-mannosidase,16274,138,1.26 [0.95-1.67],0.1048353947862722
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",15698,138,1.19 [0.86-1.65],0.2952905813862297
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANF,Mesencephalic astrocyte-derived neurotrophic factor,18660,162,1.08 [0.95-1.22],0.2412862398173081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANSC1,MANSC domain-containing protein 1,18648,157,1.86 [1.12-3.07],0.0163013736294573
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANSC4,MANSC domain-containing protein 4,15718,133,1.05 [0.83-1.33],0.6917111910803764
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,15723,135,1.78 [1.02-3.09],0.0408229872090889
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,15718,133,1.12 [0.90-1.39],0.3066868170637243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP2,Microtubule-associated protein 2,16250,141,1.56 [1.15-2.11],0.0039542747065533
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,16196,139,1.09 [0.84-1.41],0.5048236951665422
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,18533,160,1.02 [0.88-1.18],0.7719714228839769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,18156,158,1.10 [0.95-1.28],0.2032945167310248
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,18369,157,1.07 [0.93-1.22],0.3489690406076137
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPK13,Mitogen-activated protein kinase 13,15698,138,1.17 [0.79-1.73],0.4267845482386838
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPK9,Mitogen-activated protein kinase 9,18533,160,1.02 [0.72-1.43],0.9280405191675376
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPKAPK2,MAP kinase-activated protein kinase 2,15972,137,1.14 [0.90-1.43],0.2721691985447093
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPRE3,Microtubule-associated protein RP/EB family member 3,15698,138,1.01 [0.89-1.14],0.9118413629411526
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPT,Microtubule-associated protein tau,18150,155,1.23 [0.93-1.64],0.1501021549188229
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MARCO,Macrophage receptor MARCO,18584,161,2.20 [1.28-3.77],0.0041727105056199
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MARS1,"Methionine--tRNA ligase, cytoplasmic",15920,138,1.05 [0.86-1.29],0.6378468865176837
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MASP1,Mannan-binding lectin serine protease 1,18369,157,0.65 [0.35-1.18],0.1549888209457273
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MATN2,Matrilin-2,18607,162,2.96 [1.90-4.63],1.6865930274442585e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MATN3,Matrilin-3,18368,157,1.90 [1.26-2.86],0.0020643347821661
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAVS,Mitochondrial antiviral-signaling protein,18156,158,1.23 [1.05-1.45],0.0102290730869431
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAX,Protein max,18150,155,1.09 [0.95-1.26],0.217375354810123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MB,Myoglobin,18801,163,1.13 [0.89-1.44],0.3068670017164694
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MBL2,Mannose-binding protein C,16074,136,1.22 [1.04-1.43],0.0167635796665572
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCAM,Cell surface glycoprotein MUC18,18671,161,0.88 [0.57-1.35],0.5607321473220757
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",16246,139,1.00 [0.68-1.48],0.9907035617384156
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCEMP1,Mast cell-expressed membrane protein 1,15792,137,1.09 [0.91-1.32],0.334029060510943
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCFD2,Multiple coagulation factor deficiency protein 2,18493,161,1.59 [1.15-2.20],0.0054909717902464
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCTS1,Malignant T-cell-amplified sequence 1,16196,139,0.50 [0.24-1.05],0.0672736007437591
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,18398,157,0.86 [0.70-1.05],0.1279734051789549
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDH1,"Malate dehydrogenase, cytoplasmic",16200,140,0.86 [0.56-1.31],0.4781557594287685
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDK,Midkine,18606,156,1.72 [1.40-2.10],1.8789968480439082e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDM1,Nuclear protein MDM1,15834,134,1.13 [0.65-1.95],0.6738790571258658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",15876,134,1.36 [1.14-1.64],0.0008857278688555
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MED18,Mediator of RNA polymerase II transcription subunit 18,18156,158,1.13 [0.93-1.38],0.2116174433946535
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MED21,Mediator of RNA polymerase II transcription subunit 21,15718,133,0.76 [0.49-1.16],0.1958817770751331
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEGF10,Multiple epidermal growth factor-like domains protein 10,18581,162,1.28 [0.87-1.87],0.20749257506977
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEGF11,Multiple epidermal growth factor-like domains protein 11,15718,133,1.31 [0.85-2.04],0.2238044295503343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEGF9,Multiple epidermal growth factor-like domains protein 9,18745,163,0.83 [0.41-1.67],0.5969342022347371
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MELTF,Melanotransferrin,16274,138,0.66 [0.38-1.14],0.1390592298368178
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MENT,Protein MENT,15945,138,0.17 [0.09-0.33],6.958641426921635e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEP1A,Meprin A subunit alpha,16196,139,1.04 [0.83-1.30],0.7318434380029138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEP1B,Meprin A subunit beta,18584,161,0.68 [0.60-0.76],5.694511341259827e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEPE,Matrix extracellular phosphoglycoprotein,18581,162,0.95 [0.57-1.58],0.8448548785299927
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MERTK,Tyrosine-protein kinase Mer,18753,162,2.13 [1.25-3.61],0.0052885978881073
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MESD,LRP chaperone MESD,18585,160,1.11 [0.98-1.25],0.0981790768438772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MET,Hepatocyte growth factor receptor,18619,159,0.31 [0.16-0.62],0.0008664946643213
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",METAP1,Methionine aminopeptidase 1,18150,155,0.89 [0.53-1.49],0.6535555223676339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",18533,160,1.27 [1.06-1.51],0.0080278049258604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",METAP2,Methionine aminopeptidase 2,18693,163,1.15 [0.89-1.48],0.2954398930724145
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP3,Microfibril-associated glycoprotein 3,18206,158,0.97 [0.71-1.32],0.8306486693854449
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP3L,Microfibrillar-associated protein 3-like,15834,134,1.02 [0.79-1.31],0.8807343182226104
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP4,Microfibril-associated glycoprotein 4,15945,138,1.99 [1.23-3.23],0.0051307927736247
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP5,Microfibrillar-associated protein 5,18801,163,1.24 [0.88-1.73],0.2161065811134439
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFGE8,Lactadherin,18585,160,1.22 [0.89-1.68],0.2212207750005831
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MGLL,Monoglyceride lipase,18629,162,0.99 [0.84-1.17],0.8946649510786936
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MGMT,Methylated-DNA--protein-cysteine methyltransferase,18533,160,0.99 [0.88-1.12],0.9275641483488736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MIA,Melanoma-derived growth regulatory protein,18648,157,1.18 [0.81-1.73],0.3922566052250097
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MICALL2,MICAL-like protein 2,15834,134,1.29 [1.05-1.58],0.0140601653960132
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,18533,160,1.10 [0.99-1.23],0.0878667242435672
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MIF,Macrophage migration inhibitory factor,18558,159,1.08 [0.87-1.34],0.49508500635674
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MILR1,Allergin-1,18225,158,1.56 [1.21-2.01],0.0006911471471087
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,16206,140,1.16 [0.99-1.36],0.0693263197853156
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MINK1,Misshapen-like kinase 1,16250,141,1.08 [0.90-1.30],0.3918904970047349
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MITD1,MIT domain-containing protein 1,18398,157,1.13 [0.96-1.32],0.1310116709788987
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MKI67,Proliferation marker protein Ki-67,15792,137,1.15 [0.75-1.75],0.5269774677715926
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MLLT1,Protein ENL,15698,138,1.21 [0.97-1.50],0.0853121674953725
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MLN,Promotilin,18533,160,1.03 [0.88-1.21],0.7016255563259346
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MME,Neprilysin,18490,159,1.23 [1.04-1.45],0.0158291410519723
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP1,Interstitial collagenase,17879,153,1.30 [1.09-1.54],0.0033175722271255
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP10,Stromelysin-2,18536,161,1.55 [1.24-1.93],9.357581601477374e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP12,Macrophage metalloelastase,18575,161,1.94 [1.56-2.41],2.65306006140526e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP13,Collagenase 3,18150,155,1.19 [0.77-1.85],0.4364821077528189
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP15,Matrix metalloproteinase-15,16274,138,1.18 [0.88-1.59],0.2737304686578603
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP3,Stromelysin-1,18585,160,1.72 [1.40-2.11],2.178654023543213e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP7,Matrilysin,18175,158,2.17 [1.60-2.94],5.018550403145025e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP8,Neutrophil collagenase,18691,161,1.53 [1.28-1.83],2.6064677455194075e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP9,Matrix metalloproteinase-9,18550,160,1.61 [1.27-2.05],7.67524346157587e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",15718,133,1.48 [1.08-2.02],0.0147396941881415
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MN1,Transcriptional activator MN1,15834,134,0.86 [0.62-1.20],0.3889835185429684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MNAT1,CDK-activating kinase assembly factor MAT1,15972,137,0.98 [0.66-1.47],0.9239601487744514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MNDA,Myeloid cell nuclear differentiation antigen,18554,161,1.07 [0.94-1.23],0.3065426213839057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MOCS2,Molybdopterin synthase catalytic subunit,15945,138,1.21 [0.94-1.55],0.1407497689738852
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MOG,Myelin-oligodendrocyte glycoprotein,18723,163,0.86 [0.58-1.29],0.478229319604635
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORC3,MORC family CW-type zinc finger protein 3,16250,141,1.39 [0.79-2.42],0.2497374808034722
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORF4L1,Mortality factor 4-like protein 1,15972,137,1.12 [0.75-1.67],0.5934106639720299
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORF4L2,Mortality factor 4-like protein 2,15698,138,1.00 [0.62-1.60],0.9984438191167436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORN4,MORN repeat-containing protein 4,15698,138,0.98 [0.78-1.24],0.8959798723512093
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPHOSPH8,M-phase phosphoprotein 8,18206,158,1.11 [0.92-1.34],0.2750214936745009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPI,Mannose-6-phosphate isomerase,18490,159,1.06 [0.89-1.26],0.4936246689239211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,18629,162,1.12 [0.92-1.37],0.2543311321943775
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPO,Myeloperoxidase,18585,160,1.39 [1.06-1.84],0.0177554536992892
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPRIP,Myosin phosphatase Rho-interacting protein,16172,139,1.01 [0.69-1.46],0.9634741962068843
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRC1,Macrophage mannose receptor 1,16290,140,4.45 [2.80-7.08],2.9298420257974715e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRI1,Methylthioribose-1-phosphate isomerase,15834,134,0.69 [0.54-0.87],0.0017337372534004
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL24,"39S ribosomal protein L24, mitochondrial",15718,133,1.25 [0.85-1.83],0.2526088466797794
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL28,"39S ribosomal protein L28, mitochondrial",16246,139,0.85 [0.50-1.45],0.5587813422510155
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL46,"39S ribosomal protein L46, mitochondrial",18150,155,1.83 [1.23-2.72],0.0027755602875535
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL52,"39S ribosomal protein L52, mitochondrial",15662,138,1.12 [0.63-1.98],0.710793254634936
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",16246,139,1.39 [1.15-1.67],0.0005247346625793
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPS16,"28S ribosomal protein S16, mitochondrial",15792,137,1.14 [0.63-2.08],0.6618500753504106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSLN,Mesothelin,18458,159,1.49 [1.21-1.83],0.0001910175055694
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSLNL,Mesothelin-like protein,15834,134,1.41 [1.01-1.99],0.046723270750202
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSMB,Beta-microseminoprotein,18548,162,1.13 [0.94-1.36],0.2047354658205783
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,18723,162,2.21 [1.65-2.96],8.748583926762615e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSRA,Mitochondrial peptide methionine sulfoxide reductase,18648,157,1.08 [0.88-1.32],0.4613278242361346
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MST1,Hepatocyte growth factor-like protein,16030,135,1.00 [0.78-1.30],0.9789693422510468
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSTN,Growth/differentiation factor 8,18206,158,0.79 [0.62-1.02],0.0665905013231715
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTDH,Protein LYRIC,15792,137,1.10 [0.92-1.32],0.3079254106709398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",16250,141,1.62 [1.06-2.49],0.0267266785587701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,15972,137,1.00 [0.86-1.16],0.9808380436235112
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTIF3,"Translation initiation factor IF-3, mitochondrial",16196,139,1.24 [1.03-1.50],0.0252996023241572
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTPN,Myotrophin,18206,158,0.84 [0.52-1.34],0.4572033350714092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTR,Methionine synthase,15718,133,1.04 [0.80-1.35],0.7925715776133535
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTSS1,Protein MTSS 1,16196,139,1.07 [0.92-1.24],0.3925353741067438
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTSS2,Protein MTSS 2,16206,140,1.09 [0.92-1.29],0.3143717731736786
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTUS1,Microtubule-associated tumor suppressor 1,15972,137,1.45 [1.12-1.88],0.0050020629332441
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUC13,Mucin-13,18150,155,1.43 [1.11-1.85],0.0056087872399725
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUC16,Mucin-16,18490,159,1.04 [0.96-1.13],0.3026474920006217
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUC2,Mucin-2,16282,139,1.12 [0.94-1.33],0.2199221547649279
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUCL3,Mucin-like protein 3,15698,138,1.01 [0.69-1.47],0.9731294423298328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MVK,Mevalonate kinase,18225,158,1.46 [1.24-1.73],6.829938585567486e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MXRA8,Matrix remodeling-associated protein 8,15945,138,0.71 [0.42-1.21],0.2064814072484748
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYBPC1,"Myosin-binding protein C, slow-type",16274,138,1.22 [0.98-1.51],0.0726197780463182
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYBPC2,"Myosin-binding protein C, fast-type",15876,134,1.12 [0.95-1.32],0.1880236337830432
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,16246,139,1.14 [0.91-1.44],0.2549939823917462
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYDGF,Myeloid-derived growth factor,16274,138,1.18 [1.00-1.40],0.0550843253464872
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYH4,Myosin-4,15718,133,1.23 [0.88-1.73],0.2243345083478701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYH7B,Myosin-7B,15698,138,1.36 [0.98-1.89],0.064948061000115
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYH9,Myosin-9,16282,139,1.11 [0.96-1.29],0.1552163106620246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",15718,133,1.00 [0.65-1.55],0.9981207695907984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL3,Myosin light chain 3,15876,134,1.06 [0.85-1.32],0.6080009328579563
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL4,Myosin light chain 4,15876,134,1.25 [0.96-1.63],0.0940084073416922
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL6B,Myosin light chain 6B,15834,134,1.02 [0.84-1.23],0.8640516044532038
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",15834,134,1.22 [0.90-1.65],0.20633000807613
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYO6,Unconventional myosin-VI,16246,139,1.17 [0.75-1.82],0.4839965464013346
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYO9B,Unconventional myosin-IXb,18225,158,1.15 [0.92-1.42],0.2176889054613049
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOC,Myocilin,18585,160,0.90 [0.65-1.24],0.5079945616461872
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOM1,Myomesin-1,15723,135,0.92 [0.64-1.32],0.652607455413583
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOM2,Myomesin-2,15718,133,1.01 [0.71-1.43],0.9768241768721804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOM3,Myomesin-3,15945,138,1.03 [0.86-1.22],0.7584418472254129
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,18638,162,2.41 [1.93-3.01],1.1343298375483375e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MZT1,Mitotic-spindle organizing protein 1,18156,158,1.24 [0.94-1.63],0.1349935007503542
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAA10,N-alpha-acetyltransferase 10,15718,133,1.14 [0.81-1.59],0.4507103493743823
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAA80,N-alpha-acetyltransferase 80,15834,134,1.01 [0.87-1.17],0.901309759073262
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAAA,N-acylethanolamine-hydrolyzing acid amidase,18309,153,0.74 [0.57-0.96],0.0237389765289026
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NACC1,Nucleus accumbens-associated protein 1,16206,140,1.24 [0.94-1.65],0.1341108858243996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NADK,NAD kinase,18584,161,1.10 [0.86-1.41],0.4295144971793792
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAGA,Alpha-N-acetylgalactosaminidase,15755,136,0.98 [0.69-1.39],0.9100964229365102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAGK,N-acetyl-D-glucosamine kinase,15842,134,1.12 [0.83-1.50],0.458393176158211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,15945,138,1.91 [0.88-4.16],0.1022362703339376
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAMPT,Nicotinamide phosphoribosyltransferase,18156,158,1.23 [0.99-1.54],0.0655464553088773
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAP1L4,Nucleosome assembly protein 1-like 4,16159,139,0.94 [0.63-1.42],0.7742242453152612
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAPRT,Nicotinate phosphoribosyltransferase,16250,141,0.82 [0.48-1.40],0.4721307455480282
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NARS1,"Asparagine--tRNA ligase, cytoplasmic",16246,139,1.03 [0.72-1.48],0.8541719206735998
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NBL1,Neuroblastoma suppressor of tumorigenicity 1,18648,157,3.01 [1.90-4.79],3.060569364896344e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NBN,Nibrin,18225,158,1.03 [0.78-1.35],0.8606038723161602
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAM1,Neural cell adhesion molecule 1,18671,161,0.84 [0.52-1.34],0.4581997164947965
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAM2,Neural cell adhesion molecule 2,18585,160,0.80 [0.47-1.37],0.4158057295334476
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAN,Neurocan core protein,18723,162,0.54 [0.39-0.76],0.0003439467396731
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCF2,Neutrophil cytosol factor 2,18511,160,1.13 [0.96-1.32],0.1501371719778077
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCK2,Cytoplasmic protein NCK2,18660,162,1.05 [0.91-1.20],0.4908635676298573
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCLN,Nicalin,18225,158,1.07 [0.80-1.43],0.6378688805921716
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCR1,Natural cytotoxicity triggering receptor 1,18505,160,1.45 [1.01-2.09],0.0450649383435474
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,16196,139,2.87 [1.96-4.21],6.108703373940036e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCS1,Neuronal calcium sensor 1,18723,163,1.44 [0.89-2.33],0.1365975867123303
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDRG1,Protein NDRG1,18150,155,1.14 [0.94-1.40],0.1873789928490272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,16206,140,1.02 [0.79-1.31],0.8804480321994088
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,15772,137,1.46 [0.90-2.37],0.1254870903847603
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,16196,139,1.10 [0.91-1.33],0.3261652786785272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",18156,158,1.27 [1.10-1.47],0.0009073325236496
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEB,Nebulin,15718,133,1.31 [0.88-1.95],0.1840783209156125
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECAP2,Adaptin ear-binding coat-associated protein 2,15718,133,1.11 [0.86-1.41],0.4237373924535164
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN1,Nectin-1,15792,137,1.44 [0.89-2.33],0.1410160766531772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN2,Nectin-2,18550,161,2.77 [1.90-4.05],1.2308683376322348e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN4,Nectin-4,18648,157,2.28 [1.66-3.13],3.6957615524107387e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,15792,137,0.96 [0.68-1.35],0.797562624745746
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEDD9,Enhancer of filamentation 1,15792,137,0.87 [0.50-1.52],0.6216674803467342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEFL,Neurofilament light polypeptide,18097,154,1.43 [1.07-1.92],0.014966067773859
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEK7,Serine/threonine-protein kinase Nek7,15972,137,0.90 [0.70-1.16],0.4246262624966992
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NELL1,Protein kinase C-binding protein NELL1,18648,157,0.70 [0.50-0.97],0.029680095534334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NELL2,Protein kinase C-binding protein NELL2,18660,162,1.03 [0.65-1.63],0.906345209881513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NENF,Neudesin,16206,140,1.09 [0.95-1.25],0.2020612644146232
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEO1,Neogenin,16246,139,1.12 [0.54-2.30],0.7604787085085056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEXN,Nexilin,16290,140,1.11 [0.87-1.41],0.4088498896577269
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFASC,Neurofascin,18753,162,2.80 [1.81-4.35],3.986766901155506e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFAT5,Nuclear factor of activated T-cells 5,15792,137,1.26 [1.06-1.51],0.0107467083183484
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",18533,160,1.02 [0.88-1.19],0.7888333054227273
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",18225,158,1.36 [1.10-1.67],0.0039392086204596
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFE2,Transcription factor NF-E2 45 kDa subunit,15876,134,1.13 [0.90-1.43],0.2901362384686663
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFIC,Nuclear factor 1 C-type,16246,139,1.17 [0.88-1.55],0.2704359536839272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFKB1,Nuclear factor NF-kappa-B p105 subunit,15718,133,1.30 [1.03-1.65],0.0291302208735256
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFKB2,Nuclear factor NF-kappa-B p100 subunit,15972,137,0.99 [0.73-1.35],0.9580697059684228
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFKBIE,NF-kappa-B inhibitor epsilon,18156,158,1.14 [0.84-1.53],0.3984427450736809
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",16196,139,1.26 [1.07-1.48],0.006044013917362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFX1,Transcriptional repressor NF-X1,15718,133,0.99 [0.76-1.29],0.9339950331839344
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFYA,Nuclear transcription factor Y subunit alpha,15718,133,1.12 [0.72-1.73],0.6193069117778764
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NGF,Beta-nerve growth factor,18398,157,2.16 [0.62-7.46],0.2242008057866745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NGFR,Tumor necrosis factor receptor superfamily member 16,16274,138,1.03 [0.60-1.77],0.9216109883969502
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NGRN,Neugrin,16250,141,1.88 [1.02-3.47],0.0429254751894104
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NHLRC3,NHL repeat-containing protein 3,15545,136,4.03 [2.43-6.67],6.678287218349827e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NID1,Nidogen-1,18604,161,1.77 [1.25-2.51],0.0014155349707244
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NID2,Nidogen-2,18585,160,1.18 [0.97-1.42],0.0939272865005423
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NINJ1,Ninjurin-1,18156,158,1.33 [1.06-1.66],0.0120388318252223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NIT1,Deaminated glutathione amidase,15876,134,0.75 [0.52-1.06],0.1053350553809324
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NIT2,Omega-amidase NIT2,16214,138,0.98 [0.78-1.23],0.8509101666680271
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NLGN1,Neuroligin-1,15834,134,0.97 [0.73-1.27],0.8036039529310064
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NLGN2,Neuroligin-2,15723,135,1.03 [0.72-1.47],0.8851854297031934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NME1,Nucleoside diphosphate kinase A,15792,137,1.87 [0.89-3.94],0.097808227169578
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NME3,Nucleoside diphosphate kinase 3,18607,162,2.51 [1.61-3.90],4.430831345778336e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMI,N-myc-interactor,16156,140,1.39 [1.12-1.74],0.0035264796917189
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,18398,157,1.00 [0.82-1.22],0.971543032078142
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMRK2,Nicotinamide riboside kinase 2,15698,138,1.27 [0.89-1.80],0.1843852291461259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,16246,139,1.21 [0.96-1.51],0.1026910677423359
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOMO1,Nodal modulator 1,18585,160,1.44 [0.77-2.67],0.2508718358798492
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOP56,Nucleolar protein 56,15718,133,0.86 [0.71-1.04],0.1243451613045641
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS1,"Nitric oxide synthase, brain",18150,155,1.36 [1.05-1.75],0.0207754592289991
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS2,"Nitric oxide synthase, inducible",15718,133,1.17 [0.78-1.75],0.4468466239656943
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS3,"Nitric oxide synthase, endothelial",18150,155,1.68 [1.40-2.01],1.5265503067162986e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH1,Neurogenic locus notch homolog protein 1,18801,163,0.63 [0.27-1.48],0.2838460946078397
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH2,Neurogenic locus notch homolog protein 2,16282,139,1.19 [0.55-2.59],0.6642576771033459
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH3,Neurogenic locus notch homolog protein 3,18801,163,1.76 [1.20-2.57],0.0037465306981165
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,15997,138,2.44 [1.77-3.36],4.596365890715885e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,18584,161,2.12 [1.55-2.89],2.034238405357766e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPHS1,Nephrin,15792,137,1.12 [0.70-1.81],0.629785567835879
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPHS2,Podocin,15792,137,0.91 [0.76-1.08],0.2832056620022374
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPL,N-acetylneuraminate lyase,16274,138,1.25 [0.90-1.74],0.1782772300036985
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPPB,Natriuretic peptides B,18206,158,1.24 [1.12-1.37],2.7578496699696576e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPPC,C-type natriuretic peptide,18533,160,1.59 [1.29-1.97],1.8308528808120097e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPR1,Atrial natriuretic peptide receptor 1,15718,133,1.21 [0.79-1.84],0.3781434484201874
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTN,Neuroplastin,18156,158,0.94 [0.77-1.15],0.5627332391364074
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTX1,Neuronal pentraxin-1,18585,160,1.07 [0.77-1.50],0.6830113195900787
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTX2,Neuronal pentraxin-2,16282,139,2.49 [1.64-3.78],1.916801450455102e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTXR,Neuronal pentraxin receptor,18584,161,0.43 [0.27-0.68],0.000332238008598
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPY,Pro-neuropeptide Y,18723,163,0.81 [0.66-1.00],0.0545872903497446
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRCAM,Neuronal cell adhesion molecule,18584,161,1.51 [0.95-2.40],0.0835430448328417
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRGN,Neurogranin,16290,140,1.04 [0.87-1.25],0.6702754500303715
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRN1,Neuritin,16246,139,1.46 [0.99-2.15],0.0543760709935358
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRP1,Neuropilin-1,18698,161,2.47 [1.53-4.00],0.0002294607044374
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRP2,Neuropilin-2,18585,160,1.29 [0.79-2.08],0.3059799269829739
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRTN,Neurturin,18225,158,0.97 [0.72-1.30],0.8292245938068284
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRXN3,Neurexin-3,15834,134,1.08 [0.68-1.73],0.7420373355712908
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NSFL1C,NSFL1 cofactor p47,18723,162,1.09 [0.88-1.36],0.4324385066140904
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",16274,138,1.03 [0.82-1.29],0.8118643529386087
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,16250,141,2.23 [1.57-3.17],7.17303586805514e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C3A,Cytosolic 5'-nucleotidase 3A,18512,159,0.98 [0.83-1.16],0.7835269756003643
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5E,5'-nucleotidase,18648,157,1.23 [0.96-1.57],0.0987900919914219
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTF3,Neurotrophin-3,18533,160,1.08 [0.73-1.59],0.7137451580328353
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTF4,Neurotrophin-4,18156,158,1.09 [0.74-1.61],0.6602752742959463
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTRK2,BDNF/NT-3 growth factors receptor,18584,161,0.49 [0.28-0.85],0.011067310843891
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTRK3,NT-3 growth factor receptor,18723,162,0.60 [0.32-1.14],0.1213607575504008
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,18584,161,1.38 [1.25-1.53],4.3139961012720575e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUB1,NEDD8 ultimate buster 1,18533,160,1.05 [0.88-1.26],0.5545673025006441
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,16206,140,1.01 [0.85-1.22],0.8764550206064163
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUCB2,Nucleobindin-2,18688,163,2.02 [1.41-2.90],0.0001315036871267
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDC,Nuclear migration protein nudC,18753,162,1.17 [0.93-1.48],0.1815537007078652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,15876,134,1.34 [0.72-2.52],0.357687777174825
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,15718,133,0.89 [0.61-1.29],0.5370104654605994
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT16,U8 snoRNA-decapping enzyme,16162,138,1.24 [1.02-1.50],0.0320245231083984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],18490,159,0.92 [0.70-1.21],0.5680777480891976
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT5,ADP-sugar pyrophosphatase,18585,160,1.40 [1.07-1.82],0.0135108659429321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUMB,Protein numb homolog,15792,137,1.00 [0.81-1.23],0.9942156606538692
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUP50,Nuclear pore complex protein Nup50,15718,133,1.17 [0.71-1.92],0.5430405525074674
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NXPE4,NXPE family member 4,15718,133,1.43 [0.90-2.26],0.1271733178351108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NXPH1,Neurexophilin-1,18150,155,1.11 [0.78-1.57],0.569013019520938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NXPH3,Neurexophilin-3,15792,137,1.05 [0.61-1.80],0.8547796448240841
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OBP2B,Odorant-binding protein 2b,18342,157,1.26 [1.04-1.53],0.0207189281636865
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OCLN,Occludin,16246,139,2.41 [1.85-3.14],7.325535243662782e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ODAM,Odontogenic ameloblast-associated protein,18124,154,0.71 [0.53-0.95],0.0220083374114647
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OFD1,Oral-facial-digital syndrome 1 protein,15972,137,1.18 [0.94-1.49],0.1613616290807623
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGA,Protein O-GlcNAcase,16196,139,1.19 [0.94-1.51],0.1531965844370136
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGFR,Opioid growth factor receptor,18490,159,1.13 [0.74-1.74],0.568517607531579
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGN,Mimecan,18585,160,1.46 [1.09-1.97],0.0121045978974832
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,15972,137,0.90 [0.66-1.23],0.5043954273021504
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OLFM4,Olfactomedin-4,15345,135,1.16 [1.00-1.34],0.0449713767634374
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OLR1,Oxidized low-density lipoprotein receptor 1,18399,158,1.30 [1.05-1.61],0.0173178703419696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMD,Osteomodulin,18660,162,0.86 [0.63-1.18],0.3485762716502231
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMG,Oligodendrocyte-myelin glycoprotein,18490,159,0.71 [0.58-0.88],0.0018292978509342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMP,Olfactory marker protein,15723,135,0.91 [0.63-1.31],0.6019659357974885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OPHN1,Oligophrenin-1,16250,141,1.06 [0.91-1.24],0.4526732243454662
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OPLAH,5-oxoprolinase,15876,134,1.26 [0.98-1.62],0.072842723054031
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OPTC,Opticin,18490,159,1.31 [0.98-1.74],0.065657255972761
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ORM1,Alpha-1-acid glycoprotein 1,16244,138,2.70 [1.26-5.80],0.0109052633094797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSBPL2,Oxysterol-binding protein-related protein 2,16250,141,1.17 [0.80-1.71],0.4178454371722088
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,18607,162,2.90 [1.92-4.38],4.141906495870902e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSM,Oncostatin-M,18450,158,1.43 [1.17-1.75],0.0004064238347511
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSMR,Oncostatin-M-specific receptor subunit beta,18698,161,2.55 [1.33-4.88],0.0048204033645308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSTN,Osteocrin,15834,134,1.18 [0.84-1.66],0.3425254151898629
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OTOA,Otoancorin,15723,135,1.07 [0.79-1.44],0.6767437679840451
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OTUD6B,Deubiquitinase OTUD6B,16196,139,1.13 [0.85-1.50],0.4082532075676321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OTUD7B,OTU domain-containing protein 7B,16246,139,1.27 [0.98-1.66],0.074678584501634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",15876,134,1.30 [1.03-1.64],0.0268746435741137
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OXT,Oxytocin-neurophysin 1,18723,162,1.17 [1.06-1.28],0.0017742407089645
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",P4HB,Protein disulfide-isomerase,18508,155,1.42 [0.97-2.08],0.0693388903931751
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PACS2,Phosphofurin acidic cluster sorting protein 2,15718,133,1.12 [0.85-1.49],0.4234397321909102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PADI2,Protein-arginine deiminase type-2,18225,158,1.22 [0.97-1.53],0.086328389531272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PADI4,Protein-arginine deiminase type-4,18124,154,0.91 [0.73-1.13],0.3770847558224169
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAEP,Glycodelin,18398,157,1.27 [1.12-1.45],0.0002493082238693
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,16246,139,1.06 [0.92-1.23],0.4302960957484443
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",15972,137,0.99 [0.69-1.42],0.9684766829972176
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,18206,158,1.35 [1.07-1.71],0.0118874354185994
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAGR1,PAXIP1-associated glutamate-rich protein 1,15876,134,0.85 [0.56-1.30],0.4641544914314106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,15672,138,0.92 [0.65-1.32],0.6621509021444539
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAK4,Serine/threonine-protein kinase PAK 4,18150,155,1.18 [0.94-1.50],0.1595106907495751
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALLD,Palladin,15792,137,1.19 [0.81-1.77],0.3795877536512001
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM,Paralemmin-1,16102,139,1.00 [0.60-1.67],0.9943358039105212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM2,Paralemmin-2,16250,141,2.20 [1.56-3.11],7.702870248344619e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM3,Paralemmin-3,15718,133,1.03 [0.80-1.33],0.7919119335464673
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAM,Peptidyl-glycine alpha-amidating monooxygenase,18723,163,1.15 [0.70-1.90],0.5803023412798323
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAMR1,Inactive serine protease PAMR1,18585,160,0.51 [0.31-0.85],0.0102468668227998
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAPPA,Pappalysin-1,18225,158,1.30 [0.95-1.76],0.0964964305789375
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PARD3,Partitioning defective 3 homolog,15972,137,1.16 [0.95-1.40],0.1385561042222794
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PARK7,Parkinson disease protein 7,18585,160,1.17 [0.89-1.55],0.2639074371422411
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PARP1,Poly [ADP-ribose] polymerase 1,18533,160,1.04 [0.81-1.33],0.7726233715317997
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAXX,Protein PAXX,15945,138,1.13 [0.77-1.64],0.5352535424951803
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PBK,Lymphokine-activated killer T-cell-originated protein kinase,15698,138,0.96 [0.56-1.67],0.8895819609949338
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PBLD,Phenazine biosynthesis-like domain-containing protein,18150,155,0.87 [0.65-1.18],0.366938946353301
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,16196,139,0.93 [0.53-1.63],0.7952473441468711
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCARE,Photoreceptor cilium actin regulator,15723,135,1.12 [0.94-1.34],0.2058242207215775
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,15920,138,1.24 [0.88-1.75],0.2086502566728093
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCBP2,Poly(rC)-binding protein 2,16246,139,1.02 [0.81-1.30],0.8512646043415741
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH1,Protocadherin-1,18689,162,1.23 [0.65-2.33],0.5177474402446044
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH12,Protocadherin-12,16246,139,2.04 [1.08-3.86],0.0276673909753375
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH17,Protocadherin-17,18584,161,1.38 [0.96-1.98],0.0825065965073459
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH7,Protocadherin-7,16196,139,0.86 [0.52-1.40],0.5322081482092393
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH9,Protocadherin-9,16196,139,0.60 [0.37-0.96],0.0319801602223655
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDHB15,Protocadherin beta-15,16206,140,2.12 [1.49-3.04],3.451431211866237e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCNA,Proliferating cell nuclear antigen,15698,138,1.18 [0.93-1.49],0.1652099925873767
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCSK7,Proprotein convertase subtilisin/kexin type 7,16206,140,1.23 [0.90-1.67],0.1955984885054171
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCSK9,Proprotein convertase subtilisin/kexin type 9,18801,163,1.45 [1.03-2.06],0.0357394968412589
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCYT2,Ethanolamine-phosphate cytidylyltransferase,16196,139,1.16 [0.92-1.45],0.2075373687286585
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDAP1,28 kDa heat- and acid-stable phosphoprotein,16274,138,1.03 [0.86-1.22],0.7804989822091981
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD1,Programmed cell death protein 1,18689,161,1.31 [0.97-1.75],0.0752155492647191
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD1LG2,Programmed cell death 1 ligand 2,18490,159,1.90 [1.24-2.91],0.00313303970836
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD5,Programmed cell death protein 5,18723,162,1.24 [0.97-1.59],0.0815109773848485
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD6,Programmed cell death protein 6,18584,161,1.15 [0.92-1.44],0.2200056560090805
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCL2,Phosducin-like protein 2,15698,138,1.17 [0.90-1.51],0.2413441794558579
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",15698,138,1.11 [0.84-1.48],0.4622239636672943
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",15718,133,1.19 [0.93-1.52],0.1662784318312387
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",15945,138,1.01 [0.85-1.19],0.929614017188003
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFA,Platelet-derived growth factor subunit A,18801,163,1.19 [0.98-1.45],0.0798551539176441
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFB,Platelet-derived growth factor subunit B,18660,162,1.10 [0.93-1.30],0.2572585586368507
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFC,Platelet-derived growth factor C,18156,158,1.18 [0.72-1.93],0.5211990079975292
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFRA,Platelet-derived growth factor receptor alpha,18584,161,1.46 [0.91-2.36],0.1197740959585277
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFRB,Platelet-derived growth factor receptor beta,18801,163,0.58 [0.39-0.86],0.0075046462807701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA2,Protein disulfide-isomerase A2,15698,138,1.06 [0.71-1.58],0.7893822874433968
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA3,Protein disulfide-isomerase A3,15945,138,1.66 [0.88-3.13],0.1174917194061013
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA4,Protein disulfide-isomerase A4,16282,139,1.23 [0.93-1.61],0.1421660847748466
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA5,Protein disulfide-isomerase A5,15698,138,0.94 [0.69-1.27],0.6735989711715433
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDLIM5,PDZ and LIM domain protein 5,16246,139,1.06 [0.91-1.22],0.4703185303092331
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDLIM7,PDZ and LIM domain protein 7,18660,162,1.08 [0.96-1.21],0.2059938472864084
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",18156,158,1.12 [0.84-1.49],0.4479611136685073
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDRG1,p53 and DNA damage-regulated protein 1,15834,134,1.06 [0.77-1.45],0.7385066245586269
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,15698,138,1.10 [0.87-1.41],0.4276149374827929
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZD2,PDZ domain-containing protein 2,15718,133,1.45 [1.14-1.86],0.0028007872994011
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,15792,137,1.72 [1.25-2.37],0.0007826103700467
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PEAR1,Platelet endothelial aggregation receptor 1,18801,163,1.62 [0.86-3.03],0.1335830822481007
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PEBP1,Phosphatidylethanolamine-binding protein 1,18585,160,1.17 [0.91-1.50],0.2183121467052002
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PECAM1,Platelet endothelial cell adhesion molecule,18585,160,1.80 [1.13-2.86],0.0132030701091581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PECR,Peroxisomal trans-2-enoyl-CoA reductase,15876,134,1.58 [0.96-2.61],0.0736897222170281
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PENK,Proenkephalin-A,15945,138,1.35 [0.85-2.12],0.1994137098955983
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PEPD,Xaa-Pro dipeptidase,16290,140,1.10 [0.59-2.04],0.77525428680301
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PER3,Period circadian protein homolog 3,15792,137,1.20 [1.06-1.37],0.0043942740144207
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PF4,Platelet factor 4,16175,137,1.07 [0.90-1.27],0.4577075458458018
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PFDN2,Prefoldin subunit 2,18150,155,1.06 [0.81-1.40],0.6607886998442805
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PFDN4,Prefoldin subunit 4,15698,138,1.10 [0.80-1.53],0.5499814075614964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PFDN6,Prefoldin subunit 6,15834,134,1.11 [0.88-1.40],0.3736398499425998
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",18451,158,1.10 [0.91-1.32],0.3292276686701532
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGA4,Pepsin A-4,16290,140,1.28 [1.05-1.57],0.0168572441998608
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",16274,138,1.05 [0.76-1.44],0.772895096834063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGF,Placenta growth factor,18753,162,3.57 [2.40-5.32],3.963313657026141e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP1,Peptidoglycan recognition protein 1,18725,163,1.62 [1.22-2.15],0.0008568093130076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,16098,136,0.58 [0.33-1.00],0.0508439018143587
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP4,Peptidoglycan recognition protein 4,15718,133,1.41 [1.13-1.77],0.0023932154149883
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGM2,Phosphoglucomutase-2,15834,134,1.01 [0.75-1.35],0.9623882349212728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGR,Progesterone receptor,15792,137,0.88 [0.69-1.11],0.2778732541089503
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHACTR2,Phosphatase and actin regulator 2,16246,139,1.11 [0.95-1.28],0.1883357937978641
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHLDB1,Pleckstrin homology-like domain family B member 1,16196,139,1.86 [1.39-2.48],2.464999800025841e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHLDB2,Pleckstrin homology-like domain family B member 2,15698,138,0.91 [0.75-1.11],0.3574936922185106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,18398,157,2.14 [1.30-3.50],0.0025973749276211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,15945,138,1.10 [0.72-1.68],0.6501934529591165
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PI16,Peptidase inhibitor 16,16290,140,0.55 [0.29-1.03],0.0620928188224744
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PI3,Elafin,18354,160,1.87 [1.55-2.26],4.903490179814422e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",16246,139,1.04 [0.83-1.30],0.7383636243146408
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIGR,Polymeric immunoglobulin receptor,18345,158,3.60 [2.59-5.02],3.441033240067675e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,18533,160,0.93 [0.73-1.18],0.5273811317502897
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,18585,160,2.26 [1.52-3.36],6.0432191690574445e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,15792,137,1.21 [0.92-1.60],0.1783882298437802
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,18585,160,2.82 [2.03-3.92],7.710349037579013e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,18584,161,1.99 [1.52-2.60],4.95363109209434e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,15945,138,0.98 [0.77-1.25],0.8993908248704889
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PITHD1,PITH domain-containing protein 1,15672,138,0.92 [0.73-1.15],0.4633071854193238
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKD1,Polycystin-1,16274,138,2.98 [1.62-5.48],0.0004353448240827
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKD2,Polycystin-2,15718,133,1.39 [1.06-1.82],0.0165172281370627
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKLR,Pyruvate kinase PKLR,18603,162,0.96 [0.77-1.19],0.713235680480818
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKN3,Serine/threonine-protein kinase N3,15972,137,1.12 [0.90-1.40],0.2972971949825936
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G10,Group 10 secretory phospholipase A2,18398,157,0.97 [0.76-1.24],0.8048740630538866
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G15,Phospholipase A2 group XV,18648,157,4.16 [2.60-6.64],2.413503143989319e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G1B,Phospholipase A2,18778,163,0.58 [0.45-0.76],5.791582621222248e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G2A,"Phospholipase A2, membrane associated",18528,161,1.48 [1.22-1.79],6.489884492195864e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G4A,Cytosolic phospholipase A2,18660,162,1.09 [0.92-1.28],0.3199030187795342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G7,Platelet-activating factor acetylhydrolase,18585,160,0.55 [0.37-0.84],0.0050106762706591
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAT,Tissue-type plasminogen activator,18745,163,2.06 [1.57-2.70],1.633695608500158e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAU,Urokinase-type plasminogen activator,18585,160,1.74 [1.22-2.48],0.0023248186879352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,18464,162,5.45 [3.65-8.16],1.38519563507715e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLB1,"Phospholipase B1, membrane-associated",16250,141,0.92 [0.71-1.21],0.566562475893464
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",15792,137,1.12 [0.76-1.64],0.5775213094050364
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",16250,141,1.13 [0.95-1.34],0.1746566255547526
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLEKHO1,Pleckstrin homology domain-containing family O member 1,16250,141,1.13 [0.89-1.44],0.3024710503277258
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLG,Plasminogen,15897,135,0.61 [0.28-1.33],0.2159100703501432
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLIN1,Perilipin-1,18150,155,1.12 [0.75-1.68],0.5760782653151395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLIN3,Perilipin-3,18584,161,1.57 [1.14-2.15],0.0054426601295081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLPBP,Pyridoxal phosphate homeostasis protein,18584,161,1.11 [0.89-1.37],0.3491761914544038
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLSCR3,Phospholipid scramblase 3,16216,141,1.27 [0.95-1.70],0.1058041656930857
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLTP,Phospholipid transfer protein,18752,163,1.12 [0.77-1.63],0.5507353648820384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXDC1,Plexin domain-containing protein 1,18156,158,0.91 [0.57-1.44],0.6809837984299374
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXDC2,Plexin domain-containing protein 2,16250,141,1.86 [1.09-3.16],0.022283055510303
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXNA4,Plexin-A4,18533,160,1.13 [0.95-1.35],0.1638756780748174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXNB2,Plexin-B2,18701,163,2.85 [1.67-4.86],0.0001179758266378
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXNB3,Plexin-B3,18528,160,1.09 [0.80-1.48],0.6039718341417688
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,18482,160,1.04 [0.96-1.13],0.3322208155245661
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMCH,Pro-MCH,15718,133,0.90 [0.71-1.15],0.4002026983699156
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMM2,Phosphomannomutase 2,15718,133,1.24 [0.94-1.65],0.1298240161191743
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMS1,PMS1 protein homolog 1,15834,134,1.21 [0.87-1.67],0.2501859360039392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMVK,Phosphomevalonate kinase,18115,155,1.07 [0.93-1.24],0.345228043286094
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNLIP,Pancreatic triacylglycerol lipase,16290,140,0.72 [0.57-0.91],0.0060862985353665
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNLIPRP1,Inactive pancreatic lipase-related protein 1,16250,141,0.77 [0.63-0.93],0.007291517452686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNLIPRP2,Pancreatic lipase-related protein 2,18581,162,0.97 [0.92-1.01],0.1477928037845181
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNMA1,Paraneoplastic antigen Ma1,15876,134,1.11 [0.82-1.51],0.4936455149250732
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNMA2,Paraneoplastic antigen Ma2,15723,135,0.92 [0.62-1.37],0.6714832007485261
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",18225,158,1.11 [0.98-1.25],0.103444020598537
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PODXL,Podocalyxin,18490,159,1.08 [0.43-2.75],0.8671199441386597
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PODXL2,Podocalyxin-like protein 2,18648,157,0.83 [0.50-1.40],0.4909227055902936
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POF1B,Protein POF1B,15792,137,1.49 [1.08-2.06],0.0147514591769013
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POLR2A,DNA-directed RNA polymerase II subunit RPB1,15792,137,0.92 [0.50-1.72],0.80364596565362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",18490,159,1.59 [1.14-2.22],0.0057537435280377
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POMC,Pro-opiomelanocortin,15876,134,0.90 [0.71-1.14],0.3774482560140292
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON1,Serum paraoxonase/arylesterase 1,16290,140,0.39 [0.25-0.63],8.205299012325763e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON2,Serum paraoxonase/arylesterase 2,18206,158,1.79 [1.20-2.66],0.0043640116289417
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON3,Serum paraoxonase/lactonase 3,18660,162,0.47 [0.35-0.64],9.021306783198688e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POSTN,Periostin,16282,139,1.40 [0.90-2.16],0.1336483038899504
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPBP,Platelet basic protein,16184,137,1.01 [0.83-1.24],0.8942768653734812
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPCDC,Phosphopantothenoylcysteine decarboxylase,18723,162,1.25 [0.93-1.70],0.143860328240187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPIB,Peptidyl-prolyl cis-trans isomerase B,18605,163,1.13 [0.97-1.32],0.1199040197795644
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPIE,Peptidyl-prolyl cis-trans isomerase E,15972,137,0.95 [0.72-1.24],0.6906401760277718
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",16282,139,1.31 [1.04-1.65],0.022215360813431
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPL,Periplakin,15792,137,1.20 [0.73-1.97],0.4702520665698081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPM1A,Protein phosphatase 1A,18156,158,1.05 [0.66-1.67],0.8457502405877735
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPM1B,Protein phosphatase 1B,15792,137,0.86 [0.61-1.21],0.3810921179237023
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPM1F,Protein phosphatase 1F,16274,138,1.03 [0.74-1.42],0.873869334591807
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPME1,Protein phosphatase methylesterase 1,18490,159,1.13 [0.89-1.43],0.3246518377203868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,16206,140,0.94 [0.77-1.16],0.5662869746984542
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,18648,157,1.09 [0.93-1.27],0.2735847202600764
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,15972,137,0.89 [0.68-1.15],0.3636405025238245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,16246,139,1.14 [0.93-1.40],0.2054971838401017
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,16246,139,1.78 [1.29-2.45],0.0003905865181179
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R2,Protein phosphatase inhibitor 2,18584,161,1.10 [0.92-1.32],0.297103818107331
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R9B,Neurabin-2,18753,162,1.09 [0.93-1.27],0.2916971497890916
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,16196,139,1.13 [0.98-1.30],0.0879570222146979
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP3R1,Calcineurin subunit B type 1,18398,157,1.70 [1.20-2.40],0.0028806270493597
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPT1,Palmitoyl-protein thioesterase 1,15834,134,1.07 [0.86-1.32],0.5640578887221961
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPY,Pancreatic prohormone,18567,156,0.97 [0.84-1.12],0.6697173202515468
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PQBP1,Polyglutamine-binding protein 1,18156,158,0.97 [0.74-1.28],0.8341918734989677
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRAME,Melanoma antigen preferentially expressed in tumors,15698,138,1.22 [0.65-2.32],0.5346226725656571
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRAP1,Proline-rich acidic protein 1,16282,139,2.55 [1.68-3.87],1.2122443564497742e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRC1,Protein regulator of cytokinesis 1,16206,140,1.10 [0.80-1.51],0.5688194256933656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRCP,Lysosomal Pro-X carboxypeptidase,18712,162,1.71 [1.16-2.52],0.0063188465643688
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX1,Peroxiredoxin-1,18026,153,1.11 [0.94-1.31],0.2308598571911967
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX2,Peroxiredoxin-2,15994,138,0.78 [0.60-1.03],0.0768061082410002
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",18225,158,1.37 [1.12-1.66],0.001706409528268
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX5,"Peroxiredoxin-5, mitochondrial",18753,162,0.98 [0.79-1.22],0.853049562099074
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX6,Peroxiredoxin-6,18723,163,0.92 [0.73-1.17],0.5014059663213656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PREB,Prolactin regulatory element-binding protein,18225,158,1.10 [0.68-1.80],0.6943952132377949
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRELP,Prolargin,18581,162,1.40 [0.77-2.53],0.2679051738494442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRG2,Bone marrow proteoglycan,16282,139,1.86 [1.38-2.50],4.266201394534287e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRG3,Proteoglycan 3,16282,139,1.37 [0.97-1.93],0.0766849478523408
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,18225,158,1.09 [0.83-1.43],0.5518134074773985
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,15834,134,0.94 [0.54-1.64],0.816261727333297
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,18584,161,1.08 [0.91-1.29],0.367453098554253
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,16225,141,1.05 [0.85-1.30],0.6596120595536746
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKCQ,Protein kinase C theta type,18225,158,1.23 [0.91-1.66],0.179670648136483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKD2,Serine/threonine-protein kinase D2,15718,133,1.04 [0.73-1.48],0.8212573596672238
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKG1,cGMP-dependent protein kinase 1,15945,138,1.05 [0.91-1.20],0.5149088583413952
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,18156,158,1.14 [0.91-1.41],0.2503962286472072
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRL,Prolactin,18723,162,1.24 [1.03-1.50],0.0238883106067589
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRND,Prion-like protein doppel,16250,141,1.54 [1.15-2.05],0.003560825334202
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROC,Vitamin K-dependent protein C,18634,161,0.31 [0.18-0.52],9.635439945999524e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROCR,Endothelial protein C receptor,15718,133,0.94 [0.56-1.58],0.8203127541280748
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROK1,Prokineticin-1,18533,160,1.36 [1.13-1.62],0.0008059023274432
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROS1,Vitamin K-dependent protein S,16302,138,0.55 [0.29-1.06],0.0757099890597351
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRR4,Proline-rich protein 4,15818,138,1.13 [0.90-1.42],0.2768677031440855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRR5,Proline-rich protein 5,15792,137,0.70 [0.46-1.05],0.0869295770190328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRRT3,Proline-rich transmembrane protein 3,15876,134,1.19 [0.79-1.79],0.3932234871071243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS2,Trypsin-2,18671,161,1.13 [0.89-1.43],0.3110612091483504
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS22,Brain-specific serine protease 4,15792,137,2.18 [1.64-2.89],7.60250359451687e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS27,Serine protease 27,18529,161,1.24 [0.87-1.77],0.2362683614880373
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS53,Serine protease 53,16250,141,1.47 [0.95-2.28],0.0832426493347224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS8,Prostasin,18503,162,2.84 [2.13-3.80],1.711398087304702e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,18150,155,1.03 [0.90-1.18],0.6535480957013583
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRTG,Protogenin,18723,163,2.69 [1.55-4.68],0.0004410278059833
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRTN3,Myeloblastin,18090,156,1.48 [1.17-1.88],0.0013109206522134
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRUNE2,Protein prune homolog 2,15972,137,1.34 [0.80-2.24],0.2674071360357699
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSAP,Prosaposin,16114,139,2.81 [1.94-4.08],4.7024931486147526e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSAPL1,Proactivator polypeptide-like 1,16196,139,1.16 [0.84-1.60],0.3567361158151548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSCA,Prostate stem cell antigen,16196,139,1.00 [0.94-1.06],0.9150143360342056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSG1,Pregnancy-specific beta-1-glycoprotein 1,18398,157,1.10 [0.96-1.25],0.1683530958493715
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSIP1,PC4 and SFRS1-interacting protein,18533,160,1.13 [0.91-1.39],0.2693819459660942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMA1,Proteasome subunit alpha type-1,18156,158,1.20 [0.89-1.60],0.2282559278293223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMC3,26S proteasome regulatory subunit 6A,15698,138,1.49 [0.86-2.60],0.153755598385042
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMD1,26S proteasome non-ATPase regulatory subunit 1,16246,139,0.96 [0.69-1.35],0.820174825543868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMD5,26S proteasome non-ATPase regulatory subunit 5,15834,134,1.16 [0.89-1.50],0.2707859187790497
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMD9,26S proteasome non-ATPase regulatory subunit 9,18490,159,0.97 [0.75-1.26],0.8415451024129114
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSME1,Proteasome activator complex subunit 1,18361,157,1.19 [0.81-1.75],0.3783535340410456
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSME2,Proteasome activator complex subunit 2,18305,156,1.25 [0.85-1.84],0.2619612856412669
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMG3,Proteasome assembly chaperone 3,18533,160,1.12 [0.85-1.47],0.4164280491754316
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMG4,Proteasome assembly chaperone 4,15792,137,0.91 [0.68-1.24],0.5596487181250648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSPN,Persephin,18533,160,1.25 [1.12-1.40],9.037551156015954e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSRC1,Proline/serine-rich coiled-coil protein 1,18156,158,1.21 [0.95-1.54],0.1170668870464745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,15386,131,1.02 [0.87-1.21],0.7787000261116255
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",18150,155,0.87 [0.53-1.44],0.5944153867629622
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGDS,Prostaglandin-H2 D-isomerase,18437,159,2.10 [1.48-2.98],2.9849751857540543e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGES2,Prostaglandin E synthase 2,15668,133,1.41 [1.03-1.95],0.0326935511166396
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGR1,Prostaglandin reductase 1,16274,138,1.30 [1.08-1.57],0.0055296389045313
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTH,Parathyroid hormone,15834,134,1.19 [0.99-1.43],0.0710004044860197
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,18533,160,1.04 [0.71-1.51],0.855531234034347
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTK7,Inactive tyrosine-protein kinase 7,18150,155,2.07 [1.43-2.98],0.00010386756062
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTN,Pleiotrophin,18206,158,1.77 [1.37-2.29],1.259752668365918e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTP4A3,Protein tyrosine phosphatase type IVA 3,15792,137,1.30 [0.98-1.71],0.0642114109138632
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,18398,157,1.28 [1.07-1.53],0.007654547415876
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,18629,162,1.04 [0.88-1.23],0.6203829085766167
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,15769,137,1.06 [0.66-1.70],0.8052155179049576
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRB,Receptor-type tyrosine-protein phosphatase beta,16274,138,0.81 [0.46-1.43],0.4611718781801447
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRC,Receptor-type tyrosine-protein phosphatase C,16282,139,1.76 [0.90-3.43],0.0992737134388555
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRF,Receptor-type tyrosine-protein phosphatase F,18801,163,0.79 [0.49-1.29],0.3504997703240439
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRH,Receptor-type tyrosine-protein phosphatase H,16196,139,1.40 [1.01-1.94],0.0433080069725463
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,16196,139,3.04 [1.78-5.18],4.359656129094189e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRM,Receptor-type tyrosine-protein phosphatase mu,18510,159,1.29 [0.71-2.32],0.4004049096116944
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,18345,157,1.01 [0.66-1.53],0.9662109051506916
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRR,Receptor-type tyrosine-protein phosphatase R,16250,141,0.72 [0.47-1.09],0.1225676467933676
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRS,Receptor-type tyrosine-protein phosphatase S,18801,163,0.50 [0.29-0.87],0.0150580112055647
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,16274,138,1.01 [0.62-1.65],0.970083396266074
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,15945,138,0.83 [0.62-1.10],0.1900464343043869
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTS,6-pyruvoyl tetrahydrobiopterin synthase,18059,153,1.08 [0.83-1.40],0.5576061823177978
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTTG1,Securin,15972,137,1.13 [0.78-1.64],0.5190541637201378
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTX3,Pentraxin-related protein PTX3,18533,160,1.48 [1.07-2.05],0.0185342099323681
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PVALB,Parvalbumin alpha,18621,161,0.94 [0.82-1.07],0.3224143950481803
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PVR,Poliovirus receptor,18723,162,2.40 [1.74-3.31],1.123420803934898e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PXDNL,Peroxidasin-like protein,16206,140,1.12 [0.86-1.45],0.4134266547504552
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PXN,Paxillin,18150,155,1.23 [0.93-1.62],0.1447230240362365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PYDC1,Pyrin domain-containing protein 1,15876,134,0.88 [0.58-1.33],0.5374220253584223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PYY,Peptide YY,15718,133,1.08 [0.92-1.27],0.3484538913247722
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PZP,Pregnancy zone protein,16302,138,0.48 [0.35-0.66],3.54222275751806e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QDPR,Dihydropteridine reductase,18497,160,1.20 [0.86-1.69],0.2787563850786707
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QPCT,Glutaminyl-peptide cyclotransferase,18626,162,2.25 [1.42-3.57],0.0005796451304923
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QSOX1,Sulfhydryl oxidase 1,15976,136,1.47 [1.10-1.96],0.0085046704676236
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB10,Ras-related protein Rab-10,16274,138,1.19 [0.88-1.61],0.2671490295571427
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB11FIP3,Rab11 family-interacting protein 3,16274,138,1.03 [0.88-1.21],0.697433842578141
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB27B,Ras-related protein Rab-27B,16274,138,1.16 [0.94-1.44],0.1613310498653966
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB2B,Ras-related protein Rab-2B,16206,140,1.02 [0.78-1.35],0.8651083712681978
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB33A,Ras-related protein Rab-33A,15718,133,0.97 [0.75-1.27],0.8469604357974321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB37,Ras-related protein Rab-37,18225,158,1.13 [0.96-1.33],0.1347996390571046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB39B,Ras-related protein Rab-39B,15718,133,0.95 [0.76-1.17],0.6070657515767011
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,15723,135,0.95 [0.69-1.30],0.753508493153427
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB44,Ras-related protein Rab-44,16206,140,1.01 [0.68-1.50],0.9636830608542766
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB6A,Ras-related protein Rab-6A,18533,160,0.63 [0.47-0.85],0.0020499660477127
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB6B,Ras-related protein Rab-6B,18150,155,1.42 [1.12-1.81],0.0036746199493397
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RABEP1,Rab GTPase-binding effector protein 1,15945,138,1.04 [0.83-1.29],0.7513035975050377
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RABEPK,Rab9 effector protein with kelch motifs,18156,158,1.39 [1.12-1.72],0.0028887062142115
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RABGAP1L,Rab GTPase-activating protein 1-like,18225,158,1.18 [0.93-1.50],0.1691080249285895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAC3,Ras-related C3 botulinum toxin substrate 3,15834,134,0.82 [0.61-1.11],0.2076086517835073
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAD23B,UV excision repair protein RAD23 homolog B,18156,158,1.19 [0.86-1.63],0.2941138327746865
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAD51,DNA repair protein RAD51 homolog 1,15972,137,1.23 [0.97-1.56],0.089134829646283
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RALB,Ras-related protein Ral-B,15792,137,2.60 [1.53-4.43],0.0004276234594581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RALY,RNA-binding protein Raly,16206,140,1.10 [0.79-1.53],0.5672041054219605
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RANBP1,Ran-specific GTPase-activating protein,15876,134,0.84 [0.60-1.16],0.2790638812858436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RANBP2,E3 SUMO-protein ligase RanBP2,15723,135,1.44 [0.88-2.35],0.1495755367149056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RANGAP1,Ran GTPase-activating protein 1,18156,158,0.97 [0.71-1.34],0.8612284277381346
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAP1A,Ras-related protein Rap-1A,15792,137,0.92 [0.70-1.20],0.5186854721809708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAPGEF2,Rap guanine nucleotide exchange factor 2,15972,137,0.98 [0.71-1.36],0.9270873266508566
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RARRES1,Retinoic acid receptor responder protein 1,18156,158,1.50 [1.06-2.13],0.0223384511351724
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,18698,161,1.60 [1.24-2.08],0.0003371709860231
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RASA1,Ras GTPase-activating protein 1,18150,155,0.94 [0.58-1.50],0.7812089662127046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,15698,138,0.94 [0.64-1.37],0.739720946825729
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RASSF2,Ras association domain-containing protein 2,18156,158,1.24 [1.01-1.53],0.0427716302850231
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,16246,139,2.09 [1.60-2.73],6.122435333440214e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBKS,Ribokinase,18114,152,1.11 [0.83-1.48],0.4956718622169195
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBM17,Splicing factor 45,16246,139,1.11 [0.89-1.38],0.351277952903624
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBM19,Probable RNA-binding protein 19,15718,133,1.24 [0.90-1.71],0.1849712660688056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBM25,RNA-binding protein 25,15698,138,1.22 [0.85-1.74],0.2756021733273656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP1,Retinol-binding protein 1,15834,134,1.05 [0.81-1.35],0.7375913451559614
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP2,Retinol-binding protein 2,18490,159,1.41 [1.18-1.68],0.000144711077099
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP5,Retinol-binding protein 5,18490,159,1.33 [1.05-1.68],0.0166350259353974
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP7,Retinoid-binding protein 7,16196,139,1.08 [0.82-1.41],0.5886314811106882
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBPMS,RNA-binding protein with multiple splicing,15792,137,0.96 [0.71-1.29],0.7845157269715585
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBPMS2,RNA-binding protein with multiple splicing 2,15876,134,1.19 [1.01-1.41],0.0432825056747611
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RCC1,Regulator of chromosome condensation,16206,140,1.34 [1.03-1.75],0.0294004110497223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RCOR1,REST corepressor 1,18206,158,1.08 [0.81-1.44],0.6154895901259588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,15876,134,0.66 [0.30-1.42],0.2889922147059438
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REEP4,Receptor expression-enhancing protein 4,16246,139,1.41 [1.10-1.81],0.0061520394165452
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1A,Lithostathine-1-alpha,18469,160,1.22 [0.94-1.58],0.1351028297119655
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1B,Lithostathine-1-beta,18801,163,1.08 [0.86-1.37],0.5044261998047943
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG3A,Regenerating islet-derived protein 3-alpha,18801,163,1.17 [0.96-1.43],0.1260833248175925
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG3G,Regenerating islet-derived protein 3-gamma,16206,140,0.75 [0.49-1.16],0.1954152466222247
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG4,Regenerating islet-derived protein 4,18607,162,1.34 [1.04-1.73],0.0247485542036559
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RELB,Transcription factor RelB,15792,137,1.48 [1.13-1.94],0.0040846488225986
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,18585,160,2.66 [1.87-3.79],6.393394582438704e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REN,Renin,18584,161,1.53 [1.34-1.74],3.81817022878236e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REPS1,RalBP1-associated Eps domain-containing protein 1,15792,137,1.42 [0.97-2.08],0.0741287955902004
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REST,RE1-silencing transcription factor,15698,138,1.32 [0.83-2.10],0.2377764459201548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,18490,159,0.80 [0.55-1.14],0.2167130087356142
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RETN,Resistin,18539,159,1.71 [1.29-2.27],0.0001778314196765
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REXO2,"Oligoribonuclease, mitochondrial",15718,133,0.97 [0.68-1.39],0.8716492051190113
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RFC4,Replication factor C subunit 4,16206,140,1.27 [0.58-2.80],0.5467237541761079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGCC,Regulator of cell cycle RGCC,16246,139,1.07 [0.85-1.33],0.5732990817319283
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,15972,137,1.04 [0.79-1.36],0.8021605324886361
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGMA,Repulsive guidance molecule A,18723,162,1.08 [0.70-1.68],0.7264856613063059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGMB,RGM domain family member B,18723,162,2.05 [1.29-3.27],0.0024428091806053
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGS10,Regulator of G-protein signaling 10,16246,139,1.06 [0.80-1.40],0.7007623581970153
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGS8,Regulator of G-protein signaling 8,18225,158,0.89 [0.69-1.15],0.3886891825038866
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RHOC,Rho-related GTP-binding protein RhoC,18293,157,1.09 [0.96-1.25],0.1719594848824215
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RICTOR,Rapamycin-insensitive companion of mTOR,15792,137,1.04 [0.75-1.45],0.7979153955539339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,15945,138,1.27 [0.93-1.73],0.1396384081726185
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RILP,Rab-interacting lysosomal protein,18660,162,1.08 [0.86-1.38],0.502464143703413
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RILPL2,RILP-like protein 2,16274,138,1.06 [0.89-1.27],0.4918129079792305
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,15718,133,1.20 [0.97-1.48],0.0915844553003175
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RLN1,Prorelaxin H1,16246,139,1.11 [0.81-1.53],0.5062672969213682
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RLN2,Prorelaxin H2,15916,138,1.00 [0.71-1.41],0.9926349726242956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE1,Ribonuclease pancreatic,16290,140,2.56 [1.71-3.84],5.4449607825522585e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE10,Inactive ribonuclease-like protein 10,15876,134,1.53 [1.13-2.08],0.0063220535653173
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE3,Eosinophil cationic protein,18499,161,1.04 [0.92-1.17],0.5685896989611702
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE4,Ribonuclease 4,15752,133,2.02 [1.26-3.25],0.0035272100549656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE6,Ribonuclease K6,16178,140,2.17 [1.65-2.84],2.7759813981656653e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASEH2A,Ribonuclease H2 subunit A,16246,139,0.86 [0.58-1.28],0.4543741724450604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASET2,Ribonuclease T2,18734,162,3.81 [2.54-5.71],1.0811583143967448e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,15876,134,3.02 [2.00-4.57],1.555696602878559e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF168,E3 ubiquitin-protein ligase RNF168,15792,137,0.77 [0.47-1.26],0.2978659581788606
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF31,E3 ubiquitin-protein ligase RNF31,15792,137,0.93 [0.56-1.54],0.7769130178655095
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF4,E3 ubiquitin-protein ligase RNF4,15972,137,1.03 [0.80-1.32],0.8420744638590747
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF41,E3 ubiquitin-protein ligase NRDP1,18156,158,1.15 [0.92-1.44],0.2065890378711028
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF43,E3 ubiquitin-protein ligase RNF43,15972,137,1.04 [0.78-1.37],0.8118829607711125
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF5,E3 ubiquitin-protein ligase RNF5,15876,134,1.06 [0.84-1.35],0.6138378687485204
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROBO1,Roundabout homolog 1,18607,162,1.92 [1.14-3.25],0.0146578726169503
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROBO2,Roundabout homolog 2,18723,162,0.83 [0.47-1.48],0.5298806867082774
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROBO4,Roundabout homolog 4,15876,134,2.32 [0.89-6.02],0.0848437808531727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,18584,161,0.99 [0.64-1.52],0.957528425986823
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RP2,Protein XRP2,18490,159,1.55 [1.13-2.13],0.0062926097722874
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPA2,Replication protein A 32 kDa subunit,15792,137,1.23 [0.70-2.15],0.4671103080588895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPE,Ribulose-phosphate 3-epimerase,15972,137,0.93 [0.72-1.20],0.5807013446837179
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPGR,X-linked retinitis pigmentosa GTPase regulator,15834,134,0.58 [0.36-0.95],0.0307301704800588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPL14,60S ribosomal protein L14,15876,134,0.93 [0.58-1.49],0.7705992388034882
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPS10,40S ribosomal protein S10,15718,133,1.30 [0.89-1.89],0.1697712709601845
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRAS,Ras-related protein R-Ras,15834,134,1.06 [0.92-1.20],0.4261974097999025
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRM2,Ribonucleoside-diphosphate reductase subunit M2,18156,158,1.21 [0.97-1.51],0.0870895128579656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,18156,158,1.07 [0.86-1.33],0.5454981604192908
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRP15,RRP15-like protein,15723,135,1.07 [0.89-1.27],0.4713259306756997
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO1,R-spondin-1,18398,157,2.18 [1.53-3.09],1.3414371706676836e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO3,R-spondin-3,18723,163,1.89 [1.24-2.89],0.0032202683522386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTBDN,Retbindin,18490,159,1.09 [0.70-1.72],0.6937357622411016
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTKN2,Rhotekin-2,15718,133,1.10 [0.80-1.50],0.5757907677137333
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",16246,139,1.14 [0.95-1.37],0.1584872588618849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTN4R,Reticulon-4 receptor,18723,163,1.00 [0.67-1.47],0.9856061845760804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RUVBL1,RuvB-like 1,18156,158,0.96 [0.83-1.11],0.5465105694445969
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RWDD1,RWD domain-containing protein 1,18723,162,1.13 [0.90-1.42],0.305302847918818
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RYR1,Ryanodine receptor 1,15718,133,1.06 [0.64-1.76],0.8219708258340735
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A11,Protein S100-A11,18439,159,1.34 [1.04-1.74],0.0248499783048506
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A12,Protein S100-A12,18311,155,1.18 [0.98-1.43],0.0880832071375199
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A13,Protein S100-A13,15792,137,0.97 [0.61-1.54],0.8927431461951558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A14,Protein S100-A14,16246,139,1.23 [0.92-1.64],0.1667413766773688
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A16,Protein S100-A16,18124,154,0.99 [0.77-1.26],0.9283716273707824
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A3,Protein S100-A3,16206,140,0.99 [0.66-1.48],0.9648596219348688
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A4,Protein S100-A4,18648,157,0.87 [0.67-1.12],0.2684028871939651
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100G,Protein S100-G,16246,139,1.49 [1.10-2.01],0.0097952249570905
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100P,Protein S100-P,18206,158,1.29 [1.01-1.63],0.0376357025336656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAA4,Serum amyloid A-4 protein,16302,138,0.78 [0.35-1.74],0.5473333714081721
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAFB2,Scaffold attachment factor B2,16246,139,1.33 [0.74-2.38],0.3415999603042794
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAG,S-arrestin,15723,135,0.96 [0.69-1.34],0.8230301220972297
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAMD9L,Sterile alpha motif domain-containing protein 9-like,18533,160,1.11 [0.91-1.37],0.2987453316384644
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAP18,Histone deacetylase complex subunit SAP18,15972,137,0.92 [0.71-1.18],0.5102007508912838
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SARG,Specifically androgen-regulated gene protein,16204,138,0.99 [0.85-1.16],0.8890054027501814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SART1,U4/U6.U5 tri-snRNP-associated protein 1,15718,133,1.16 [0.76-1.76],0.4889536579226237
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAT1,Diamine acetyltransferase 1,15718,133,1.00 [0.70-1.45],0.9805191718632628
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAT2,Thialysine N-epsilon-acetyltransferase,15972,137,0.99 [0.77-1.28],0.9458562511996332
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SATB1,DNA-binding protein SATB1,16246,139,1.18 [0.68-2.02],0.5588592143302928
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SBSN,Suprabasin,16246,139,1.79 [1.12-2.87],0.014456588462674
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCAMP3,Secretory carrier-associated membrane protein 3,18490,159,1.27 [1.07-1.50],0.0053192205186026
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARA5,Scavenger receptor class A member 5,18723,162,1.18 [0.75-1.84],0.478752390559897
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARB1,Scavenger receptor class B member 1,18150,155,1.02 [0.78-1.32],0.9091404036831504
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARB2,Lysosome membrane protein 2,18057,153,2.38 [1.72-3.29],1.639734840476169e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARF1,Scavenger receptor class F member 1,18801,163,1.83 [1.33-2.51],0.0001930489567253
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARF2,Scavenger receptor class F member 2,18723,162,2.38 [1.53-3.70],0.0001239036450152
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCG2,Secretogranin-2,18625,162,1.09 [0.72-1.65],0.6901423226994419
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCG3,Secretogranin-3,18607,162,1.00 [0.66-1.51],0.9927185718689256
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB1A1,Uteroglobin,18589,161,0.77 [0.61-0.97],0.0241150380651329
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB2A2,Mammaglobin-A,15718,133,1.37 [0.83-2.24],0.2142841514014103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A1,Secretoglobin family 3A member 1,15945,138,1.52 [0.85-2.73],0.1570398199405827
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A2,Secretoglobin family 3A member 2,18629,162,1.00 [0.85-1.17],0.988908232062099
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGN,Secretagogin,18225,158,0.79 [0.57-1.09],0.1434595374753318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCIN,Adseverin,15723,135,1.10 [0.89-1.36],0.3663511026765453
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCLY,Selenocysteine lyase,18660,162,1.59 [1.22-2.08],0.0006847699161598
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN2A,Sodium channel protein type 2 subunit alpha,15723,135,0.97 [0.66-1.42],0.8699222767925804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN2B,Sodium channel subunit beta-2,15834,134,1.09 [0.60-1.96],0.7799402560992225
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN3A,Sodium channel protein type 3 subunit alpha,15834,134,0.92 [0.55-1.56],0.7581860030613359
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN3B,Sodium channel subunit beta-3,15723,135,1.07 [0.77-1.49],0.6790215417679755
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN4B,Sodium channel subunit beta-4,15876,134,1.30 [0.91-1.86],0.1555352000646658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCP2,Non-specific lipid-transfer protein,18156,158,1.34 [1.14-1.57],0.0003196291549365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCPEP1,Retinoid-inducible serine carboxypeptidase,15807,134,2.12 [1.55-2.90],2.5927275504386622e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCRG1,Scrapie-responsive protein 1,16274,138,1.93 [1.19-3.13],0.0073963472975563
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCRIB,Protein scribble homolog,15876,134,1.13 [0.95-1.33],0.1705493747819345
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCRN1,Secernin-1,18533,160,1.17 [0.90-1.52],0.2387524042451121
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCT,Secretin,15834,134,0.50 [0.35-0.72],0.0001771660279203
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDC1,Syndecan-1,18584,161,1.96 [1.48-2.59],2.7174808107225944e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDC4,Syndecan-4,18584,161,0.65 [0.49-0.85],0.0018342406972995
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDCCAG8,Serologically defined colon cancer antigen 8,16206,140,1.08 [0.93-1.25],0.3074394703134666
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDHB,Succinate dehydrogenase,16196,139,1.30 [1.03-1.63],0.0254507558906704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDK2,Protein sidekick-2,15945,138,1.09 [0.71-1.66],0.7040864912407339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEC31A,Protein transport protein Sec31A,15876,134,1.00 [0.80-1.26],0.9716504527808276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEL1L,Protein sel-1 homolog 1,15876,134,2.19 [1.62-2.97],4.103773239338969e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELE,E-selectin,18801,163,1.41 [1.06-1.86],0.0167550540710593
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELENOP,Selenoprotein P,16302,138,0.23 [0.11-0.47],4.810880357066104e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELL,L-selectin,16302,138,0.89 [0.45-1.77],0.7401809443472491
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELP,P-selectin,18671,161,1.39 [1.09-1.79],0.0092651870493943
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELPLG,P-selectin glycoprotein ligand 1,18533,160,0.75 [0.47-1.21],0.2416369043841474
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA3F,Semaphorin-3F,18584,161,1.58 [0.96-2.61],0.0746375649295594
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA3G,Semaphorin-3G,15945,138,0.90 [0.62-1.31],0.5714076415495148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA4C,Semaphorin-4C,18490,159,0.82 [0.47-1.41],0.4720537302816893
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA4D,Semaphorin-4D,18723,162,1.54 [0.96-2.47],0.0726236889468652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA6C,Semaphorin-6C,15792,137,1.47 [0.76-2.84],0.2474695754021331
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA7A,Semaphorin-7A,18745,163,1.35 [0.86-2.11],0.194676139898092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN3,Neuronal-specific septin-3,16246,139,1.41 [1.16-1.72],0.0006015618655186
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN7,Septin-7,15972,137,1.25 [0.97-1.60],0.0824380160527652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN8,Septin-8,16227,141,2.16 [1.50-3.12],3.782480825114413e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN9,Septin-9,18490,159,1.19 [0.72-1.97],0.4933963420364375
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA1,Alpha-1-antitrypsin,15975,135,,
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA11,Serpin A11,18801,163,1.24 [0.89-1.72],0.1966013670238457
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA12,Serpin A12,18028,155,0.77 [0.64-0.92],0.0045287544733579
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA3,Alpha-1-antichymotrypsin,16235,137,3.15 [1.26-7.86],0.0140900842496986
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA4,Kallistatin,16010,137,0.15 [0.08-0.28],3.3450192205930355e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA5,Plasma serine protease inhibitor,16062,137,0.29 [0.16-0.53],6.778768369502374e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA6,Corticosteroid-binding globulin,16302,138,0.38 [0.15-1.00],0.0489175542114864
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA7,Thyroxine-binding globulin,16302,138,0.77 [0.31-1.88],0.5623808561046206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA9,Serpin A9,18402,157,1.20 [0.99-1.46],0.0659928360834776
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB1,Leukocyte elastase inhibitor,18523,159,1.07 [0.91-1.26],0.4273513447407505
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB5,Serpin B5,18206,158,0.81 [0.62-1.07],0.1334159957162737
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB6,Serpin B6,18664,162,1.34 [1.05-1.71],0.0202861587966982
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB8,Serpin B8,18753,162,1.38 [1.15-1.66],0.0006652827278527
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB9,Serpin B9,18398,157,1.14 [0.72-1.79],0.5767008888521976
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINC1,Antithrombin-III,16272,137,,
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPIND1,Heparin cofactor 2,16272,137,0.92 [0.51-1.66],0.7725996799029766
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINE1,Plasminogen activator inhibitor 1,18801,163,1.34 [1.08-1.67],0.0088862910239297
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINE2,Glia-derived nexin,16274,138,1.10 [0.86-1.41],0.4552725662310443
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINF1,Pigment epithelium-derived factor,16036,136,2.10 [1.16-3.81],0.0140414485296162
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINF2,Alpha-2-antiplasmin,15982,135,,
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPING1,Plasma protease C1 inhibitor,16272,137,0.73 [0.30-1.79],0.495249543720897
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINH1,Serpin H1,15972,137,1.11 [0.97-1.26],0.1162804249212921
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINI1,Neuroserpin,15920,138,1.05 [0.63-1.76],0.8484001364626517
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINI2,Serpin I2,16196,139,0.75 [0.55-1.02],0.0645177291738901
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,18150,155,1.08 [0.86-1.37],0.5087174986624783
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SETMAR,Histone-lysine N-methyltransferase SETMAR,18330,156,1.14 [0.72-1.82],0.5785495141836987
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEZ6,Seizure protein 6 homolog,15834,134,1.19 [0.70-2.04],0.5215975946561009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEZ6L,Seizure 6-like protein,18648,157,0.87 [0.53-1.42],0.5753366548704193
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEZ6L2,Seizure 6-like protein 2,18490,159,1.25 [0.73-2.14],0.411305740526401
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SF3B4,Splicing factor 3B subunit 4,18490,159,1.06 [0.87-1.29],0.571403662424818
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFRP1,Secreted frizzled-related protein 1,18344,157,1.57 [1.20-2.06],0.0011476230276449
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFRP4,Secreted frizzled-related protein 4,15945,138,0.98 [0.64-1.50],0.926823343290537
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA1,Pulmonary surfactant-associated protein A1,18156,158,1.39 [1.14-1.69],0.0010740857242242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA2,Pulmonary surfactant-associated protein A2,18156,158,1.29 [1.02-1.62],0.0342860090587316
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPD,Pulmonary surfactant-associated protein D,18584,161,1.17 [0.95-1.44],0.1349431134095628
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SGSH,N-sulphoglucosamine sulphohydrolase,15972,135,1.43 [1.08-1.89],0.0127564225476847
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH2B3,SH2B adapter protein 3,18156,158,1.13 [0.97-1.31],0.1281260038398781
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH2D1A,SH2 domain-containing protein 1A,18533,160,1.03 [0.81-1.32],0.8065574320757836
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,15723,135,1.11 [0.86-1.43],0.4297853798247875
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH3BP1,SH3 domain-binding protein 1,16196,139,1.05 [0.73-1.50],0.7935087892608951
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH3GL3,Endophilin-A3,15900,137,0.98 [0.80-1.19],0.8059540701920684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH3GLB2,Endophilin-B2,16250,141,0.98 [0.77-1.26],0.8857510624474281
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHBG,Sex hormone-binding globulin,16290,140,0.95 [0.69-1.31],0.7509833083859537
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHC1,SHC-transforming protein 1,15698,138,1.02 [0.88-1.17],0.8016264912080159
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHD,SH2 domain-containing adapter protein D,15681,132,0.96 [0.78-1.18],0.7022475230631358
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHH,Sonic hedgehog protein,15792,137,0.95 [0.62-1.45],0.8215046675411031
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHISA5,Protein shisa-5,16282,139,2.64 [1.87-3.73],3.8131067016545734e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHMT1,"Serine hydroxymethyltransferase, cytosolic",18629,162,1.09 [0.92-1.29],0.3430799479822581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHPK,Sedoheptulokinase,15972,137,1.29 [0.89-1.86],0.1754980350321174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIAE,Sialate O-acetylesterase,18618,156,1.96 [1.45-2.66],1.358593147492978e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC1,Sialoadhesin,18660,162,2.48 [1.84-3.33],1.873819649765301e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,18533,160,2.01 [1.41-2.85],9.509576478860117e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC15,Sialic acid-binding Ig-like lectin 15,18150,155,1.17 [1.00-1.37],0.0508028518517214
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC5,Sialic acid-binding Ig-like lectin 5,18585,160,1.18 [1.02-1.36],0.0220240586132659
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC6,Sialic acid-binding Ig-like lectin 6,18723,163,1.05 [0.70-1.59],0.8159766264302791
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC7,Sialic acid-binding Ig-like lectin 7,18584,161,1.75 [1.06-2.87],0.0282789852722868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC8,Sialic acid-binding Ig-like lectin 8,15876,134,1.74 [1.23-2.47],0.0018267750927078
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC9,Sialic acid-binding Ig-like lectin 9,18690,162,1.83 [1.13-2.97],0.0134951472601586
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIL1,Nucleotide exchange factor SIL1,15876,134,1.33 [0.86-2.04],0.1954313684572641
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,18622,163,1.18 [0.91-1.51],0.2098172486809247
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRPB1,Signal-regulatory protein beta-1,18555,162,1.88 [1.43-2.48],7.434472883789266e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRT1,NAD-dependent protein deacetylase sirtuin-1,15792,137,0.96 [0.75-1.23],0.7467941426446393
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRT2,NAD-dependent protein deacetylase sirtuin-2,18490,159,1.08 [0.91-1.27],0.3773843696196894
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",18150,155,0.91 [0.68-1.22],0.5307425648366375
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIT1,Signaling threshold-regulating transmembrane adapter 1,18225,158,1.19 [0.92-1.52],0.1817190317888334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SKAP1,Src kinase-associated phosphoprotein 1,18369,157,1.05 [0.86-1.27],0.6477740279392538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SKAP2,Src kinase-associated phosphoprotein 2,18660,162,1.13 [0.98-1.30],0.0823370418883288
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SKIV2L,Helicase SKI2W,15718,133,1.24 [0.85-1.83],0.2642783561264319
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLA2,Src-like-adapter 2,16246,139,1.06 [0.90-1.24],0.5087704853830252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF1,Signaling lymphocytic activation molecule,18225,158,1.61 [1.28-2.04],5.896733129747672e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF6,SLAM family member 6,18156,158,1.63 [1.15-2.32],0.0064938988167853
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF7,SLAM family member 7,18533,160,1.78 [1.44-2.19],7.337038705982738e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF8,SLAM family member 8,18156,158,2.00 [1.54-2.60],2.464387761626153e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC12A2,Solute carrier family 12 member 2,15718,133,1.71 [1.01-2.87],0.043812301730006
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC13A1,Solute carrier family 13 member 1,16206,140,1.08 [0.84-1.40],0.5289933709909285
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC16A1,Monocarboxylate transporter 1,18150,155,1.38 [1.14-1.67],0.0011702042849136
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC1A4,Neutral amino acid transporter A,15834,134,1.46 [1.14-1.87],0.0025564714438399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC27A4,Long-chain fatty acid transport protein 4,18150,155,1.33 [1.11-1.60],0.002282113764915
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC28A1,Sodium/nucleoside cotransporter 1,15698,138,1.17 [0.92-1.48],0.2042390587395949
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC34A3,Sodium-dependent phosphate transport protein 2C,15698,138,0.57 [0.36-0.90],0.0157597332643664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC39A14,Zinc transporter ZIP14,18150,155,1.14 [0.79-1.65],0.4829166018311711
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC39A5,Zinc transporter ZIP5,18533,160,0.99 [0.75-1.31],0.9587825669114
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC44A4,Choline transporter-like protein 4,15834,134,1.09 [0.86-1.39],0.4776644078010789
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC4A1,Band 3 anion transport protein,16282,139,0.98 [0.69-1.39],0.8975028428941858
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC51B,Organic solute transporter subunit beta,15718,133,1.05 [0.84-1.33],0.6533599420363418
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,15945,138,1.04 [0.85-1.27],0.7031826165785701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,16196,139,1.09 [0.79-1.50],0.5904780231457514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",15698,138,1.16 [0.90-1.50],0.2474871460313017
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLIT2,Slit homolog 2 protein,18150,155,1.43 [1.13-1.82],0.0034352598685767
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK1,SLIT and NTRK-like protein 1,15792,137,0.57 [0.35-0.93],0.0235871203845195
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK2,SLIT and NTRK-like protein 2,18723,163,0.66 [0.47-0.94],0.0207458045333083
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK6,SLIT and NTRK-like protein 6,18206,158,0.76 [0.51-1.15],0.1957133909859432
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLK,STE20-like serine/threonine-protein kinase,15972,137,0.73 [0.53-0.99],0.0458776165852753
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLMAP,Sarcolemmal membrane-associated protein,16196,139,1.33 [1.09-1.62],0.0043814410593372
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLURP1,Secreted Ly-6/uPAR-related protein 1,16156,139,1.34 [0.91-1.99],0.1409653292913579
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD1,Mothers against decapentaplegic homolog 1,18156,158,1.03 [0.86-1.23],0.7263864856860205
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD2,Mothers against decapentaplegic homolog 2,16206,140,1.15 [0.92-1.46],0.2232867897405202
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD3,Mothers against decapentaplegic homolog 3,16206,140,1.24 [0.90-1.70],0.1816355603615317
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD5,Mothers against decapentaplegic homolog 5,18490,159,1.26 [0.59-2.68],0.5528993959526851
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMARCA2,Probable global transcription activator SNF2L2,18150,155,1.11 [0.91-1.36],0.3058151533929655
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMC3,Structural maintenance of chromosomes protein 3,15698,138,0.93 [0.68-1.27],0.6517597780595532
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMNDC1,Survival of motor neuron-related-splicing factor 30,16196,139,1.01 [0.76-1.35],0.9246359786939076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC1,SPARC-related modular calcium-binding protein 1,18723,163,1.85 [1.23-2.77],0.0029929726187329
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,18660,162,2.54 [1.88-3.42],8.678081492641852e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPD1,Sphingomyelin phosphodiesterase,18633,160,1.90 [1.48-2.44],4.85052874402005e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPD3,Sphingomyelin phosphodiesterase 3,15792,137,1.03 [0.72-1.46],0.8768078768104626
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,18634,162,1.06 [0.86-1.31],0.5989453497650499
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,16206,140,0.96 [0.76-1.21],0.7293804854154737
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMS,Spermine synthase,15723,135,1.24 [0.95-1.61],0.1100886237989338
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMTN,Smoothelin,16226,141,1.31 [1.11-1.55],0.0014139905056919
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAP23,Synaptosomal-associated protein 23,18584,161,1.08 [0.91-1.28],0.3884768608196477
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAP25,Synaptosomal-associated protein 25,15723,135,1.38 [0.99-1.94],0.0585706247918631
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAP29,Synaptosomal-associated protein 29,18648,157,1.12 [0.95-1.31],0.1834758943523975
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAPIN,SNARE-associated protein Snapin,16246,139,1.07 [0.79-1.43],0.6735198391431874
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNCA,Alpha-synuclein,15945,138,0.98 [0.84-1.13],0.7562948835079386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNCG,Gamma-synuclein,18398,157,1.08 [0.88-1.34],0.4513109590202061
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",15876,134,1.63 [1.08-2.45],0.0196176798816925
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNRPB2,U2 small nuclear ribonucleoprotein B'',16250,141,1.22 [0.89-1.66],0.2238809233703801
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNU13,NHP2-like protein 1,15718,133,0.99 [0.74-1.31],0.9243708340196672
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX15,Sorting nexin-15,15945,138,0.96 [0.70-1.31],0.7834156136048602
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX18,Sorting nexin-18,16196,139,1.26 [0.89-1.78],0.1960780234983077
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX2,Sorting nexin-2,16206,140,1.00 [0.82-1.24],0.9639620629449418
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX5,Sorting nexin-5,15876,134,1.07 [0.59-1.92],0.8335011735728453
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX9,Sorting nexin-9,18584,161,1.15 [0.93-1.42],0.1854958353990629
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD1,Superoxide dismutase [Cu-Zn],18236,159,1.15 [0.86-1.55],0.3404554589544045
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD2,"Superoxide dismutase [Mn], mitochondrial",18585,160,1.87 [1.37-2.54],6.490990322917197e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD3,Extracellular superoxide dismutase,16290,140,1.04 [0.80-1.35],0.7788133264918311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORBS1,Sorbin and SH3 domain-containing protein 1,16246,139,1.26 [0.91-1.76],0.169869691456087
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,18156,158,1.55 [1.09-2.21],0.0146728446040317
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORD,Sorbitol dehydrogenase,18636,161,0.98 [0.79-1.21],0.8296898653002617
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORT1,Sortilin,18550,161,1.15 [0.79-1.68],0.4593966437894465
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOST,Sclerostin,18550,161,0.85 [0.60-1.21],0.3654057989276611
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,15834,134,0.88 [0.63-1.24],0.4778153001003435
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOX2,Transcription factor SOX-2,16209,139,0.94 [0.46-1.91],0.8569510030344626
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOX9,Transcription factor SOX-9,15834,134,1.04 [0.56-1.93],0.8932189865263218
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,16246,139,1.54 [0.93-2.56],0.09547321467711
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPAG1,Sperm-associated antigen 1,16246,139,0.85 [0.60-1.19],0.3315810056324595
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPARC,SPARC,18648,157,1.15 [0.93-1.42],0.2072755665395169
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPARCL1,SPARC-like protein 1,18608,160,0.90 [0.54-1.50],0.6965120694003564
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPART,Spartin,15945,138,1.17 [0.93-1.46],0.1792949983516919
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPESP1,Sperm equatorial segment protein 1,16274,138,2.44 [1.57-3.80],7.981074800352915e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,18585,160,1.70 [1.31-2.19],5.722361094714776e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK2,Serine protease inhibitor Kazal-type 2,15945,138,2.01 [1.38-2.92],0.0002408371212745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,18533,160,1.29 [1.06-1.57],0.0109667707269753
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK5,Serine protease inhibitor Kazal-type 5,18585,160,1.51 [1.03-2.21],0.0351512479382306
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK6,Serine protease inhibitor Kazal-type 6,18723,163,1.40 [1.06-1.85],0.0162421208299514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK8,Serine protease inhibitor Kazal-type 8,15718,133,0.91 [0.58-1.44],0.692910468009968
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,18531,159,2.90 [1.92-4.37],3.7703893862641353e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT2,Kunitz-type protease inhibitor 2,18660,162,1.90 [1.34-2.67],0.000269735217311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT3,Kunitz-type protease inhibitor 3,16196,139,1.11 [1.05-1.19],0.0005453213229884
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPOCK1,Testican-1,18398,157,0.99 [0.57-1.74],0.9771569051992772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON1,Spondin-1,18607,162,2.38 [1.71-3.32],3.175575303502391e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON2,Spondin-2,18496,160,3.03 [2.14-4.28],3.505746422293342e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPP1,Osteopontin,18781,163,1.61 [1.22-2.12],0.0006841343115343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",15792,137,1.20 [0.80-1.80],0.3714523111753236
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRING1,SREBP regulating gene protein,15698,138,1.04 [0.77-1.41],0.7790831858394214
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRR1B,Cornifin-B,15972,137,1.04 [0.85-1.27],0.6863710586842633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRR3,Small proline-rich protein 3,16250,141,0.80 [0.64-1.00],0.0500587998461797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRY2,Protein sprouty homolog 2,18225,158,1.12 [0.96-1.31],0.1597412558669735
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",15723,135,0.77 [0.43-1.36],0.3591555530137483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPTLC1,Serine palmitoyltransferase 1,16250,141,1.42 [0.98-2.05],0.0622563092639565
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRC,Proto-oncogene tyrosine-protein kinase Src,18616,157,1.00 [0.88-1.13],0.9943794474968308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRP14,Signal recognition particle 14 kDa protein,18490,159,1.13 [0.88-1.44],0.3304057004269233
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRPK2,SRSF protein kinase 2,18533,160,1.07 [0.90-1.27],0.4420503336688861
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRPX,Sushi repeat-containing protein SRPX,16274,138,1.85 [1.19-2.88],0.006498401955828
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSB,Lupus La protein,18150,155,1.09 [0.85-1.40],0.5151233312119863
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",15792,137,0.81 [0.48-1.37],0.4348491205413133
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,18550,161,0.76 [0.66-0.87],4.207328434279223e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,18671,161,1.03 [0.73-1.44],0.8854053153904546
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSH3,Protein phosphatase Slingshot homolog 3,15698,138,1.10 [0.65-1.86],0.7141532275548191
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSNA1,Sjoegren syndrome nuclear autoantigen 1,16196,139,1.16 [0.84-1.59],0.3728375413511117
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST13,Hsc70-interacting protein,15945,138,0.79 [0.58-1.08],0.1385295594533542
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",18490,159,1.00 [0.71-1.40],0.9906145180380648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",18801,163,2.81 [1.94-4.05],3.99515647115889e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",15792,137,0.95 [0.63-1.42],0.7952142791319322
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAB2,Stabilin-2,16282,139,1.64 [0.93-2.91],0.0897266456606748
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAM,Signal transducing adapter molecule 1,16206,140,1.36 [0.95-1.94],0.0948149352369762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAMBP,STAM-binding protein,18369,157,1.09 [0.87-1.38],0.4476011890261657
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAT2,Signal transducer and activator of transcription 2,15792,137,1.19 [0.95-1.48],0.1373819474308434
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAT5B,Signal transducer and activator of transcription 5B,18490,159,1.02 [0.92-1.14],0.7202180609693909
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,15698,138,1.08 [0.84-1.40],0.5428574899922285
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STC1,Stanniocalcin-1,18723,162,1.61 [1.21-2.15],0.0011324366423821
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STC2,Stanniocalcin-2,18562,159,1.64 [0.95-2.82],0.0758734298384768
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STEAP4,Metalloreductase STEAP4,15723,135,1.01 [0.81-1.26],0.9162396947138124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STIP1,Stress-induced-phosphoprotein 1,18558,159,1.08 [0.87-1.35],0.4818578619769893
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STK11,Serine/threonine-protein kinase STK11,18206,158,1.21 [0.99-1.48],0.0610839986731975
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STK24,Serine/threonine-protein kinase 24,18150,155,1.04 [0.82-1.33],0.7429712387615116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STK4,Serine/threonine-protein kinase 4,18584,161,1.06 [0.90-1.26],0.4728319266777941
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STOML2,"Stomatin-like protein 2, mitochondrial",15698,138,1.06 [0.87-1.29],0.562650085481737
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX16,Syntaxin-16,18156,158,1.09 [0.85-1.40],0.501503036067845
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX1B,Syntaxin-1B,15834,134,0.70 [0.42-1.15],0.159407188164714
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX3,Syntaxin-3,16250,141,1.20 [0.81-1.80],0.3660939714691126
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX4,Syntaxin-4,18490,159,1.42 [1.17-1.73],0.0003764419829838
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX5,Syntaxin-5,15792,137,1.06 [0.71-1.58],0.7874368129271575
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX6,Syntaxin-6,18156,158,1.23 [1.00-1.51],0.0554089970166989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX7,Syntaxin-7,15792,137,1.08 [0.77-1.53],0.6542384294077169
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX8,Syntaxin-8,18533,160,1.55 [1.17-2.06],0.0022305389299562
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STXBP1,Syntaxin-binding protein 1,16246,139,1.06 [0.85-1.32],0.5922924130357967
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STXBP3,Syntaxin-binding protein 3,18156,158,1.28 [0.93-1.76],0.1237990926275173
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUGP1,SURP and G-patch domain-containing protein 1,16196,139,1.34 [0.89-2.01],0.1651959987921157
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUGT1,Protein SGT1 homolog,18156,158,1.09 [0.90-1.31],0.3820433104927152
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SULT1A1,Sulfotransferase 1A1,18723,162,1.09 [0.97-1.22],0.1354570046829476
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SULT2A1,Bile salt sulfotransferase,18533,160,1.43 [1.18-1.74],0.0002989039178303
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUMF1,Formylglycine-generating enzyme,15792,137,1.08 [0.84-1.39],0.5354553088700631
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,18723,162,1.33 [0.99-1.78],0.0550692113544388
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUOX,"Sulfite oxidase, mitochondrial",16246,139,1.36 [1.08-1.72],0.0096381741942333
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD1,Sushi domain-containing protein 1,18206,158,1.10 [0.81-1.49],0.5308331253338314
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD2,Sushi domain-containing protein 2,18585,160,1.82 [1.19-2.80],0.0057202616695508
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD4,Sushi domain-containing protein 4,16206,140,1.06 [0.72-1.56],0.757198896029373
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD5,Sushi domain-containing protein 5,15861,137,0.92 [0.57-1.46],0.7086009087521832
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SV2A,Synaptic vesicle glycoprotein 2A,15834,134,1.27 [1.02-1.60],0.0357304175448926
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SWAP70,Switch-associated protein 70,16196,139,1.19 [0.75-1.87],0.4631636013598897
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYAP1,Synapse-associated protein 1,15945,138,0.89 [0.66-1.21],0.4710521152602502
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,15723,135,1.15 [0.89-1.49],0.271709379224734
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYT1,Synaptotagmin-1,16250,141,1.09 [0.73-1.64],0.6651889944196678
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYTL4,Synaptotagmin-like protein 4,16274,138,1.13 [0.91-1.41],0.2819527098855978
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,15972,137,1.12 [0.95-1.32],0.1787328325658398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TACC3,Transforming acidic coiled-coil-containing protein 3,18490,159,1.00 [0.88-1.13],0.9990053312548174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TACSTD2,Tumor-associated calcium signal transducer 2,16421,136,2.50 [1.68-3.72],5.693908731798916e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TADA3,Transcriptional adapter 3,16206,140,1.20 [0.79-1.81],0.3933393464331747
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAFA5,Chemokine-like protein TAFA-5,18490,159,1.65 [1.17-2.31],0.0040418727902197
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAGLN3,Transgelin-3,15698,138,0.94 [0.71-1.26],0.6883183524770653
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TALDO1,Transaldolase,16209,139,1.20 [0.83-1.75],0.3304815936682684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TANK,TRAF family member-associated NF-kappa-B activator,18225,158,1.06 [0.85-1.31],0.6282034274231041
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAP1,Antigen peptide transporter 1,15972,137,0.89 [0.65-1.23],0.4807688050638186
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TARBP2,RISC-loading complex subunit TARBP2,18150,155,1.18 [0.98-1.43],0.0850791993171447
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",15834,134,1.02 [0.83-1.25],0.8518138083354074
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",16206,140,1.14 [0.72-1.78],0.5774098814003044
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAX1BP1,Tax1-binding protein 1,16250,141,1.32 [1.02-1.70],0.0323906427669796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBC1D17,TBC1 domain family member 17,18150,155,1.20 [0.89-1.62],0.2205665397424114
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBC1D23,TBC1 domain family member 23,18490,159,1.18 [1.00-1.39],0.0454021935013614
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBC1D5,TBC1 domain family member 5,18533,160,1.22 [1.02-1.45],0.0278936959407031
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBCA,Tubulin-specific chaperone A,15945,138,0.97 [0.79-1.19],0.7854462459405726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBCB,Tubulin-folding cofactor B,18398,157,1.13 [0.97-1.31],0.1245356590031173
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBCC,Tubulin-specific chaperone C,18398,157,1.09 [0.91-1.31],0.3635112867153665
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBL1X,F-box-like/WD repeat-containing protein TBL1X,18156,158,1.06 [0.89-1.26],0.5386281556211718
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBR1,T-box brain protein 1,15834,134,1.00 [0.71-1.40],0.9771457935183164
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCL1A,T-cell leukemia/lymphoma protein 1A,18379,157,0.88 [0.76-1.02],0.0856723353062246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCL1B,T-cell leukemia/lymphoma protein 1B,18206,158,1.06 [0.89-1.26],0.5241881977123012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCN1,Transcobalamin-1,15963,138,2.23 [1.58-3.14],5.3784677304766575e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCN2,Transcobalamin-2,18781,163,1.82 [1.22-2.69],0.0030221536404083
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCOF1,Treacle protein,16274,138,1.40 [0.88-2.25],0.1592624208972672
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCP11,T-complex protein 11 homolog,15972,137,1.17 [0.91-1.51],0.2098001619216356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCTN3,Tectonic-3,16274,138,2.43 [1.39-4.26],0.0018054702653132
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDGF1,Teratocarcinoma-derived growth factor 1,18150,155,0.96 [0.87-1.06],0.453634930368083
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDO2,"Tryptophan 2,3-dioxygenase",15834,134,1.25 [0.84-1.85],0.2732150940020452
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDP1,Tyrosyl-DNA phosphodiesterase 1,16206,140,0.92 [0.69-1.21],0.5348118494467256
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDRKH,Tudor and KH domain-containing protein,18150,155,1.25 [1.05-1.49],0.0106900547198228
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEF,Thyrotroph embryonic factor,15718,133,1.10 [0.76-1.60],0.6032758959055391
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEK,Angiopoietin-1 receptor,18648,157,1.33 [0.69-2.55],0.3896545701387434
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TERF1,Telomeric repeat-binding factor 1,15792,137,1.22 [0.67-2.23],0.5225052359093509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TET2,Methylcytosine dioxygenase TET2,15931,137,1.03 [0.87-1.22],0.70960887573789
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEX101,Testis-expressed protein 101,15834,134,1.23 [0.99-1.52],0.0611330052191467
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEX33,Testis-expressed protein 33,15972,137,1.09 [0.79-1.49],0.6043142709711071
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TF,Serotransferrin,16302,138,0.97 [0.44-2.12],0.9406300276523836
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFAP2A,Transcription factor AP-2-alpha,15723,135,1.06 [0.81-1.39],0.6878331564811133
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF1,Trefoil factor 1,18488,159,1.27 [1.09-1.48],0.0026015573747825
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF2,Trefoil factor 2,18629,162,1.70 [1.38-2.09],5.121716095266393e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF3,Trefoil factor 3,18569,159,1.61 [1.27-2.04],9.589333971509652e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI,Tissue factor pathway inhibitor,18548,161,1.22 [0.78-1.91],0.3761447712444291
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,18598,156,1.58 [1.27-1.97],4.394722693065942e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFRC,Transferrin receptor protein 1,18664,159,1.38 [0.98-1.94],0.068645195383382
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TG,Thyroglobulin,16206,140,0.94 [0.81-1.10],0.4428489700575951
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFA,Protransforming growth factor alpha,18533,160,2.01 [1.57-2.58],2.9885806245210954e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFB1,Transforming growth factor beta-1 proprotein,18722,162,2.44 [1.78-3.36],3.8732393418596736e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFB2,Transforming growth factor beta-2 proprotein,16206,140,1.24 [0.92-1.68],0.1490821405773648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBI,Transforming growth factor-beta-induced protein ig-h3,18483,160,1.51 [0.91-2.52],0.1110011572019451
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR1,TGF-beta receptor type-1,15792,137,1.68 [0.88-3.22],0.1169928016164006
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR2,TGF-beta receptor type-2,18648,157,2.39 [1.75-3.28],5.2249578815216854e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR3,Transforming growth factor beta receptor type 3,18801,163,1.68 [1.08-2.59],0.0200373205790223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGM2,Protein-glutamine gamma-glutamyltransferase 2,18560,161,1.05 [0.87-1.27],0.5876197588075749
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGOLN2,Trans-Golgi network integral membrane protein 2,16290,140,2.02 [1.16-3.53],0.0136139543074297
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THAP12,52 kDa repressor of the inhibitor of the protein kinase,15672,138,0.94 [0.76-1.15],0.5278471927449476
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBD,Thrombomodulin,18584,161,1.95 [1.26-3.02],0.0028123016009095
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS2,Thrombospondin-2,18585,160,2.37 [1.79-3.14],1.9417344860499822e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS4,Thrombospondin-4,18604,161,1.46 [1.07-1.97],0.0152382338223338
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THOP1,Thimet oligopeptidase,18489,161,1.06 [0.67-1.66],0.8113596969964637
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THPO,Thrombopoietin,18206,158,0.98 [0.68-1.41],0.9096023416066814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THRAP3,Thyroid hormone receptor-associated protein 3,15718,133,1.14 [0.99-1.30],0.0641111500666057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THSD1,Thrombospondin type-1 domain-containing protein 1,15661,133,1.43 [0.86-2.37],0.1706080320063204
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THTPA,Thiamine-triphosphatase,16185,140,0.85 [0.70-1.03],0.0947427391383865
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THY1,Thy-1 membrane glycoprotein,18723,162,2.01 [1.32-3.08],0.0012329554124315
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIA1,Nucleolysin TIA-1 isoform p40,18000,155,1.11 [0.98-1.25],0.1005123243337166
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIE1,Tyrosine-protein kinase receptor Tie-1,18801,163,1.44 [0.98-2.12],0.065292879654239
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",18121,155,1.36 [1.01-1.83],0.0417047852408372
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,15972,137,0.84 [0.54-1.33],0.4614647756881713
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,18671,161,1.56 [1.16-2.10],0.0034818223280257
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,16274,138,1.20 [0.80-1.79],0.3778934983449754
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,16250,141,1.10 [0.90-1.34],0.3579428107965108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,18389,158,3.32 [2.34-4.72],1.7396689715349543e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP2,Metalloproteinase inhibitor 2,16274,138,1.59 [1.11-2.29],0.0123886672705135
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP3,Metalloproteinase inhibitor 3,18660,162,1.12 [1.02-1.24],0.0240735333014629
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP4,Metalloproteinase inhibitor 4,18585,160,2.16 [1.65-2.82],1.57162932981484e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TINAGL1,Tubulointerstitial nephritis antigen-like,18520,161,2.65 [1.45-4.85],0.0015419004543868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TJAP1,Tight junction-associated protein 1,18648,157,1.07 [0.89-1.28],0.4645080787465494
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TJP3,Tight junction protein ZO-3,15723,135,1.47 [1.07-2.03],0.0190297404106598
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TK1,"Thymidine kinase, cytosolic",15972,137,0.97 [0.66-1.42],0.8748310732614283
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR1,Toll-like receptor 1,15792,137,1.72 [0.93-3.20],0.0842228880717965
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR2,Toll-like receptor 2,15972,137,1.80 [0.86-3.76],0.1204459243458307
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR3,Toll-like receptor 3,18753,162,1.01 [0.81-1.28],0.9015386032339608
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR4,Toll-like receptor 4,15792,137,1.76 [1.04-2.99],0.0367673175379556
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,15834,134,1.08 [0.78-1.49],0.6386642143926125
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMED1,Transmembrane emp24 domain-containing protein 1,15972,137,0.99 [0.73-1.36],0.9730872586803188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMED10,Transmembrane emp24 domain-containing protein 10,15718,133,0.78 [0.48-1.26],0.3085732407380998
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMED4,Transmembrane emp24 domain-containing protein 4,15718,133,1.11 [0.83-1.49],0.4746994613114513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMED8,Protein TMED8,16196,139,1.11 [0.94-1.31],0.2199418599328403
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMEM106A,Transmembrane protein 106A,16206,140,1.03 [0.82-1.30],0.7758855634373526
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMEM132A,Transmembrane protein 132A,15876,134,1.75 [1.39-2.20],1.8855935517677217e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMEM25,Transmembrane protein 25,16246,139,1.25 [0.90-1.73],0.1900785253510492
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMOD4,Tropomodulin-4,15698,138,1.26 [0.86-1.85],0.2410282186326343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS11B,Transmembrane protease serine 11B,15723,135,0.96 [0.76-1.20],0.7000644718714029
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS11D,Transmembrane protease serine 11D,16227,141,1.86 [1.32-2.62],0.000357002816608
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS15,Enteropeptidase,18490,159,0.85 [0.72-0.99],0.0394533053576103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS5,Transmembrane protease serine 5,18319,156,0.91 [0.62-1.34],0.6472830701013361
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMSB10,Thymosin beta-10,18585,160,1.22 [1.01-1.48],0.0435394481061642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNC,Tenascin,18671,161,1.93 [1.47-2.54],2.5182988708354646e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNF,Tumor necrosis factor,18187,158,1.50 [1.11-2.01],0.0076527048005396
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,16196,139,1.41 [1.03-1.93],0.0304722529961797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,18225,158,0.86 [0.57-1.30],0.4707770041351465
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,15945,138,0.87 [0.65-1.15],0.3202677040253479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,18398,157,2.75 [2.03-3.73],7.852321554141656e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,18398,157,1.64 [1.38-1.95],1.639350062933469e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,18642,163,1.29 [0.96-1.72],0.0875815201375096
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,18753,162,1.95 [1.45-2.61],7.749453392098926e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,18581,162,2.98 [1.97-4.49],2.207696228125184e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,18648,157,2.47 [1.79-3.40],3.0409556343015405e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,18607,162,1.59 [1.20-2.12],0.0014854235658357
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,18225,158,0.76 [0.53-1.08],0.1203480153003768
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,18607,162,2.99 [2.07-4.30],4.342903540136509e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,15945,138,1.72 [1.20-2.48],0.0033381745104581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,18723,163,2.03 [1.45-2.84],4.014414919953944e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,18585,160,2.94 [2.08-4.16],9.57279034062578e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,18585,160,1.82 [1.46-2.26],6.875810793442339e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,18723,162,2.49 [1.57-3.97],0.0001190079582403
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,18722,162,2.04 [1.50-2.77],4.9878993747539e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,18398,157,1.74 [1.42-2.13],1.1812329714197385e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,18723,162,1.27 [0.95-1.69],0.1014504507772569
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,18398,157,1.64 [1.29-2.09],6.0356196424121735e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF10,Tumor necrosis factor ligand superfamily member 10,18753,162,0.47 [0.28-0.80],0.0055787139175377
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF11,Tumor necrosis factor ligand superfamily member 11,18533,160,0.79 [0.63-1.00],0.049662184654736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF12,Tumor necrosis factor ligand superfamily member 12,18753,162,0.42 [0.26-0.68],0.0004375180273317
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,18660,162,3.84 [2.39-6.17],2.506573451955668e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,18774,163,1.97 [1.34-2.91],0.0005927339960871
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF14,Tumor necrosis factor ligand superfamily member 14,18398,157,1.36 [1.07-1.73],0.012405830207059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF8,Tumor necrosis factor ligand superfamily member 8,16282,139,1.91 [1.29-2.83],0.0013094661250439
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNIP1,TNFAIP3-interacting protein 1,16250,141,1.16 [0.96-1.40],0.1318340954096373
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNN,Tenascin-N,16282,139,0.72 [0.49-1.05],0.0894081179977057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNNI3,"Troponin I, cardiac muscle",18206,158,1.12 [0.95-1.34],0.1863653518498501
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNPO1,Transportin-1,15972,137,0.80 [0.48-1.33],0.3867690458007795
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNR,Tenascin-R,18398,157,0.56 [0.40-0.77],0.0004155546110781
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNXB,Tenascin-X,18585,160,1.01 [0.57-1.77],0.9825636556578726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,16274,138,1.25 [1.02-1.53],0.0315044848360385
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOP1,DNA topoisomerase 1,16196,139,1.19 [1.03-1.37],0.0205232202738424
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOP1MT,"DNA topoisomerase I, mitochondrial",15698,138,0.85 [0.57-1.26],0.4076097968061901
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOP2B,DNA topoisomerase 2-beta,15792,137,1.07 [0.86-1.33],0.5258408167388517
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOR1AIP1,Torsin-1A-interacting protein 1,15876,134,1.10 [0.79-1.54],0.5644474697560902
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53,Cellular tumor antigen p53,18156,158,1.15 [0.81-1.62],0.4437004520910366
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53BP1,TP53-binding protein 1,15792,137,1.07 [0.87-1.31],0.5098581954016932
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53I3,Quinone oxidoreductase PIG3,15602,135,1.23 [0.89-1.70],0.2006502979161228
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53INP1,Tumor protein p53-inducible nuclear protein 1,18206,158,1.11 [0.72-1.71],0.6393199025759884
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP73,Tumor protein p73,15834,134,1.03 [0.62-1.70],0.918176158445928
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPBGL,Trophoblast glycoprotein-like,15834,134,1.19 [0.81-1.75],0.3719734454851975
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPD52L2,Tumor protein D54,15945,138,1.01 [0.86-1.19],0.8598144497481451
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPK1,Thiamin pyrophosphokinase 1,16274,138,1.05 [0.58-1.90],0.8786946776940883
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPM3,Tropomyosin alpha-3 chain,15718,133,1.09 [0.74-1.59],0.6685086030761368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPMT,Thiopurine S-methyltransferase,18156,158,1.00 [0.82-1.22],0.9914067526519476
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPP1,Tripeptidyl-peptidase 1,18458,161,1.98 [1.56-2.52],2.4929791007519004e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPPP2,Tubulin polymerization-promoting protein family member 2,15972,137,0.88 [0.70-1.11],0.2833872242457845
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPPP3,Tubulin polymerization-promoting protein family member 3,18150,155,0.86 [0.57-1.30],0.4766927796637346
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPR,Nucleoprotein TPR,15718,133,1.15 [0.84-1.58],0.3836954012553077
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPRKB,EKC/KEOPS complex subunit TPRKB,15698,138,0.98 [0.75-1.29],0.8821956032622074
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPSAB1,Tryptase alpha/beta-1,18724,162,0.78 [0.59-1.03],0.0857546788452087
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPSD1,Tryptase delta,16246,139,1.14 [0.74-1.76],0.5639981036608477
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPSG1,Tryptase gamma,15792,137,1.01 [0.52-1.97],0.981359393777409
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPT1,Translationally-controlled tumor protein,18225,158,0.84 [0.65-1.09],0.1937448618196807
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRAF2,TNF receptor-associated factor 2,18533,160,0.92 [0.74-1.13],0.4132880257077781
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRAF3,"TNF receptor-associated factor 3, Isoform 2",15792,137,0.75 [0.45-1.27],0.2826359301230768
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,15718,133,1.00 [0.69-1.44],0.9928759790428118
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,15972,137,1.27 [1.09-1.48],0.0026364382860844
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREH,Trehalase,16282,139,0.78 [0.62-0.97],0.0270138087970953
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREM2,Triggering receptor expressed on myeloid cells 2,18581,162,1.40 [1.08-1.81],0.0100008708498012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREML1,Trem-like transcript 1 protein,16290,140,1.14 [0.84-1.55],0.409993965867186
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREML2,Trem-like transcript 2 protein,18585,160,0.79 [0.53-1.19],0.264420605212133
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIAP1,TP53-regulated inhibitor of apoptosis 1,18723,163,1.38 [1.10-1.74],0.0060516368921618
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM21,E3 ubiquitin-protein ligase TRIM21,18533,160,0.98 [0.81-1.18],0.828585810042553
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM24,Transcription intermediary factor 1-alpha,15944,137,1.23 [0.96-1.59],0.0993175025792604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,16196,139,1.10 [0.94-1.29],0.237377483191167
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM26,Tripartite motif-containing protein 26,15698,138,0.97 [0.72-1.33],0.8685962417064546
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM40,E3 ubiquitin ligase TRIM40,15834,134,1.09 [0.86-1.39],0.4709501978399567
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM5,Tripartite motif-containing protein 5,18533,160,1.04 [0.87-1.23],0.6717483613126686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM58,E3 ubiquitin-protein ligase TRIM58,16206,140,1.12 [0.92-1.35],0.2690899492547826
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRPV3,Transient receptor potential cation channel subfamily V member 3,15718,133,0.99 [0.69-1.42],0.96907449744752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSC1,Hamartin,15792,137,0.93 [0.71-1.23],0.6304789839411852
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSC22D1,TSC22 domain family protein 1,16246,139,1.27 [1.01-1.60],0.0437230790852413
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSHB,Thyrotropin subunit beta,18584,161,0.94 [0.79-1.13],0.5320674327456348
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSLP,Thymic stromal lymphopoietin,18206,158,1.18 [0.96-1.45],0.1102342390401693
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSNAX,Translin-associated protein X,15718,133,1.06 [0.68-1.65],0.8105914018674903
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN1,Tetraspanin-1,18206,158,0.86 [0.69-1.07],0.1824654340192226
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN15,Tetraspanin-15,15718,133,0.95 [0.68-1.35],0.7855261568509513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN7,Tetraspanin-7,15723,135,0.97 [0.80-1.19],0.8012977978672853
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN8,Tetraspanin-8,16196,139,1.32 [1.13-1.55],0.0004075868481015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPYL1,Testis-specific Y-encoded-like protein 1,15792,137,0.97 [0.62-1.51],0.8908223275186292
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TST,Thiosulfate sulfurtransferase,18110,155,1.28 [1.05-1.55],0.0145968335276029
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TTF2,Transcription termination factor 2,15834,134,1.27 [0.90-1.80],0.1778620526288692
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TTN,Titin,15718,133,1.07 [0.81-1.40],0.6386926257772079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TTR,Transthyretin,16127,136,0.14 [0.08-0.25],1.3291893182387702e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TUBB3,Tubulin beta-3 chain,15723,135,1.71 [0.95-3.07],0.0727535089345373
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TWF2,Twinfilin-2,16282,139,1.10 [0.90-1.34],0.3560761847112405
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXK,Tyrosine-protein kinase TXK,15972,137,0.88 [0.68-1.13],0.314611533560229
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXLNA,Alpha-taxilin,18398,157,1.16 [0.98-1.38],0.083226983696556
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXN,Thioredoxin,16027,137,1.01 [0.69-1.47],0.9520079040663472
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC15,Thioredoxin domain-containing protein 15,18648,157,3.76 [2.32-6.09],7.478924318009853e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC5,Thioredoxin domain-containing protein 5,18723,162,1.54 [1.25-1.88],3.102704187340567e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC9,Thioredoxin domain-containing protein 9,16250,141,1.13 [0.82-1.54],0.4591888363030971
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNL1,Thioredoxin-like protein 1,15689,134,1.03 [0.85-1.23],0.78003876382135
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",18585,160,1.16 [0.85-1.59],0.3521495902132839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYMP,Thymidine phosphorylase,18455,158,1.32 [1.06-1.65],0.0138244131966773
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYRO3,Tyrosine-protein kinase receptor TYRO3,18584,161,1.17 [0.71-1.93],0.5271959452412198
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",15792,137,1.06 [0.81-1.38],0.6889301831588869
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBAC1,Ubiquitin-associated domain-containing protein 1,18490,159,0.99 [0.66-1.49],0.9629410619374796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBE2B,Ubiquitin-conjugating enzyme E2 B,16206,140,1.31 [0.73-2.37],0.3700497759322044
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,16274,138,1.37 [1.04-1.80],0.0255697446842502
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,15792,137,0.91 [0.66-1.26],0.5795635068702462
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBQLN3,Ubiquilin-3,15718,133,1.38 [1.09-1.75],0.0065083385967157
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBXN1,UBX domain-containing protein 1,15945,138,0.99 [0.77-1.27],0.9082603869637228
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,16196,139,1.02 [0.90-1.15],0.7849523148668787
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UGDH,UDP-glucose 6-dehydrogenase,15718,133,1.08 [0.91-1.29],0.3788365564097586
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UHRF2,E3 ubiquitin-protein ligase UHRF2,15718,133,1.16 [0.72-1.87],0.5322828021153105
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ULBP2,UL16-binding protein 2,18398,157,2.12 [1.55-2.90],2.8427549091721886e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UMOD,Uromodulin,18748,163,0.53 [0.42-0.66],7.67385851471465e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UNC5D,Netrin receptor UNC5D,15792,137,1.16 [0.59-2.27],0.6733902005603662
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UNC79,Protein unc-79 homolog,15698,138,1.05 [0.77-1.44],0.7488924970002571
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UNG,Uracil-DNA glycosylase,16206,140,1.77 [1.14-2.76],0.0113832878270338
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UPB1,Beta-ureidopropionase,16274,138,1.11 [0.93-1.33],0.2452843989011559
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UPK3A,Uroplakin-3a,15723,135,1.13 [0.81-1.56],0.4826384674184054
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UPK3BL1,Uroplakin-3b-like protein 1,15935,137,1.24 [0.96-1.60],0.0986279015712078
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UROD,Uroporphyrinogen decarboxylase,15945,138,0.89 [0.69-1.14],0.354491829818092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UROS,Uroporphyrinogen-III synthase,15834,134,1.00 [0.78-1.29],0.9934842635572696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USO1,General vesicular transport factor p115,18490,159,1.21 [1.03-1.42],0.0223893797038876
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP25,Ubiquitin carboxyl-terminal hydrolase 25,16206,140,1.06 [0.84-1.35],0.6136197374707894
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP28,Ubiquitin carboxyl-terminal hydrolase 28,16250,141,1.36 [0.93-1.97],0.1083502505471107
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP47,Ubiquitin carboxyl-terminal hydrolase 47,15718,133,1.03 [0.84-1.26],0.7846844504066257
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP8,Ubiquitin carboxyl-terminal hydrolase 8,18206,158,1.06 [0.91-1.24],0.4592981362108984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UXS1,UDP-glucuronic acid decarboxylase 1,18156,158,1.13 [0.87-1.46],0.3579885497221465
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAMP5,Vesicle-associated membrane protein 5,18206,158,1.51 [1.25-1.82],1.4819454755035732e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAMP8,Vesicle-associated membrane protein 8,15792,137,1.20 [0.99-1.46],0.065002712262401
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VASH1,Tubulinyl-Tyr carboxypeptidase 1,18533,160,0.97 [0.81-1.16],0.7424773600528473
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VASN,Vasorin,18281,156,0.69 [0.40-1.17],0.1669683457129998
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VASP,Vasodilator-stimulated phosphoprotein,16290,140,1.01 [0.80-1.27],0.96540747341571
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,18490,159,0.59 [0.28-1.24],0.1662774060230544
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAV3,Guanine nucleotide exchange factor VAV3,15723,135,1.01 [0.85-1.21],0.879718473769989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCAM1,Vascular cell adhesion protein 1,18634,161,2.54 [1.64-3.95],3.3419179462746665e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCAN,Versican core protein,18723,162,2.02 [1.29-3.15],0.0020834165010203
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCPKMT,Protein-lysine methyltransferase METTL21D,15698,138,1.12 [0.94-1.33],0.2008502219697349
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFA,Vascular endothelial growth factor A,18696,162,1.55 [1.24-1.93],0.0001017331268187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFB,Vascular endothelial growth factor B,15792,137,5.19 [3.08-8.74],5.897970529621354e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFC,Vascular endothelial growth factor C,18648,157,1.06 [0.82-1.37],0.6614679334927986
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFD,Vascular endothelial growth factor D,18725,162,1.19 [0.82-1.74],0.3626717714959113
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VGF,Neurosecretory protein VGF,16246,139,0.75 [0.45-1.26],0.2745442281743653
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VIM,Vimentin,18206,158,1.07 [0.93-1.23],0.3605110843702792
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VIPR1,Vasoactive intestinal polypeptide receptor 1,15876,134,1.01 [0.48-2.12],0.983526151157033
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VIT,Vitrin,16274,138,2.21 [1.49-3.29],7.707710168026114e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VMO1,Vitelline membrane outer layer protein 1 homolog,18490,159,1.06 [0.85-1.31],0.6236904070780873
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VNN1,Pantetheinase,16290,140,1.09 [0.86-1.39],0.4563412695755837
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VNN2,Vascular non-inflammatory molecule 2,18490,159,1.87 [1.33-2.63],0.0003199335007179
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VPS28,Vacuolar protein sorting-associated protein 28 homolog,15972,137,1.07 [0.82-1.38],0.6279951253889253
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VPS37A,Vacuolar protein sorting-associated protein 37A,18490,159,0.99 [0.82-1.19],0.907621745730464
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VPS4B,Vacuolar protein sorting-associated protein 4B,16206,140,0.93 [0.78-1.12],0.4529581873799503
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VPS53,Vacuolar protein sorting-associated protein 53 homolog,18490,159,1.12 [0.93-1.35],0.2208651165304924
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG10,V-set and immunoglobulin domain-containing protein 10,16206,140,1.47 [0.99-2.19],0.0574946033223759
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,15718,133,1.68 [1.08-2.61],0.0211322996921147
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,16206,140,1.72 [1.40-2.10],1.3237863573451854e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,18562,159,2.14 [1.62-2.84],1.1392793522623093e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,18554,161,1.37 [1.10-1.69],0.0042497487399282
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSNL1,Visinin-like protein 1,16250,141,1.60 [1.11-2.31],0.0109364055277767
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSTM1,V-set and transmembrane domain-containing protein 1,18150,155,1.24 [0.93-1.65],0.1490104312200695
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSTM2B,V-set and transmembrane domain-containing protein 2B,15972,137,1.13 [0.76-1.68],0.5313861003133107
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,18206,158,0.99 [0.76-1.28],0.9107549854732256
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,18723,162,1.13 [0.93-1.39],0.2167125122070655
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VTCN1,V-set domain-containing T-cell activation inhibitor 1,18156,158,1.75 [1.17-2.60],0.0059080422815388
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,15945,138,1.27 [0.96-1.69],0.0955730447919193
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWA1,von Willebrand factor A domain-containing protein 1,18693,163,2.40 [1.75-3.29],5.1680764338419655e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWA5A,von Willebrand factor A domain-containing protein 5A,15698,138,1.26 [1.08-1.48],0.0041831726947979
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWC2,Brorin,18339,157,0.97 [0.68-1.37],0.8500202675004753
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWC2L,von Willebrand factor C domain-containing protein 2-like,16246,139,0.68 [0.43-1.07],0.0936790640158055
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWF,von Willebrand factor,18801,163,1.32 [1.09-1.60],0.003978034988772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WARS,"Tryptophan--tRNA ligase, cytoplasmic",18585,160,1.70 [1.17-2.47],0.005244994562298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WAS,Wiskott-Aldrich syndrome protein,18225,158,1.06 [0.85-1.32],0.6276169352660962
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASF1,Wiskott-Aldrich syndrome protein family member 1,18206,158,1.17 [1.00-1.36],0.0493148651449648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASF3,Wiskott-Aldrich syndrome protein family member 3,18150,155,1.00 [0.84-1.20],0.9596514952813064
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASHC3,WASH complex subunit 3,16250,141,1.17 [0.94-1.45],0.1649130309020779
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASL,Neural Wiskott-Aldrich syndrome protein,15792,137,0.99 [0.74-1.34],0.9673406428095148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WDR46,WD repeat-containing protein 46,16206,140,1.00 [0.61-1.63],0.9891314605480392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC1,WAP four-disulfide core domain protein 1,15884,139,1.23 [0.96-1.58],0.1043555607997979
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC12,WAP four-disulfide core domain protein 12,18694,162,1.62 [1.35-1.95],3.494828796506668e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,17672,144,2.55 [2.00-3.26],4.160603543200688e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",18330,156,0.51 [0.37-0.70],3.177532182412566e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",18607,162,1.34 [0.89-2.01],0.155267930645403
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WIF1,Wnt inhibitory factor 1,18723,163,1.48 [1.01-2.17],0.0465203242256312
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WNT9A,Protein Wnt-9a,18225,158,2.15 [1.45-3.18],0.0001328230979222
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,18398,157,1.06 [0.80-1.41],0.6641820870617938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XCL1,Lymphotactin,18723,163,1.38 [1.11-1.71],0.0040731357347509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XG,Glycoprotein Xg,18723,163,0.70 [0.52-0.96],0.0242559486685704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XIAP,E3 ubiquitin-protein ligase XIAP,15792,137,1.19 [0.88-1.60],0.2623983528762876
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XPNPEP2,Xaa-Pro aminopeptidase 2,18648,157,0.86 [0.75-0.99],0.0368700827355281
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XRCC4,DNA repair protein XRCC4,18150,155,1.50 [1.04-2.16],0.0286125902492311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YAP1,Transcriptional coactivator YAP1,16250,141,2.04 [1.29-3.20],0.0021112441618639
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",16196,139,1.12 [0.99-1.26],0.0690562639349152
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YES1,Tyrosine-protein kinase Yes,18490,159,1.10 [0.97-1.26],0.1355341343416668
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YJU2,Splicing factor YJU2,16206,140,1.15 [0.69-1.92],0.587775024708062
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YOD1,Ubiquitin thioesterase OTU1,15718,133,0.84 [0.64-1.11],0.2173954056337668
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YTHDF3,YTH domain-containing family protein 3,18225,158,1.08 [0.90-1.28],0.4130117266288452
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YWHAQ,14-3-3 protein theta,15945,138,1.02 [0.81-1.29],0.8811793545743604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YY1,Transcriptional repressor protein YY1,15792,137,0.70 [0.37-1.31],0.2632506050329953
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBP1,Z-DNA-binding protein 1,15792,137,0.98 [0.62-1.56],0.9409163470119204
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBTB16,Zinc finger and BTB domain-containing protein 16,18156,158,1.11 [0.91-1.36],0.3107978804813661
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBTB17,Zinc finger and BTB domain-containing protein 17,18206,158,1.73 [1.38-2.17],1.953035897859318e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZCCHC8,Zinc finger CCHC domain-containing protein 8,15718,133,1.07 [0.82-1.40],0.6047415384571159
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZFYVE19,Abscission/NoCut checkpoint regulator,16196,139,0.98 [0.81-1.19],0.8378205295861211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZHX2,Zinc fingers and homeoboxes protein 2,16250,141,0.88 [0.50-1.57],0.6745327698128629
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNF174,Zinc finger protein 174,15792,137,1.16 [0.75-1.79],0.5099812587277547
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNF75D,Zinc finger protein 75D,15972,137,1.06 [0.83-1.35],0.6488342011474328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNF830,Zinc finger protein 830,16206,140,1.01 [0.81-1.26],0.9193645973306466
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNRD2,Protein ZNRD2,16196,139,1.23 [0.98-1.54],0.0778694465507903
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,16206,140,0.96 [0.71-1.32],0.8163726997537182
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZP3,Zona pellucida sperm-binding protein 3,15876,134,0.99 [0.93-1.06],0.8276356477125546
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZP4,Zona pellucida sperm-binding protein 4,15698,138,1.33 [0.91-1.96],0.1447978985709981
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZPR1,Zinc finger protein ZPR1,15723,135,1.00 [0.83-1.19],0.962145777839163
